Title,URL,Description,Details,ShortDetails,Resource,Type,Identifiers,Db,EntrezUID,Properties
"Hepatitis B virus large surface protein is priming for hepatocellular carcinoma development via induction of cytokinesis failure.","/pubmed/30246253","Musa J, Li J, Grünewald TGP.","J Pathol. 2018 Sep 23. doi: 10.1002/path.5169. [Epub ahead of print]","J Pathol.  2018","PubMed","citation","PMID:30246253","pubmed","30246253","create date:2018/09/25 | first author:Musa J",
"Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.","/pubmed/30242316","Wang DY, Salem JE, Cohen JV, Chandra S, Menzer C, Ye F, Zhao S, Das S, Beckermann KE, Ha L, Rathmell WK, Ancell KK, Balko JM, Bowman C, Davis EJ, Chism DD, Horn L, Long GV, Carlino MS, Lebrun-Vignes B, Eroglu Z, Hassel JC, et al.","JAMA Oncol. 2018 Sep 13. doi: 10.1001/jamaoncol.2018.3923. [Epub ahead of print]","JAMA Oncol.  2018","PubMed","citation","PMID:30242316","pubmed","30242316","create date:2018/09/23 | first author:Wang DY",
"Size Matters: Dissecting Key Parameters for Panel-Based Tumor Mutational Burden (TMB) Analysis.","/pubmed/30238975","Buchhalter I, Rempel E, Endris V, Allgäuer M, Neumann O, Volckmar AL, Kirchner M, Leichsenring J, Lier A, von Winterfeld M, Penzel R, Christopoulos P, Thomas M, Fröhling S, Schirmacher P, Budczies J, Stenzinger A.","Int J Cancer. 2018 Sep 21. doi: 10.1002/ijc.31878. [Epub ahead of print]","Int J Cancer.  2018","PubMed","citation","PMID:30238975","pubmed","30238975","create date:2018/09/22 | first author:Buchhalter I",
"Melanoma.","/pubmed/30238891","Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, Stang A, Roesch A, Ugurel S.","Lancet. 2018 Sep 15;392(10151):971-984. doi: 10.1016/S0140-6736(18)31559-9. Review.","Lancet.  2018","PubMed","citation","PMID:30238891","pubmed","30238891","create date:2018/09/22 | first author:Schadendorf D",
"The novel immunoglobulin super family receptor SLAMF9 identified in TAM of murine and human melanoma influences pro-inflammatory cytokine secretion and migration.","/pubmed/30232321","Dollt C, Michel J, Kloss L, Melchers S, Schledzewski K, Becker K, Sauer A, Krewer A, Koll F, Schmieder A.","Cell Death Dis. 2018 Sep 19;9(10):939. doi: 10.1038/s41419-018-1011-1.","Cell Death Dis.  2018","PubMed","citation","PMID:30232321 | PMCID:PMC6145869","pubmed","30232321","create date:2018/09/21 | first author:Dollt C",
"Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas.","/pubmed/30231561","Poggio T, Duyster J, Illert AL.","Cancers (Basel). 2018 Sep 18;10(9). pii: E339. doi: 10.3390/cancers10090339. Review.","Cancers (Basel).  2018","PubMed","citation","PMID:30231561 | PMCID:PMC6162531","pubmed","30231561","create date:2018/09/21 | first author:Poggio T",
"Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonists.","/pubmed/30196908","Stein A, Markus M, Jörg T, Eray G, Vogel A.","Crit Rev Oncol Hematol. 2018 Oct;130:13-26. doi: 10.1016/j.critrevonc.2018.07.001. Epub 2018 Jul 11. Review.","Crit Rev Oncol Hematol.  2018","PubMed","citation","PMID:30196908","pubmed","30196908","create date:2018/09/11 | first author:Stein A",
"POLE gene hotspot mutations in advanced pancreatic cancer.","/pubmed/30194485","Guenther M, Veninga V, Kumbrink J, Haas M, Westphalen CB, Kruger S, Heinemann V, Kirchner T, Boeck S, Jung A, Ormanns S.","J Cancer Res Clin Oncol. 2018 Sep 7. doi: 10.1007/s00432-018-2746-x. [Epub ahead of print]","J Cancer Res Clin Oncol.  2018","PubMed","citation","PMID:30194485","pubmed","30194485","create date:2018/09/09 | first author:Guenther M",
"microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-associated Protein 1 to Suppress Hepatocarcinogenesis.","/pubmed/30165047","Roy S, Hooiveld GJ, Seehawer M, Caruso S, Heinzmann F, Schneider AT, Frank AK, Cardenas DV, Sonntag R, Luedde M, Trautwein C, Stein I, Pikarsky E, Loosen S, Tacke F, Ringelhan M, Avsaroglu SK, Goga A, Buendia MA, Vucur M, Heikenwalder M, Zucman-Rossi J, et al.","Gastroenterology. 2018 Aug 27. pii: S0016-5085(18)34918-7. doi: 10.1053/j.gastro.2018.08.032. [Epub ahead of print]","Gastroenterology.  2018","PubMed","citation","PMID:30165047","pubmed","30165047","create date:2018/08/31 | first author:Roy S",
"Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults.","/pubmed/30155920","McGee EE, Castro FA, Engels EA, Freedman ND, Pfeiffer RM, Nogueira L, Stolzenberg-Solomon R, McGlynn KA, Hemminki K, Koshiol J.","Int J Cancer. 2018 Aug 28. doi: 10.1002/ijc.31835. [Epub ahead of print]","Int J Cancer.  2018","PubMed","citation","PMID:30155920","pubmed","30155920","create date:2018/08/30 | first author:McGee EE",
"Primary leiomyosarcoma of the skin: a comprehensive review on diagnosis and treatment.","/pubmed/30140957","Zacher M, Heppt MV, Brinker TJ, Hayani KM, Flaig MJ, Berking C.","Med Oncol. 2018 Aug 23;35(10):135. doi: 10.1007/s12032-018-1196-2. Review.","Med Oncol.  2018","PubMed","citation","PMID:30140957","pubmed","30140957","create date:2018/08/25 | first author:Zacher M",
"Molecular imaging of T cell co-regulator factor B7-H3 with (89)Zr-DS-5573a.","/pubmed/30128047","Burvenich IJG, Parakh S, Lee FT, Guo N, Liu Z, Gan HK, Rigopoulos A, O'Keefe GJ, Gong SJ, Goh YW, Tochon-Danguy H, Scott FE, Kotsuma M, Hirotani K, Senaldi G, Scott AM.","Theranostics. 2018 Jul 30;8(15):4199-4209. doi: 10.7150/thno.25575. eCollection 2018.","Theranostics.  2018","PubMed","citation","PMID:30128047 | PMCID:PMC6096400","pubmed","30128047","create date:2018/08/22 | first author:Burvenich IJG",
"Patient-reported outcomes with nivolumab in advanced solid cancers.","/pubmed/30125799","Tykodi SS, Schadendorf D, Cella D, Reck M, Harrington K, Wagner S, Shaw JW.","Cancer Treat Rev. 2018 Aug 2;70:75-87. doi: 10.1016/j.ctrv.2018.08.001. [Epub ahead of print] Review.","Cancer Treat Rev.  2018","PubMed","citation","PMID:30125799","pubmed","30125799","create date:2018/08/21 | first author:Tykodi SS",
"Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET-CT.","/pubmed/30123922","Dimitrakopoulou-Strauss A.","Cancer Immunol Immunother. 2018 Aug 19. doi: 10.1007/s00262-018-2229-6. [Epub ahead of print] Review.","Cancer Immunol Immunother.  2018","PubMed","citation","PMID:30123922","pubmed","30123922","create date:2018/08/21 | first author:Dimitrakopoulou-Strauss A",
"Treatment of glioblastoma in adults.","/pubmed/30083233","Wick W, Osswald M, Wick A, Winkler F.","Ther Adv Neurol Disord. 2018 Jul 25;11:1756286418790452. doi: 10.1177/1756286418790452. eCollection 2018. Review.","Ther Adv Neurol Disord.  2018","PubMed","citation","PMID:30083233 | PMCID:PMC6071154","pubmed","30083233","create date:2018/08/08 | first author:Wick W",
"Ibrutinib.","/pubmed/30069629","Charalambous A, Schwarzbich MA, Witzens-Harig M.","Recent Results Cancer Res. 2018;212:133-168. doi: 10.1007/978-3-319-91439-8_7.","Recent Results Cancer Res.  2018","PubMed","citation","PMID:30069629","pubmed","30069629","create date:2018/08/03 | first author:Charalambous A",
"BRAF Mutations-A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC?","/pubmed/30056857","Arulananda S, Mitchell P.","J Thorac Oncol. 2018 Aug;13(8):1055-1057. doi: 10.1016/j.jtho.2018.06.002. Epub 2018 Jul 2. No abstract available. ","J Thorac Oncol.  2018","PubMed","citation","PMID:30056857","pubmed","30056857","create date:2018/07/31 | first author:Arulananda S",
"Mismatch Repair Protein Defects and Microsatellite Instability in Malignant Pleural Mesothelioma.","/pubmed/30056163","Arulananda S, Thapa B, Walkiewicz M, Zapparoli GV, Williams DS, Dobrovic A, John T.","J Thorac Oncol. 2018 Oct;13(10):1588-1594. doi: 10.1016/j.jtho.2018.07.015. Epub 2018 Jul 26.","J Thorac Oncol.  2018","PubMed","citation","PMID:30056163","pubmed","30056163","create date:2018/07/30 | first author:Arulananda S",
"Phase 3, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment for patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.","/pubmed/30052729","Bang YJ, Ruiz EY, Van Cutsem E, Lee KW, Wyrwicz L, Schenker M, Alsina M, Ryu MH, Chung HC, Evesque L, Al-Batran SE, Park SH, Lichinitser M, Boku N, Moehler MH, Hong J, Xiong H, Hallwachs R, Conti I, Taieb J.","Ann Oncol. 2018 Jul 24. doi: 10.1093/annonc/mdy264. [Epub ahead of print]","Ann Oncol.  2018","PubMed","citation","PMID:30052729","pubmed","30052729","create date:2018/07/28 | first author:Bang YJ",
"Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma.","/pubmed/30042403","Halse H, Colebatch AJ, Petrone P, Henderson MA, Mills JK, Snow H, Westwood JA, Sandhu S, Raleigh JM, Behren A, Cebon J, Darcy PK, Kershaw MH, McArthur GA, Gyorki DE, Neeson PJ.","Sci Rep. 2018 Jul 24;8(1):11158. doi: 10.1038/s41598-018-28944-3.","Sci Rep.  2018","PubMed","citation","PMID:30042403 | PMCID:PMC6057961","pubmed","30042403","create date:2018/07/26 | first author:Halse H",
"Radiotherapy, tumor mutational burden, and immune checkpoint inhibitors: time to do the math.","/pubmed/30030581","Giordano FA, Veldwijk MR, Herskind C, Wenz F.","Strahlenther Onkol. 2018 Oct;194(10):873-875. doi: 10.1007/s00066-018-1341-z. Epub 2018 Jul 20. No abstract available. ","Strahlenther Onkol.  2018","PubMed","citation","PMID:30030581","pubmed","30030581","create date:2018/07/22 | first author:Giordano FA",
"Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells.","/pubmed/30024314","Stock S, Hoffmann JM, Schubert ML, Wang L, Wang S, Gong W, Neuber B, Gern U, Schmitt A, Müller-Tidow C, Dreger P, Schmitt M, Sellner L.","Hum Gene Ther. 2018 Oct;29(10):1167-1182. doi: 10.1089/hum.2017.237. Epub 2018 Sep 5.","Hum Gene Ther.  2018","PubMed","citation","PMID:30024314","pubmed","30024314","create date:2018/07/20 | first author:Stock S",
"Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and Beyond.","/pubmed/30002656","Buder-Bakhaya K, Hassel JC.","Front Immunol. 2018 Jun 28;9:1474. doi: 10.3389/fimmu.2018.01474. eCollection 2018. Review.","Front Immunol.  2018","PubMed","citation","PMID:30002656 | PMCID:PMC6031714","pubmed","30002656","create date:2018/07/14 | first author:Buder-Bakhaya K",
"Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate.","/pubmed/29988124","Bunse L, Pusch S, Bunse T, Sahm F, Sanghvi K, Friedrich M, Alansary D, Sonner JK, Green E, Deumelandt K, Kilian M, Neftel C, Uhlig S, Kessler T, von Landenberg A, Berghoff AS, Marsh K, Steadman M, Zhu D, Nicolay B, Wiestler B, Breckwoldt MO, et al.","Nat Med. 2018 Aug;24(8):1192-1203. doi: 10.1038/s41591-018-0095-6. Epub 2018 Jul 9.","Nat Med.  2018","PubMed","citation","PMID:29988124","pubmed","29988124","create date:2018/07/11 | first author:Bunse L",
"Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors.","/pubmed/29942309","Weber R, Fleming V, Hu X, Nagibin V, Groth C, Altevogt P, Utikal J, Umansky V.","Front Immunol. 2018 Jun 11;9:1310. doi: 10.3389/fimmu.2018.01310. eCollection 2018. Review.","Front Immunol.  2018","PubMed","citation","PMID:29942309 | PMCID:PMC6004385","pubmed","29942309","create date:2018/06/27 | first author:Weber R",
"Cytokine release syndrome.","/pubmed/29907163","Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, Schlößer HA, Schlaak M, Kochanek M, Böll B, von Bergwelt-Baildon MS.","J Immunother Cancer. 2018 Jun 15;6(1):56. doi: 10.1186/s40425-018-0343-9. Review.","J Immunother Cancer.  2018","PubMed","citation","PMID:29907163 | PMCID:PMC6003181","pubmed","29907163","create date:2018/06/17 | first author:Shimabukuro-Vornhagen A",
"Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade.","/pubmed/29906735","Milsch L, Gesierich A, Kreft S, Livingstone E, Zimmer L, Goebeler M, Schadendorf D, Schilling B.","Eur J Cancer. 2018 Aug;99:58-65. doi: 10.1016/j.ejca.2018.05.012. Epub 2018 Jun 12.","Eur J Cancer.  2018","PubMed","citation","PMID:29906735","pubmed","29906735","create date:2018/06/16 | first author:Milsch L",
"Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models.","/pubmed/29900058","Grees M, Sharbi-Yunger A, Evangelou C, Baumann D, Cafri G, Tzehoval E, Eichmüller SB, Offringa R, Utikal J, Eisenbach L, Umansky V.","Oncoimmunology. 2018 Mar 26;7(7):e1445457. doi: 10.1080/2162402X.2018.1445457. eCollection 2018.","Oncoimmunology.  2018","PubMed","citation","PMID:29900058 | PMCID:PMC5993502","pubmed","29900058","create date:2018/06/15 | first author:Grees M",
"Complex pattern of immune evasion in MSI colorectal cancer.","/pubmed/29900056","Ozcan M, Janikovits J, von Knebel Doeberitz M, Kloor M.","Oncoimmunology. 2018 Mar 26;7(7):e1445453. doi: 10.1080/2162402X.2018.1445453. eCollection 2018.","Oncoimmunology.  2018","PubMed","citation","PMID:29900056 | PMCID:PMC5993484","pubmed","29900056","create date:2018/06/15 | first author:Ozcan M",
"Large-scale database mining reveals hidden trends and future directions for cancer immunotherapy.","/pubmed/29900054","Kather JN, Berghoff AS, Ferber D, Suarez-Carmona M, Reyes-Aldasoro CC, Valous NA, Rojas-Moraleda R, Jäger D, Halama N.","Oncoimmunology. 2018 Mar 29;7(7):e1444412. doi: 10.1080/2162402X.2018.1444412. eCollection 2018.","Oncoimmunology.  2018","PubMed","citation","PMID:29900054 | PMCID:PMC5993505","pubmed","29900054","create date:2018/06/15 | first author:Kather JN",
"Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML.","/pubmed/29795051","Kubasch AS, Platzbecker U.","Cancers (Basel). 2018 May 24;10(6). pii: E158. doi: 10.3390/cancers10060158. Review.","Cancers (Basel).  2018","PubMed","citation","PMID:29795051 | PMCID:PMC6025349","pubmed","29795051","create date:2018/05/26 | first author:Kubasch AS",
"Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.","/pubmed/29731394","Hellmann MD, Callahan MK, Awad MM, Calvo E, Ascierto PA, Atmaca A, Rizvi NA, Hirsch FR, Selvaggi G, Szustakowski JD, Sasson A, Golhar R, Vitazka P, Chang H, Geese WJ, Antonia SJ.","Cancer Cell. 2018 May 14;33(5):853-861.e4. doi: 10.1016/j.ccell.2018.04.001. Epub 2018 May 3.","Cancer Cell.  2018","PubMed","citation","PMID:29731394","pubmed","29731394","create date:2018/05/08 | first author:Hellmann MD",
"Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells.","/pubmed/29721394","Gaiser MR, Weis CA, Gaiser T, Jiang H, Buder-Bakhaya K, Herpel E, Warth A, Xiao Y, Miao L, Brownell I.","Oncoimmunology. 2018 Feb 8;7(5):e1426517. doi: 10.1080/2162402X.2018.1426517. eCollection 2018.","Oncoimmunology.  2018","PubMed","citation","PMID:29721394 | PMCID:PMC5927480","pubmed","29721394","create date:2018/05/04 | first author:Gaiser MR",
"Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E.","/pubmed/29720980","Kordaß T, Osen W, Eichmüller SB.","Front Immunol. 2018 Apr 18;9:813. doi: 10.3389/fimmu.2018.00813. eCollection 2018. Review.","Front Immunol.  2018","PubMed","citation","PMID:29720980 | PMCID:PMC5915482","pubmed","29720980","create date:2018/05/04 | first author:Kordaß T",
"Checkpoints and beyond - Immunotherapy in colorectal cancer.","/pubmed/29716829","Gutting T, Burgermeister E, Härtel N, Ebert MP.","Semin Cancer Biol. 2018 Apr 28. pii: S1044-579X(17)30268-7. doi: 10.1016/j.semcancer.2018.04.003. [Epub ahead of print] Review.","Semin Cancer Biol.  2018","PubMed","citation","PMID:29716829","pubmed","29716829","create date:2018/05/03 | first author:Gutting T",
"Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.","/pubmed/29656892","Shukla SA, Bachireddy P, Schilling B, Galonska C, Zhan Q, Bango C, Langer R, Lee PC, Gusenleitner D, Keskin DB, Babadi M, Mohammad A, Gnirke A, Clement K, Cartun ZJ, Van Allen EM, Miao D, Huang Y, Snyder A, Merghoub T, Wolchok JD, Garraway LA, et al.","Cell. 2018 Apr 19;173(3):624-633.e8. doi: 10.1016/j.cell.2018.03.026. Epub 2018 Apr 12.","Cell.  2018","PubMed","citation","PMID:29656892 | PMCID:PMC6044280","pubmed","29656892","create date:2018/04/17 | first author:Shukla SA",
"Nivolumab maintenance after salvage autologous stem cell transplantation results in long-term remission in multiple relapsed primary CNS lymphoma.","/pubmed/29624748","Terziev D, Hutter B, Klink B, Stenzinger A, Stögbauer F, Glimm H, Fröhling S, Wickenhauser C, Jordan K, Hurtz HJ, Müller LP, Rüssel J, Weber T.","Eur J Haematol. 2018 Jul;101(1):115-118. doi: 10.1111/ejh.13072. Epub 2018 May 11.","Eur J Haematol.  2018","PubMed","citation","PMID:29624748","pubmed","29624748","create date:2018/04/07 | first author:Terziev D",
"A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy.","/pubmed/29599921","Eckstein M, Wirtz RM, Pfannstil C, Wach S, Stoehr R, Breyer J, Erlmeier F, Günes C, Nitschke K, Weichert W, Otto W, Keck B, Eidt S, Burger M, Taubert H, Wullich B, Bolenz C, Hartmann A, Erben P.","Oncotarget. 2018 Feb 19;9(19):15001-15014. doi: 10.18632/oncotarget.24531. eCollection 2018 Mar 13.","Oncotarget.  2018","PubMed","citation","PMID:29599921 | PMCID:PMC5871092","pubmed","29599921","create date:2018/03/31 | first author:Eckstein M",
"Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial.","/pubmed/29571083","Gao Y, Weenink B, van den Bent MJ, Erdem-Eraslan L, Kros JM, Sillevis Smitt P, Hoang-Xuan K, Brandes AA, Vos M, Dhermain F, Enting R, Ryan GF, Chinot O, Ben Hassel M, van Linde ME, Mason WP, Gijtenbeek JMM, Balana C, von Deimling A, Gorlia T, Stupp R, Hegi ME, et al.","Eur J Cancer. 2018 May;94:168-178. doi: 10.1016/j.ejca.2018.02.023. Epub 2018 Mar 20.","Eur J Cancer.  2018","PubMed","citation","PMID:29571083","pubmed","29571083","create date:2018/03/24 | first author:Gao Y",
"[Systemic immune checkpoint inhibition : A promising treatment for urological tumors?]","/pubmed/29569115","Roos FC, Becker C, Stope MB, Tsaur I; Fachgruppe Molekulare Urologie der Arbeitsgruppe urologische Forschung (AuF) der Deutschen Gesellschaft für Urologie..","Urologe A. 2018 May;57(5):583-590. doi: 10.1007/s00120-018-0622-6. Review. German. ","Urologe A.  2018","PubMed","citation","PMID:29569115","pubmed","29569115","create date:2018/03/24 | first author:Roos FC",
"Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner.","/pubmed/29562203","O'Reilly LA, Putoczki TL, Mielke LA, Low JT, Lin A, Preaudet A, Herold MJ, Yaprianto K, Tai L, Kueh A, Pacini G, Ferrero RL, Gugasyan R, Hu Y, Christie M, Wilcox S, Grumont R, Griffin MDW, O'Connor L, Smyth GK, Ernst M, Waring P, et al.","Immunity. 2018 Mar 20;48(3):570-583.e8. doi: 10.1016/j.immuni.2018.03.003.","Immunity.  2018","PubMed","citation","PMID:29562203","pubmed","29562203","create date:2018/03/22 | first author:O'Reilly LA",
"Autocrine Adenosine Regulates Tumor Polyfunctional CD73(+)CD4(+) Effector T Cells Devoid of Immune Checkpoints.","/pubmed/29559470","Gourdin N, Bossennec M, Rodriguez C, Vigano S, Machon C, Jandus C, Bauché D, Faget J, Durand I, Chopin N, Tredan O, Marie JC, Dubois B, Guitton J, Romero P, Caux C, Ménétrier-Caux C.","Cancer Res. 2018 Jul 1;78(13):3604-3618. doi: 10.1158/0008-5472.CAN-17-2405. Epub 2018 Mar 20.","Cancer Res.  2018","PubMed","citation","PMID:29559470","pubmed","29559470","create date:2018/03/22 | first author:Gourdin N",
"Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.","/pubmed/29552014","Da Gama Duarte J, Parakh S, Andrews MC, Woods K, Pasam A, Tutuka C, Ostrouska S, Blackburn JM, Behren A, Cebon J.","Front Immunol. 2018 Mar 2;9:411. doi: 10.3389/fimmu.2018.00411. eCollection 2018.","Front Immunol.  2018","PubMed","citation","PMID:29552014 | PMCID:PMC5840202","pubmed","29552014","create date:2018/03/20 | first author:Da Gama Duarte J",
"Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.","/pubmed/29550565","Hewitt LC, Inam IZ, Saito Y, Yoshikawa T, Quaas A, Hoelscher A, Bollschweiler E, Fazzi GE, Melotte V, Langley RE, Nankivell M, Cunningham D, Allum W, Hutchins GG, Grabsch HI.","Eur J Cancer. 2018 May;94:104-114. doi: 10.1016/j.ejca.2018.02.014. Epub 2018 Mar 20.","Eur J Cancer.  2018","PubMed","citation","PMID:29550565 | PMCID:PMC5914544","pubmed","29550565","create date:2018/03/20 | first author:Hewitt LC",
"Concepts for Immunotherapies in Gliomas.","/pubmed/29548053","Platten M, Reardon DA.","Semin Neurol. 2018 Feb;38(1):62-72. doi: 10.1055/s-0037-1620274. Epub 2018 Mar 16.","Semin Neurol.  2018","PubMed","citation","PMID:29548053","pubmed","29548053","create date:2018/03/17 | first author:Platten M",
"Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells.","/pubmed/29535740","Lichtenegger FS, Rothe M, Schnorfeil FM, Deiser K, Krupka C, Augsberger C, Schlüter M, Neitz J, Subklewe M.","Front Immunol. 2018 Feb 27;9:385. doi: 10.3389/fimmu.2018.00385. eCollection 2018.","Front Immunol.  2018","PubMed","citation","PMID:29535740 | PMCID:PMC5835137","pubmed","29535740","create date:2018/03/15 | first author:Lichtenegger FS",
"Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.","/pubmed/29534901","Zhang X, Niedermann G.","Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):63-73. doi: 10.1016/j.ijrobp.2018.01.094. Epub 2018 Feb 3.","Int J Radiat Oncol Biol Phys.  2018","PubMed","citation","PMID:29534901","pubmed","29534901","create date:2018/03/15 | first author:Zhang X",
"Simvastatin exerts anticancer effects in osteosarcoma cell lines via geranylgeranylation and c-Jun activation.","/pubmed/29532878","Kany S, Woschek M, Kneip N, Sturm R, Kalbitz M, Hanschen M, Relja B.","Int J Oncol. 2018 Apr;52(4):1285-1294. doi: 10.3892/ijo.2018.4288. Epub 2018 Feb 28.","Int J Oncol.  2018","PubMed","citation","PMID:29532878","pubmed","29532878","create date:2018/03/14 | first author:Kany S",
"Translational profiling of B cells infected with the Epstein-Barr virus reveals 5' leader ribosome recruitment through upstream open reading frames.","/pubmed/29529302","Bencun M, Klinke O, Hotz-Wagenblatt A, Klaus S, Tsai MH, Poirey R, Delecluse HJ.","Nucleic Acids Res. 2018 Apr 6;46(6):2802-2819. doi: 10.1093/nar/gky129.","Nucleic Acids Res.  2018","PubMed","citation","PMID:29529302 | PMCID:PMC5887285","pubmed","29529302","create date:2018/03/13 | first author:Bencun M",
"Downregulation of BTLA on NKT Cells Promotes Tumor Immune Control in a Mouse Model of Mammary Carcinoma.","/pubmed/29518903","Sekar D, Govene L, Del Río ML, Sirait-Fischer E, Fink AF, Brüne B, Rodriguez-Barbosa JI, Weigert A.","Int J Mol Sci. 2018 Mar 7;19(3). pii: E752. doi: 10.3390/ijms19030752.","Int J Mol Sci.  2018","PubMed","citation","PMID:29518903 | PMCID:PMC5877613","pubmed","29518903","create date:2018/03/10 | first author:Sekar D",
"Genomics and emerging biomarkers for immunotherapy of colorectal cancer.","/pubmed/29501787","Kather JN, Halama N, Jaeger D.","Semin Cancer Biol. 2018 Oct;52(Pt 2):189-197. doi: 10.1016/j.semcancer.2018.02.010. Epub 2018 Mar 1. Review.","Semin Cancer Biol.  2018","PubMed","citation","PMID:29501787","pubmed","29501787","create date:2018/03/05 | first author:Kather JN",
"Anal squamous cell carcinoma - State of the art management and future perspectives.","/pubmed/29494827","Martin D, Balermpas P, Winkelmann R, Rödel F, Rödel C, Fokas E.","Cancer Treat Rev. 2018 Apr;65:11-21. doi: 10.1016/j.ctrv.2018.02.001. Epub 2018 Feb 22. Review.","Cancer Treat Rev.  2018","PubMed","citation","PMID:29494827","pubmed","29494827","create date:2018/03/02 | first author:Martin D",
"STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-α.","/pubmed/29485532","Machiraju D, Moll I, Gebhardt C, Sucker A, Buder-Bakhaya K, Schadendorf D, Hassel JC.","Melanoma Res. 2018 Jun;28(3):204-210. doi: 10.1097/CMR.0000000000000435.","Melanoma Res.  2018","PubMed","citation","PMID:29485532","pubmed","29485532","create date:2018/02/28 | first author:Machiraju D",
"PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma.","/pubmed/29478343","Gaiser MR, Bongiorno M, Brownell I.","Expert Rev Clin Pharmacol. 2018 Apr;11(4):345-359. doi: 10.1080/17512433.2018.1445966. Epub 2018 Mar 14. Review.","Expert Rev Clin Pharmacol.  2018","PubMed","citation","PMID:29478343","pubmed","29478343","create date:2018/02/27 | first author:Gaiser MR",
"Adjuvant vemurafenib in resected, BRAF(V600) mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.","/pubmed/29477665","Maio M, Lewis K, Demidov L, Mandalà M, Bondarenko I, Ascierto PA, Herbert C, Mackiewicz A, Rutkowski P, Guminski A, Goodman GR, Simmons B, Ye C, Yan Y, Schadendorf D; BRIM8 Investigators..","Lancet Oncol. 2018 Apr;19(4):510-520. doi: 10.1016/S1470-2045(18)30106-2. Epub 2018 Feb 21. Erratum in: Lancet Oncol. 2018 Apr;19(4):e184. ","Lancet Oncol.  2018","PubMed","citation","PMID:29477665","pubmed","29477665","create date:2018/02/27 | first author:Maio M",
"Concurrent radiotherapy and nivolumab in metachronous metastatic primary adenosquamous-cell carcinoma of the prostate.","/pubmed/29477368","Eze C, Manapov F, Gratzke C, Schmidt-Hegemann NS, Jung A, Kirchner T, Heinemann V, Stief CG, Belka C, Boeck S.","Eur J Cancer. 2018 May;95:109-111. doi: 10.1016/j.ejca.2018.01.086. Epub 2018 Feb 21. No abstract available. ","Eur J Cancer.  2018","PubMed","citation","PMID:29477368","pubmed","29477368","create date:2018/02/27 | first author:Eze C",
"Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation.","/pubmed/29473162","Kaaks R, Fortner RT, Hüsing A, Barrdahl M, Hopper M, Johnson T, Tjønneland A, Hansen L, Overvad K, Fournier A, Boutron-Ruault MC, Kvaskoff M, Dossus L, Johansson M, Boeing H, Trichopoulou A, Benetou V, La Vecchia C, Sieri S, Mattiello A, Palli D, Tumino R, et al.","Int J Cancer. 2018 Aug 1;143(3):515-526. doi: 10.1002/ijc.31335. Epub 2018 Mar 8.","Int J Cancer.  2018","PubMed","citation","PMID:29473162 | PMCID:PMC6019150","pubmed","29473162","create date:2018/02/24 | first author:Kaaks R",
"AMPK promotes survival of c-Myc-positive melanoma cells by suppressing oxidative stress.","/pubmed/29440228","Kfoury A, Armaro M, Collodet C, Sordet-Dessimoz J, Giner MP, Christen S, Moco S, Leleu M, de Leval L, Koch U, Trumpp A, Sakamoto K, Beermann F, Radtke F.","EMBO J. 2018 Mar 1;37(5). pii: e97673. doi: 10.15252/embj.201797673. Epub 2018 Feb 12.","EMBO J.  2018","PubMed","citation","PMID:29440228 | PMCID:PMC5830923","pubmed","29440228","create date:2018/02/15 | first author:Kfoury A",
"Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy.","/pubmed/29435365","Manegold C, Adjei A, Bussolino F, Cappuzzo F, Crino L, Dziadziuszko R, Ettinger D, Fennell D, Kerr K, Le Chevalier T, Leighl N, Papotti M, Paz-Ares L, Pérol M, Peters S, Pirker R, Quoix E, Reck M, Smit E, Vokes E, van Zandwijk N, Zhou C.","ESMO Open. 2017 Jan 13;1(6):e000118. doi: 10.1136/esmoopen-2016-000118. eCollection 2016.","ESMO Open.  2016","PubMed","citation","PMID:29435365 | PMCID:PMC5729303","pubmed","29435365","create date:2018/02/13 | first author:Manegold C",
"Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations-Chances and Challenges.","/pubmed/29417399","Kuske M, Rauschenberg R, Garzarolli M, Meredyth-Stewart M, Beissert S, Troost EGC, Glitza OIC, Meier F.","Am J Clin Dermatol. 2018 Aug;19(4):529-541. doi: 10.1007/s40257-018-0346-9. Review.","Am J Clin Dermatol.  2018","PubMed","citation","PMID:29417399 | PMCID:PMC6061393","pubmed","29417399","create date:2018/02/09 | first author:Kuske M",
"Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.","/pubmed/29408986","Vokes EE, Ready N, Felip E, Horn L, Burgio MA, Antonia SJ, Arén Frontera O, Gettinger S, Holgado E, Spigel D, Waterhouse D, Domine M, Garassino M, Chow LQM, Blumenschein G Jr, Barlesi F, Coudert B, Gainor J, Arrieta O, Brahmer J, Butts C, Steins M, et al.","Ann Oncol. 2018 Apr 1;29(4):959-965. doi: 10.1093/annonc/mdy041.","Ann Oncol.  2018","PubMed","citation","PMID:29408986","pubmed","29408986","create date:2018/02/07 | first author:Vokes EE",
"[Nivolumab for pretreated metastatic anal cancer : Immune checkpoint blockade is also advised in combination with radiochemotherapy].","/pubmed/29392353","Martin D, Rödel C, Fokas E.","Strahlenther Onkol. 2018 Apr;194(4):356-357. doi: 10.1007/s00066-018-1272-8. German.  No abstract available. ","Strahlenther Onkol.  2018","PubMed","citation","PMID:29392353","pubmed","29392353","create date:2018/02/03 | first author:Martin D",
"Radiation effects on antitumor immune responses: current perspectives and challenges.","/pubmed/29383033","Walle T, Martinez Monge R, Cerwenka A, Ajona D, Melero I, Lecanda F.","Ther Adv Med Oncol. 2018 Jan 18;10:1758834017742575. doi: 10.1177/1758834017742575. eCollection 2018. Review.","Ther Adv Med Oncol.  2018","PubMed","citation","PMID:29383033 | PMCID:PMC5784573","pubmed","29383033","create date:2018/02/01 | first author:Walle T",
"Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients.","/pubmed/29375575","Hoffmann JM, Schubert ML, Wang L, Hückelhoven A, Sellner L, Stock S, Schmitt A, Kleist C, Gern U, Loskog A, Wuchter P, Hofmann S, Ho AD, Müller-Tidow C, Dreger P, Schmitt M.","Front Immunol. 2018 Jan 10;8:1956. doi: 10.3389/fimmu.2017.01956. eCollection 2017.","Front Immunol.  2017","PubMed","citation","PMID:29375575 | PMCID:PMC5767585","pubmed","29375575","create date:2018/01/30 | first author:Hoffmann JM",
"Short linear motif core and flanking regions modulate retinoblastoma protein binding affinity and specificity.","/pubmed/29370437","Palopoli N, González Foutel NS, Gibson TJ, Chemes LB.","Protein Eng Des Sel. 2018 Mar 1;31(3):69-77. doi: 10.1093/protein/gzx068.","Protein Eng Des Sel.  2018","PubMed","citation","PMID:29370437","pubmed","29370437","create date:2018/01/26 | first author:Palopoli N",
"The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia.","/pubmed/29321210","Nuebling T, Schumacher CE, Hofmann M, Hagelstein I, Schmiedel BJ, Maurer S, Federmann B, Rothfelder K, Roerden M, Dörfel D, Schneider P, Jung G, Salih HR.","Cancer Immunol Res. 2018 Feb;6(2):209-221. doi: 10.1158/2326-6066.CIR-17-0212. Epub 2018 Jan 10.","Cancer Immunol Res.  2018","PubMed","citation","PMID:29321210","pubmed","29321210","create date:2018/01/13 | first author:Nuebling T",
"High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancer.","/pubmed/29308317","Janikovits J, Müller M, Krzykalla J, Körner S, Echterdiek F, Lahrmann B, Grabe N, Schneider M, Benner A, Doeberitz MVK, Kloor M.","Oncoimmunology. 2017 Nov 6;7(2):e1390640. doi: 10.1080/2162402X.2017.1390640. eCollection 2018.","Oncoimmunology.  2018","PubMed","citation","PMID:29308317 | PMCID:PMC5749658","pubmed","29308317","create date:2018/01/09 | first author:Janikovits J",
"Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1.","/pubmed/29306769","Haag GM, Zoernig I, Hassel JC, Halama N, Dick J, Lang N, Podola L, Funk J, Ziegelmeier C, Juenger S, Bucur M, Umansky L, Falk CS, Freitag A, Karapanagiotou-Schenkel I, Beckhove P, Enk A, Jaeger D.","Eur J Cancer. 2018 Feb;90:122-129. doi: 10.1016/j.ejca.2017.12.001. Epub 2018 Jan 5.","Eur J Cancer.  2018","PubMed","citation","PMID:29306769","pubmed","29306769","create date:2018/01/08 | first author:Haag GM",
"Update Breast Cancer 2017 - Implementation of Novel Therapies.","/pubmed/29269955","Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Ettl J, Huober JB, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Fehm TN, Wallwiener D, Brucker SY, Schneeweiss A, Fasching PA.","Geburtshilfe Frauenheilkd. 2017 Dec;77(12):1281-1290. doi: 10.1055/s-0043-122885. Epub 2017 Dec 18.","Geburtshilfe Frauenheilkd.  2017","PubMed","citation","PMID:29269955 | PMCID:PMC5734938","pubmed","29269955","create date:2017/12/23 | first author:Lux MP",
"Senescence-associated reprogramming promotes cancer stemness.","/pubmed/29258294","Milanovic M, Fan DNY, Belenki D, Däbritz JHM, Zhao Z, Yu Y, Dörr JR, Dimitrova L, Lenze D, Monteiro Barbosa IA, Mendoza-Parra MA, Kanashova T, Metzner M, Pardon K, Reimann M, Trumpp A, Dörken B, Zuber J, Gronemeyer H, Hummel M, Dittmar G, Lee S, et al.","Nature. 2018 Jan 4;553(7686):96-100. doi: 10.1038/nature25167. Epub 2017 Dec 20.","Nature.  2018","PubMed","citation","PMID:29258294","pubmed","29258294","create date:2017/12/21 | first author:Milanovic M",
"Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients.","/pubmed/29250075","Bräunlein E, Krackhardt AM.","Front Immunol. 2017 Nov 30;8:1702. doi: 10.3389/fimmu.2017.01702. eCollection 2017. Review.","Front Immunol.  2017","PubMed","citation","PMID:29250075 | PMCID:PMC5714868","pubmed","29250075","create date:2017/12/19 | first author:Bräunlein E",
"Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III.","/pubmed/29224903","Grob JJ, Schadendorf D, Lorigan P, Ascierto P, Larkin J, Nathan P, Robert C, Hauschild A, Weber J, Daud A, Hamid O, Dummer R, Hansson J, Hoeller C, Schachter J, Van Akkooi ACJ, Garbe C.","Eur J Cancer. 2018 Mar;91:168-170. doi: 10.1016/j.ejca.2017.11.023. Epub 2017 Dec 7. No abstract available. ","Eur J Cancer.  2018","PubMed","citation","PMID:29224903","pubmed","29224903","create date:2017/12/12 | first author:Grob JJ",
"Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types.","/pubmed/29212506","Budczies J, Denkert C, Győrffy B, Schirmacher P, Stenzinger A.","BMC Med Genomics. 2017 Dec 6;10(1):74. doi: 10.1186/s12920-017-0308-8.","BMC Med Genomics.  2017","PubMed","citation","PMID:29212506 | PMCID:PMC5719741","pubmed","29212506","create date:2017/12/08 | first author:Budczies J",
"Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.","/pubmed/29209572","Cabo M, Offringa R, Zitvogel L, Kroemer G, Muntasell A, Galluzzi L.","Oncoimmunology. 2017 Aug 30;6(12):e1371896. doi: 10.1080/2162402X.2017.1371896. eCollection 2017. Review.","Oncoimmunology.  2017","PubMed","citation","PMID:29209572 | PMCID:PMC5706611","pubmed","29209572","create date:2017/12/07 | first author:Cabo M",
"Advances in targeted therapy for acute myeloid leukaemia.","/pubmed/29193012","Kayser S, Levis MJ.","Br J Haematol. 2018 Feb;180(4):484-500. doi: 10.1111/bjh.15032. Epub 2017 Nov 28. Review.","Br J Haematol.  2018","PubMed","citation","PMID:29193012 | PMCID:PMC5801209","pubmed","29193012","create date:2017/12/02 | first author:Kayser S",
"Increased cFLIP expression in thymic epithelial tumors blocks autophagy via NF-κB signalling.","/pubmed/29163772","Belharazem D, Grass A, Paul C, Vitacolonna M, Schalke B, Rieker RJ, Körner D, Jungebluth P, Simon-Keller K, Hohenberger P, Roessner EM, Wiebe K, Gräter T, Kyriss T, Ott G, Geserick P, Leverkus M, Ströbel P, Marx A.","Oncotarget. 2017 Feb 6;8(52):89580-89594. doi: 10.18632/oncotarget.15929. eCollection 2017 Oct 27.","Oncotarget.  2017","PubMed","citation","PMID:29163772 | PMCID:PMC5685693","pubmed","29163772","create date:2017/11/23 | first author:Belharazem D",
"Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment.","/pubmed/29155585","Xie J, Si X, Gu S, Wang M, Shen J, Li H, Shen J, Li D, Fang Y, Liu C, Zhu J.","J Med Chem. 2017 Dec 28;60(24):10205-10219. doi: 10.1021/acs.jmedchem.7b01520. Epub 2017 Dec 7.","J Med Chem.  2017","PubMed","citation","PMID:29155585","pubmed","29155585","create date:2017/11/21 | first author:Xie J",
"High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients.","/pubmed/29150702","Breyer J, Wirtz RM, Otto W, Erben P, Worst TS, Stoehr R, Eckstein M, Denzinger S, Burger M, Hartmann A.","Cancer Immunol Immunother. 2018 Mar;67(3):403-412. doi: 10.1007/s00262-017-2093-9. Epub 2017 Nov 17.","Cancer Immunol Immunother.  2018","PubMed","citation","PMID:29150702","pubmed","29150702","create date:2017/11/19 | first author:Breyer J",
"PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis.","/pubmed/29143824","Wartewig T, Kurgyis Z, Keppler S, Pechloff K, Hameister E, Öllinger R, Maresch R, Buch T, Steiger K, Winter C, Rad R, Ruland J.","Nature. 2017 Dec 7;552(7683):121-125. doi: 10.1038/nature24649. Epub 2017 Nov 15. Erratum in: Nature. 2017 Nov 29;:. ","Nature.  2017","PubMed","citation","PMID:29143824 | PMCID:PMC5821214","pubmed","29143824","create date:2017/11/17 | first author:Wartewig T",
"A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma.","/pubmed/29141225","Krepler C, Sproesser K, Brafford P, Beqiri M, Garman B, Xiao M, Shannan B, Watters A, Perego M, Zhang G, Vultur A, Yin X, Liu Q, Anastopoulos IN, Wubbenhorst B, Wilson MA, Xu W, Karakousis G, Feldman M, Xu X, Amaravadi R, Gangadhar TC, et al.","Cell Rep. 2017 Nov 14;21(7):1953-1967. doi: 10.1016/j.celrep.2017.10.021.","Cell Rep.  2017","PubMed","citation","PMID:29141225 | PMCID:PMC5726788","pubmed","29141225","create date:2017/11/16 | first author:Krepler C",
"Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.","/pubmed/29138515","Doerr F, George J, Schmitt A, Beleggia F, Rehkämper T, Hermann S, Walter V, Weber JP, Thomas RK, Wittersheim M, Büttner R, Persigehl T, Reinhardt HC.","Sci Rep. 2017 Nov 14;7(1):15511. doi: 10.1038/s41598-017-15840-5.","Sci Rep.  2017","PubMed","citation","PMID:29138515 | PMCID:PMC5686113","pubmed","29138515","create date:2017/11/16 | first author:Doerr F",
"Pharmacotherapeutic Management of Pediatric Lymphoma.","/pubmed/29127674","Mauz-Körholz C, Ströter N, Baumann J, Botzen A, Körholz K, Körholz D.","Paediatr Drugs. 2018 Feb;20(1):43-57. doi: 10.1007/s40272-017-0265-x. Review.","Paediatr Drugs.  2018","PubMed","citation","PMID:29127674","pubmed","29127674","create date:2017/11/12 | first author:Mauz-Körholz C",
"Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability.","/pubmed/29109526","Jäkel C, Bergmann F, Toth R, Assenov Y, van der Duin D, Strobel O, Hank T, Klöppel G, Dorrell C, Grompe M, Moss J, Dor Y, Schirmacher P, Plass C, Popanda O, Schmezer P.","Nat Commun. 2017 Nov 6;8(1):1323. doi: 10.1038/s41467-017-01118-x.","Nat Commun.  2017","PubMed","citation","PMID:29109526 | PMCID:PMC5673892","pubmed","29109526","create date:2017/11/08 | first author:Jäkel C",
"Merkel cell carcinoma.","/pubmed/29072302","Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, Nghiem P.","Nat Rev Dis Primers. 2017 Oct 26;3:17077. doi: 10.1038/nrdp.2017.77. Review.","Nat Rev Dis Primers.  2017","PubMed","citation","PMID:29072302 | PMCID:PMC6054450","pubmed","29072302","create date:2017/10/27 | first author:Becker JC",
"Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.","/pubmed/29070979","Koch J, Tesar M.","Transfus Med Hemother. 2017 Sep;44(5):337-350. doi: 10.1159/000479981. Epub 2017 Sep 11. Review.","Transfus Med Hemother.  2017","PubMed","citation","PMID:29070979 | PMCID:PMC5649249","pubmed","29070979","create date:2017/10/27 | first author:Koch J",
"Complex Immune Evasion Strategies in Classical Hodgkin Lymphoma.","/pubmed/29070649","Wein F, Weniger MA, Höing B, Arnolds J, Hüttmann A, Hansmann ML, Hartmann S, Küppers R.","Cancer Immunol Res. 2017 Dec;5(12):1122-1132. doi: 10.1158/2326-6066.CIR-17-0325. Epub 2017 Oct 25.","Cancer Immunol Res.  2017","PubMed","citation","PMID:29070649","pubmed","29070649","create date:2017/10/27 | first author:Wein F",
"Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis.","/pubmed/29055840","Franklin C, Rooms I, Fiedler M, Reis H, Milsch L, Herz S, Livingstone E, Zimmer L, Schmid KW, Dittmer U, Schadendorf D, Schilling B.","Eur J Cancer. 2017 Nov;86:248-256. doi: 10.1016/j.ejca.2017.09.019. Epub 2017 Oct 19.","Eur J Cancer.  2017","PubMed","citation","PMID:29055840","pubmed","29055840","create date:2017/10/23 | first author:Franklin C",
"Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy.","/pubmed/29045907","Glodde N, Bald T, van den Boorn-Konijnenberg D, Nakamura K, O'Donnell JS, Szczepanski S, Brandes M, Eickhoff S, Das I, Shridhar N, Hinze D, Rogava M, van der Sluis TC, Ruotsalainen JJ, Gaffal E, Landsberg J, Ludwig KU, Wilhelm C, Riek-Burchardt M, Müller AJ, Gebhardt C, Scolyer RA, et al.","Immunity. 2017 Oct 17;47(4):789-802.e9. doi: 10.1016/j.immuni.2017.09.012.","Immunity.  2017","PubMed","citation","PMID:29045907","pubmed","29045907","create date:2017/10/19 | first author:Glodde N",
"ID(H)entifying checkpoint inhibitor candidates among diffuse glioma.","/pubmed/29036631","Sahm F, Wick A.","Neuro Oncol. 2017 Oct 19;19(11):1427-1428. doi: 10.1093/neuonc/nox145. No abstract available. ","Neuro Oncol.  2017","PubMed","citation","PMID:29036631 | PMCID:PMC5737517","pubmed","29036631","create date:2017/10/17 | first author:Sahm F",
"Safe Administration of An Anti-PD-1 Antibody to Kidney-transplant Patients: 2 Clinical Cases and Review of the Literature.","/pubmed/29028789","Winkler JK, Gutzmer R, Bender C, Lang N, Zeier M, Enk AH, Hassel JC.","J Immunother. 2017 Nov/Dec;40(9):341-344. doi: 10.1097/CJI.0000000000000188. Review.","J Immunother.  2017","PubMed","citation","PMID:29028789","pubmed","29028789","create date:2017/10/14 | first author:Winkler JK",
"The level of caveolin-1 expression determines response to TGF-β as a tumour suppressor in hepatocellular carcinoma cells.","/pubmed/29022911","Moreno-Càceres J, Caballero-Díaz D, Nwosu ZC, Meyer C, López-Luque J, Malfettone A, Lastra R, Serrano T, Ramos E, Dooley S, Fabregat I.","Cell Death Dis. 2017 Oct 12;8(10):e3098. doi: 10.1038/cddis.2017.469.","Cell Death Dis.  2017","PubMed","citation","PMID:29022911 | PMCID:PMC5680590","pubmed","29022911","create date:2017/10/13 | first author:Moreno-Càceres J",
"The promises of immunotherapy in gliomas.","/pubmed/28984704","Mildenberger I, Bunse L, Ochs K, Platten M.","Curr Opin Neurol. 2017 Dec;30(6):650-658. doi: 10.1097/WCO.0000000000000491. Review.","Curr Opin Neurol.  2017","PubMed","citation","PMID:28984704","pubmed","28984704","create date:2017/10/07 | first author:Mildenberger I",
"Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model.","/pubmed/28955032","Jespersen H, Lindberg MF, Donia M, Söderberg EMV, Andersen R, Keller U, Ny L, Svane IM, Nilsson LM, Nilsson JA.","Nat Commun. 2017 Sep 27;8(1):707. doi: 10.1038/s41467-017-00786-z.","Nat Commun.  2017","PubMed","citation","PMID:28955032 | PMCID:PMC5617838","pubmed","28955032","create date:2017/09/29 | first author:Jespersen H",
"Predictors of responses to immune checkpoint blockade in advanced melanoma.","/pubmed/28928380","Jacquelot N, Roberti MP, Enot DP, Rusakiewicz S, Ternès N, Jegou S, Woods DM, Sodré AL, Hansen M, Meirow Y, Sade-Feldman M, Burra A, Kwek SS, Flament C, Messaoudene M, Duong CPM, Chen L, Kwon BS, Anderson AC, Kuchroo VK, Weide B, Aubin F, et al.","Nat Commun. 2017 Sep 19;8(1):592. doi: 10.1038/s41467-017-00608-2.","Nat Commun.  2017","PubMed","citation","PMID:28928380 | PMCID:PMC5605517","pubmed","28928380","create date:2017/09/21 | first author:Jacquelot N",
"Bridging Bio-Nano Science and Cancer Nanomedicine.","/pubmed/28926225","Björnmalm M, Thurecht KJ, Michael M, Scott AM, Caruso F.","ACS Nano. 2017 Oct 24;11(10):9594-9613. doi: 10.1021/acsnano.7b04855. Epub 2017 Sep 19.","ACS Nano.  2017","PubMed","citation","PMID:28926225","pubmed","28926225","create date:2017/09/20 | first author:Björnmalm M",
"Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells.","/pubmed/28915646","Van Audenaerde JRM, De Waele J, Marcq E, Van Loenhout J, Lion E, Van den Bergh JMJ, Jesenofsky R, Masamune A, Roeyen G, Pauwels P, Lardon F, Peeters M, Smits ELJ.","Oncotarget. 2017 May 25;8(34):56968-56979. doi: 10.18632/oncotarget.18185. eCollection 2017 Aug 22.","Oncotarget.  2017","PubMed","citation","PMID:28915646 | PMCID:PMC5593617","pubmed","28915646","create date:2017/09/17 | first author:Van Audenaerde JRM",
"Frequent PD-L1 Expression in Malignant Melanomas of the Vulva.","/pubmed/28914674","Saleh B, Kriegsmann J, Falk S, Aulmann S.","Int J Gynecol Pathol. 2018 Sep;37(5):477-481. doi: 10.1097/PGP.0000000000000454.","Int J Gynecol Pathol.  2018","PubMed","citation","PMID:28914674","pubmed","28914674","create date:2017/09/16 | first author:Saleh B",
"mTOR inhibition reduces growth and adhesion of hepatocellular carcinoma cells in vitro.","/pubmed/28901501","Engl T, Rutz J, Maxeiner S, Juengel E, Roos F, Khoder W, Bechstein WO, Nelson K, Tsaur I, Haferkamp A, Blaheta RA.","Mol Med Rep. 2017 Nov;16(5):7064-7071. doi: 10.3892/mmr.2017.7401. Epub 2017 Aug 31.","Mol Med Rep.  2017","PubMed","citation","PMID:28901501","pubmed","28901501","create date:2017/09/14 | first author:Engl T",
"Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway.","/pubmed/28892788","Li R, Zhang Z, Wang J, Huang Y, Sun W, Xie R, Hu F, Lei T.","Biomed Pharmacother. 2017 Nov;95:771-779. doi: 10.1016/j.biopha.2017.08.127. Epub 2017 Sep 8.","Biomed Pharmacother.  2017","PubMed","citation","PMID:28892788","pubmed","28892788","create date:2017/09/12 | first author:Li R",
"Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.","/pubmed/28889792","Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey CL, Lao CD, Wagstaff J, Schadendorf D, Ferrucci PF, Smylie M, Dummer R, Hill A, Hogg D, Haanen J, Carlino MS, Bechter O, Maio M, Marquez-Rodas I, Guidoboni M, McArthur G, Lebbé C, et al.","N Engl J Med. 2017 Oct 5;377(14):1345-1356. doi: 10.1056/NEJMoa1709684. Epub 2017 Sep 11.","N Engl J Med.  2017","PubMed","citation","PMID:28889792 | PMCID:PMC5706778","pubmed","28889792","create date:2017/09/12 | first author:Wolchok JD",
"[Response evaluation in nuclear medicine : Criteria, results and pitfalls].","/pubmed/28875325","Hoffend J, Sachpekidis C, Dimitrakopoulou-Strauss A.","Radiologe. 2017 Oct;57(10):834-839. doi: 10.1007/s00117-017-0295-y. Review. German. ","Radiologe.  2017","PubMed","citation","PMID:28875325","pubmed","28875325","create date:2017/09/07 | first author:Hoffend J",
"β-2-himachalen-6-ol protects against skin cancer development in vitro and in vivo.","/pubmed/28872682","Daaboul HE, Daher CF, Taleb RI, Boulos J, Bodman-Smith K, Boukamp P, Shebaby WN, Dagher C, El-Sibai M, Mroueh MA.","J Pharm Pharmacol. 2017 Nov;69(11):1552-1564. doi: 10.1111/jphp.12796. Epub 2017 Sep 5.","J Pharm Pharmacol.  2017","PubMed","citation","PMID:28872682","pubmed","28872682","create date:2017/09/06 | first author:Daaboul HE",
"[Immunotherapy as modern tumor treatment].","/pubmed/28871357","Grüllich C.","Radiologe. 2017 Oct;57(10):822-825. doi: 10.1007/s00117-017-0298-8. Review. German. ","Radiologe.  2017","PubMed","citation","PMID:28871357","pubmed","28871357","create date:2017/09/06 | first author:Grüllich C",
"Virotherapy Research in Germany: From Engineering to Translation.","/pubmed/28870120","Ungerechts G, Engeland CE, Buchholz CJ, Eberle J, Fechner H, Geletneky K, Holm PS, Kreppel F, Kühnel F, Lang KS, Leber MF, Marchini A, Moehler M, Mühlebach MD, Rommelaere J, Springfeld C, Lauer UM, Nettelbeck DM.","Hum Gene Ther. 2017 Oct;28(10):800-819. doi: 10.1089/hum.2017.138. Review.","Hum Gene Ther.  2017","PubMed","citation","PMID:28870120","pubmed","28870120","create date:2017/09/06 | first author:Ungerechts G",
"Cell-Cycle Position of Single MYC-Driven Cancer Cells Dictates Their Susceptibility to a Chemotherapeutic Drug.","/pubmed/28843484","Ryl T, Kuchen EE, Bell E, Shao C, Flórez AF, Mönke G, Gogolin S, Friedrich M, Lamprecht F, Westermann F, Höfer T.","Cell Syst. 2017 Sep 27;5(3):237-250.e8. doi: 10.1016/j.cels.2017.07.005. Epub 2017 Aug 23.","Cell Syst.  2017","PubMed","citation","PMID:28843484","pubmed","28843484","create date:2017/08/28 | first author:Ryl T",
"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity.","/pubmed/28813417","Burr ML, Sparbier CE, Chan YC, Williamson JC, Woods K, Beavis PA, Lam EYN, Henderson MA, Bell CC, Stolzenburg S, Gilan O, Bloor S, Noori T, Morgens DW, Bassik MC, Neeson PJ, Behren A, Darcy PK, Dawson SJ, Voskoboinik I, Trapani JA, Cebon J, et al.","Nature. 2017 Sep 7;549(7670):101-105. doi: 10.1038/nature23643. Epub 2017 Aug 16.","Nature.  2017","PubMed","citation","PMID:28813417 | PMCID:PMC5706633","pubmed","28813417","create date:2017/08/17 | first author:Burr ML",
"Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.","/pubmed/28797232","Heppt MV, Siepmann T, Engel J, Schubert-Fritschle G, Eckel R, Mirlach L, Kirchner T, Jung A, Gesierich A, Ruzicka T, Flaig MJ, Berking C.","BMC Cancer. 2017 Aug 10;17(1):536. doi: 10.1186/s12885-017-3529-5.","BMC Cancer.  2017","PubMed","citation","PMID:28797232 | PMCID:PMC5553744","pubmed","28797232","create date:2017/08/12 | first author:Heppt MV",
"Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection.","/pubmed/28791250","Herskind C, Wenz F, Giordano FA.","Front Oncol. 2017 Jul 24;7:147. doi: 10.3389/fonc.2017.00147. eCollection 2017. Review.","Front Oncol.  2017","PubMed","citation","PMID:28791250 | PMCID:PMC5522878","pubmed","28791250","create date:2017/08/10 | first author:Herskind C",
"Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothe...","/pubmed/28777143","Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, et al.","Adv Anat Pathol. 2017 Nov;24(6):311-335. doi: 10.1097/PAP.0000000000000161. Review.","Adv Anat Pathol.  2017","PubMed","citation","PMID:28777143 | PMCID:PMC5638696","pubmed","28777143","create date:2017/08/05 | first author:Hendry S",
"Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In S...","/pubmed/28777142","Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, et al.","Adv Anat Pathol. 2017 Sep;24(5):235-251. doi: 10.1097/PAP.0000000000000162. Review.","Adv Anat Pathol.  2017","PubMed","citation","PMID:28777142 | PMCID:PMC5564448","pubmed","28777142","create date:2017/08/05 | first author:Hendry S",
"Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts.","/pubmed/28765140","Hartmann J, Schüßler-Lenz M, Bondanza A, Buchholz CJ.","EMBO Mol Med. 2017 Sep;9(9):1183-1197. doi: 10.15252/emmm.201607485. Review.","EMBO Mol Med.  2017","PubMed","citation","PMID:28765140 | PMCID:PMC5582407","pubmed","28765140","create date:2017/08/03 | first author:Hartmann J",
"Tools to define the melanoma-associated immunopeptidome.","/pubmed/28755382","Bräunlein E, Krackhardt AM.","Immunology. 2017 Dec;152(4):536-544. doi: 10.1111/imm.12803. Epub 2017 Aug 28. Review.","Immunology.  2017","PubMed","citation","PMID:28755382 | PMCID:PMC5680071","pubmed","28755382","create date:2017/07/30 | first author:Bräunlein E",
"Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer.","/pubmed/28750120","Karn T, Jiang T, Hatzis C, Sänger N, El-Balat A, Rody A, Holtrich U, Becker S, Bianchini G, Pusztai L.","JAMA Oncol. 2017 Dec 1;3(12):1707-1711. doi: 10.1001/jamaoncol.2017.2140.","JAMA Oncol.  2017","PubMed","citation","PMID:28750120 | PMCID:PMC5824276","pubmed","28750120","create date:2017/07/28 | first author:Karn T",
"ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control.","/pubmed/28747424","Schwartz C, Khan AR, Floudas A, Saunders SP, Hams E, Rodewald HR, McKenzie ANJ, Fallon PG.","J Exp Med. 2017 Sep 4;214(9):2507-2521. doi: 10.1084/jem.20170051. Epub 2017 Jul 26.","J Exp Med.  2017","PubMed","citation","PMID:28747424 | PMCID:PMC5584124","pubmed","28747424","create date:2017/07/28 | first author:Schwartz C",
"Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.","/pubmed/28746345","Sarin N, Engel F, Kalayda GV, Mannewitz M, Cinatl J Jr, Rothweiler F, Michaelis M, Saafan H, Ritter CA, Jaehde U, Frötschl R.","PLoS One. 2017 Jul 26;12(7):e0181081. doi: 10.1371/journal.pone.0181081. eCollection 2017.","PLoS One.  2017","PubMed","citation","PMID:28746345 | PMCID:PMC5528889","pubmed","28746345","create date:2017/07/27 | first author:Sarin N",
"In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PET.","/pubmed/28744323","Yusufi N, Mall S, Bianchi HO, Steiger K, Reder S, Klar R, Audehm S, Mustafa M, Nekolla S, Peschel C, Schwaiger M, Krackhardt AM, D'Alessandria C.","Theranostics. 2017 Jun 15;7(9):2402-2416. doi: 10.7150/thno.17994. eCollection 2017.","Theranostics.  2017","PubMed","citation","PMID:28744323 | PMCID:PMC5525745","pubmed","28744323","create date:2017/07/27 | first author:Yusufi N",
"Recent developments in immunotherapy of acute myeloid leukemia.","/pubmed/28743264","Lichtenegger FS, Krupka C, Haubner S, Köhnke T, Subklewe M.","J Hematol Oncol. 2017 Jul 25;10(1):142. doi: 10.1186/s13045-017-0505-0. Review.","J Hematol Oncol.  2017","PubMed","citation","PMID:28743264 | PMCID:PMC5526264","pubmed","28743264","create date:2017/07/27 | first author:Lichtenegger FS",
"In Vivo RNAi Screening for Pancreatic Cancer Drivers: PILOTing the WDR5-MYC Axis.","/pubmed/28741490","Schneider G, Saur D.","Trends Cancer. 2016 Aug;2(8):391-392. doi: 10.1016/j.trecan.2016.07.002. Epub 2016 Jul 19.","Trends Cancer.  2016","PubMed","citation","PMID:28741490","pubmed","28741490","create date:2017/07/26 | first author:Schneider G",
"Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma.","/pubmed/28735071","Ugurel S, Kiecker F, Fröhling S, Wetter A, Bankfalvi A, Sucker A, Zimmer L, Livingstone E, Roesch A, Becker JC, Schadendorf D.","Eur J Cancer. 2017 Sep;83:142-145. doi: 10.1016/j.ejca.2017.06.020. Epub 2017 Jul 20. No abstract available. ","Eur J Cancer.  2017","PubMed","citation","PMID:28735071","pubmed","28735071","create date:2017/07/25 | first author:Ugurel S",
"[Malignant melanoma : Current status].","/pubmed/28730266","Winkler JK, Buder-Bakhaya K, Dimitrakopoulou-Strauss A, Enk A, Hassel JC.","Radiologe. 2017 Oct;57(10):814-821. doi: 10.1007/s00117-017-0281-4. Review. German. ","Radiologe.  2017","PubMed","citation","PMID:28730266","pubmed","28730266","create date:2017/07/22 | first author:Winkler JK",
"Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.","/pubmed/28729151","Long GV, Atkinson V, Cebon JS, Jameson MB, Fitzharris BM, McNeil CM, Hill AG, Ribas A, Atkins MB, Thompson JA, Hwu WJ, Hodi FS, Menzies AM, Guminski AD, Kefford R, Kong BY, Tamjid B, Srivastava A, Lomax AJ, Islam M, Shu X, Ebbinghaus S, et al.","Lancet Oncol. 2017 Sep;18(9):1202-1210. doi: 10.1016/S1470-2045(17)30428-X. Epub 2017 Jul 17.","Lancet Oncol.  2017","PubMed","citation","PMID:28729151","pubmed","28729151","create date:2017/07/22 | first author:Long GV",
"Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome.","/pubmed/28727142","Binder H, Hopp L, Schweiger MR, Hoffmann S, Jühling F, Kerick M, Timmermann B, Siebert S, Grimm C, Nersisyan L, Arakelyan A, Herberg M, Buske P, Loeffler-Wirth H, Rosolowski M, Engel C, Przybilla J, Peifer M, Friedrichs N, Moeslein G, Odenthal M, Hussong M, et al.","J Pathol. 2017 Oct;243(2):242-254. doi: 10.1002/path.4948. Epub 2017 Sep 5.","J Pathol.  2017","PubMed","citation","PMID:28727142","pubmed","28727142","create date:2017/07/21 | first author:Binder H",
"Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression.","/pubmed/28680756","Layer JP, Kronmüller MT, Quast T, van den Boorn-Konijnenberg D, Effern M, Hinze D, Althoff K, Schramm A, Westermann F, Peifer M, Hartmann G, Tüting T, Kolanus W, Fischer M, Schulte J, Hölzel M.","Oncoimmunology. 2017 Apr 28;6(6):e1320626. doi: 10.1080/2162402X.2017.1320626. eCollection 2017.","Oncoimmunology.  2017","PubMed","citation","PMID:28680756 | PMCID:PMC5486176","pubmed","28680756","create date:2017/07/07 | first author:Layer JP",
"P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1.","/pubmed/28656629","Laudato S, Patil N, Abba ML, Leupold JH, Benner A, Gaiser T, Marx A, Allgayer H.","Int J Cancer. 2017 Nov 1;141(9):1879-1890. doi: 10.1002/ijc.30854. Epub 2017 Jul 24.","Int J Cancer.  2017","PubMed","citation","PMID:28656629","pubmed","28656629","create date:2017/06/29 | first author:Laudato S",
"Health-related quality of life results from the phase III CheckMate 067 study.","/pubmed/28651159","Schadendorf D, Larkin J, Wolchok J, Hodi FS, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey CL, Lao C, Wagstaff J, Callahan MK, Postow MA, Smylie M, Ferrucci PF, Dummer R, Hill A, Taylor F, Sabater J, Walker D, Kotapati S, Abernethy A, et al.","Eur J Cancer. 2017 Sep;82:80-91. doi: 10.1016/j.ejca.2017.05.031. Epub 2017 Jun 23.","Eur J Cancer.  2017","PubMed","citation","PMID:28651159 | PMCID:PMC5737813","pubmed","28651159","create date:2017/06/27 | first author:Schadendorf D",
"Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.","/pubmed/28648699","Heppt MV, Heinzerling L, Kähler KC, Forschner A, Kirchberger MC, Loquai C, Meissner M, Meier F, Terheyden P, Schell B, Herbst R, Göppner D, Kiecker F, Rafei-Shamsabadi D, Haferkamp S, Huber MA, Utikal J, Ziemer M, Bumeder I, Pfeiffer C, Schäd SG, Schmid-Tannwald C, et al.","Eur J Cancer. 2017 Sep;82:56-65. doi: 10.1016/j.ejca.2017.05.038. Epub 2017 Jun 22.","Eur J Cancer.  2017","PubMed","citation","PMID:28648699","pubmed","28648699","create date:2017/06/27 | first author:Heppt MV",
"Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?","/pubmed/28639409","Bender C, Enk A, Gutzmer R, Hassel JC.","Cancer Med. 2017 Jul;6(7):1581-1586. doi: 10.1002/cam4.887. Epub 2017 Jun 21.","Cancer Med.  2017","PubMed","citation","PMID:28639409 | PMCID:PMC5504332","pubmed","28639409","create date:2017/06/24 | first author:Bender C",
"Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer.","/pubmed/28638732","Kruger S, Legenstein ML, Rösgen V, Haas M, Modest DP, Westphalen CB, Ormanns S, Kirchner T, Heinemann V, Holdenrieder S, Boeck S.","Oncoimmunology. 2017 Mar 31;6(5):e1310358. doi: 10.1080/2162402X.2017.1310358. eCollection 2017.","Oncoimmunology.  2017","PubMed","citation","PMID:28638732 | PMCID:PMC5467983","pubmed","28638732","create date:2017/06/24 | first author:Kruger S",
"A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancer.","/pubmed/28625637","Wehler T, Thomas M, Schumann C, Bosch-Barrera J, Viñolas Segarra N, Dickgreber NJ, Dalhoff K, Sebastian M, Corral Jaime J, Alonso M, Hynes SM, Lin J, Hurt K, Bence Lin A, Calvo E, Paz-Ares L.","Lung Cancer. 2017 Jun;108:212-216. doi: 10.1016/j.lungcan.2017.03.001. Epub 2017 Mar 6.","Lung Cancer.  2017","PubMed","citation","PMID:28625637","pubmed","28625637","create date:2017/06/20 | first author:Wehler T",
"Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.","/pubmed/28621624","Akyerli CB, Yüksel Ş, Can Ö, Erson-Omay EZ, Oktay Y, Coşgun E, Ülgen E, Erdemgil Y, Sav A, von Deimling A, Günel M, Yakıcıer MC, Pamir MN, Özduman K.","J Neurosurg. 2018 Apr;128(4):1102-1114. doi: 10.3171/2016.11.JNS16973. Epub 2017 Jun 16.","J Neurosurg.  2018","PubMed","citation","PMID:28621624","pubmed","28621624","create date:2017/06/18 | first author:Akyerli CB",
"Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer.","/pubmed/28619747","Czink E, Kloor M, Goeppert B, Fröhling S, Uhrig S, Weber TF, Meinel J, Sutter C, Weiss KH, Schirmacher P, Doeberitz MVK, Jäger D, Springfeld C.","Cold Spring Harb Mol Case Stud. 2017 Sep 1;3(5). pii: a001974. doi: 10.1101/mcs.a001974. Print 2017 Sep.","Cold Spring Harb Mol Case Stud.  2017","PubMed","citation","PMID:28619747 | PMCID:PMC5593153","pubmed","28619747","create date:2017/06/18 | first author:Czink E",
"Click chemistry enables preclinical evaluation of targeted epigenetic therapies.","/pubmed/28619718","Tyler DS, Vappiani J, Cañeque T, Lam EYN, Ward A, Gilan O, Chan YC, Hienzsch A, Rutkowska A, Werner T, Wagner AJ, Lugo D, Gregory R, Ramirez Molina C, Garton N, Wellaway CR, Jackson S, MacPherson L, Figueiredo M, Stolzenburg S, Bell CC, House C, et al.","Science. 2017 Jun 30;356(6345):1397-1401. doi: 10.1126/science.aal2066. Epub 2017 Jun 15.","Science.  2017","PubMed","citation","PMID:28619718 | PMCID:PMC5865750","pubmed","28619718","create date:2017/06/18 | first author:Tyler DS",
"Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.","/pubmed/28600969","Heppt MV, Roesch A, Weide B, Gutzmer R, Meier F, Loquai C, Kähler KC, Gesierich A, Meissner M, von Bubnoff D, Göppner D, Schlaak M, Pföhler C, Utikal J, Heinzerling L, Cosgarea I, Engel J, Eckel R, Martens A, Mirlach L, Satzger I, Schubert-Fritschle G, et al.","Eur J Cancer. 2017 Aug;81:36-44. doi: 10.1016/j.ejca.2017.05.014. Epub 2017 Jun 7.","Eur J Cancer.  2017","PubMed","citation","PMID:28600969","pubmed","28600969","create date:2017/06/11 | first author:Heppt MV",
"Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule.","/pubmed/28557430","Cheng X, Merz KH, Vatter S, Zeller J, Muehlbeyer S, Thommet A, Christ J, Wölfl S, Eisenbrand G.","J Med Chem. 2017 Jun 22;60(12):4949-4962. doi: 10.1021/acs.jmedchem.7b00324. Epub 2017 Jun 6.","J Med Chem.  2017","PubMed","citation","PMID:28557430","pubmed","28557430","create date:2017/05/31 | first author:Cheng X",
"Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions.","/pubmed/28550712","Hassel JC, Heinzerling L, Aberle J, Bähr O, Eigentler TK, Grimm MO, Grünwald V, Leipe J, Reinmuth N, Tietze JK, Trojan J, Zimmer L, Gutzmer R.","Cancer Treat Rev. 2017 Jun;57:36-49. doi: 10.1016/j.ctrv.2017.05.003. Epub 2017 May 18. Review.","Cancer Treat Rev.  2017","PubMed","citation","PMID:28550712","pubmed","28550712","create date:2017/05/28 | first author:Hassel JC",
"Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review.","/pubmed/28548892","Eltobgy M, Oweira H, Petrausch U, Helbling D, Schmidt J, Mehrabi A, Schöb O, Giryes A, Decker M, Abdel-Rahman O.","Expert Rev Neurother. 2017 Jul;17(7):725-736. doi: 10.1080/14737175.2017.1336088. Epub 2017 May 31.","Expert Rev Neurother.  2017","PubMed","citation","PMID:28548892","pubmed","28548892","create date:2017/05/27 | first author:Eltobgy M",
"EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution.","/pubmed/28548121","Gao J, Behdad A, Ji P, Wolniak KL, Frankfurt O, Chen YH.","Mod Pathol. 2017 Aug;30(8):1100-1115. doi: 10.1038/modpathol.2017.37. Epub 2017 May 26.","Mod Pathol.  2017","PubMed","citation","PMID:28548121","pubmed","28548121","create date:2017/05/27 | first author:Gao J",
"Cancer cell and macrophage cross-talk in the tumor microenvironment.","/pubmed/28538141","Dehne N, Mora J, Namgaladze D, Weigert A, Brüne B.","Curr Opin Pharmacol. 2017 Aug;35:12-19. doi: 10.1016/j.coph.2017.04.007. Epub 2017 May 21. Review.","Curr Opin Pharmacol.  2017","PubMed","citation","PMID:28538141","pubmed","28538141","create date:2017/05/26 | first author:Dehne N",
"Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy.","/pubmed/28533272","Schlenker R, Olguín-Contreras LF, Leisegang M, Schnappinger J, Disovic A, Rühland S, Nelson PJ, Leonhardt H, Harz H, Wilde S, Schendel DJ, Uckert W, Willimsky G, Noessner E.","Cancer Res. 2017 Jul 1;77(13):3577-3590. doi: 10.1158/0008-5472.CAN-16-1922. Epub 2017 May 22.","Cancer Res.  2017","PubMed","citation","PMID:28533272","pubmed","28533272","create date:2017/05/24 | first author:Schlenker R",
"Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targeting.","/pubmed/28514757","Vehlow A, Klapproth E, Storch K, Dickreuter E, Seifert M, Dietrich A, Bütof R, Temme A, Cordes N.","Oncotarget. 2017 Jul 25;8(30):49224-49237. doi: 10.18632/oncotarget.17480.","Oncotarget.  2017","PubMed","citation","PMID:28514757 | PMCID:PMC5564763","pubmed","28514757","create date:2017/05/18 | first author:Vehlow A",
"Treatment of severe forms of LPS-responsive beige-like anchor protein deficiency with allogeneic hematopoietic stem cell transplantation.","/pubmed/28502825","Seidel MG, Böhm K, Dogu F, Worth A, Thrasher A, Florkin B, İkincioğulları A, Peters A, Bakhtiar S, Meeths M, Stepensky P, Meyts I, Sharapova SO, Gámez-Díaz L, Hammarström L, Ehl S, Grimbacher B, Gennery AR; Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation..","J Allergy Clin Immunol. 2018 Feb;141(2):770-775.e1. doi: 10.1016/j.jaci.2017.04.023. Epub 2017 May 10. No abstract available. ","J Allergy Clin Immunol.  2018","PubMed","citation","PMID:28502825","pubmed","28502825","create date:2017/05/16 | first author:Seidel MG",
"The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy.","/pubmed/28501560","Martin D, Rödel F, Balermpas P, Rödel C, Fokas E.","Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):221-230. doi: 10.1016/j.bbcan.2017.05.001. Epub 2017 May 10. Review.","Biochim Biophys Acta Rev Cancer.  2017","PubMed","citation","PMID:28501560","pubmed","28501560","create date:2017/05/16 | first author:Martin D",
"Vaccine-based immunotherapeutic approaches to gliomas and beyond.","/pubmed/28497804","Weller M, Roth P, Preusser M, Wick W, Reardon DA, Platten M, Sampson JH.","Nat Rev Neurol. 2017 Jun;13(6):363-374. doi: 10.1038/nrneurol.2017.64. Epub 2017 May 12. Review.","Nat Rev Neurol.  2017","PubMed","citation","PMID:28497804","pubmed","28497804","create date:2017/05/13 | first author:Weller M",
"Combining Low Temperature Fluorescence DNA-Hybridization, Immunostaining, and Super-Resolution Localization Microscopy for Nano-Structure Analysis of ALU Elements and Their Influence on Chromatin Structure.","/pubmed/28481278","Krufczik M, Sievers A, Hausmann A, Lee JH, Hildenbrand G, Schaufler W, Hausmann M.","Int J Mol Sci. 2017 May 7;18(5). pii: E1005. doi: 10.3390/ijms18051005.","Int J Mol Sci.  2017","PubMed","citation","PMID:28481278 | PMCID:PMC5454918","pubmed","28481278","create date:2017/05/10 | first author:Krufczik M",
"The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).","/pubmed/28480996","Balermpas P, Rödel F, Krause M, Linge A, Lohaus F, Baumann M, Tinhofer I, Budach V, Sak A, Stuschke M, Gkika E, Grosu AL, Abdollahi A, Debus J, Stangl S, Ganswindt U, Belka C, Pigorsch S, Multhoff G, Combs SE, Welz S, Zips D, et al.","Int J Cancer. 2017 Aug 1;141(3):594-603. doi: 10.1002/ijc.30770. Epub 2017 May 19.","Int J Cancer.  2017","PubMed","citation","PMID:28480996","pubmed","28480996","create date:2017/05/10 | first author:Balermpas P",
"Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors.","/pubmed/28466543","Budczies J, Bockmayr M, Klauschen F, Endris V, Fröhling S, Schirmacher P, Denkert C, Stenzinger A.","Genes Chromosomes Cancer. 2017 Aug;56(8):651-659. doi: 10.1002/gcc.22468. Epub 2017 May 31.","Genes Chromosomes Cancer.  2017","PubMed","citation","PMID:28466543","pubmed","28466543","create date:2017/05/04 | first author:Budczies J",
"Management of skin adverse events associated with immune checkpoint inhibitors in patients with melanoma: A nursing perspective.","/pubmed/28436601","Thebeau M, Rubin K, Hofmann M, Grimm J, Weinstein A, Choi JN.","J Am Assoc Nurse Pract. 2017 May;29(5):294-303. doi: 10.1002/2327-6924.12458. Epub 2017 Apr 24.","J Am Assoc Nurse Pract.  2017","PubMed","citation","PMID:28436601","pubmed","28436601","create date:2017/04/25 | first author:Thebeau M",
"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.","/pubmed/28434648","El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, Kim TY, Choo SP, Trojan J, Welling TH Rd, Meyer T, Kang YK, Yeo W, Chopra A, Anderson J, Dela Cruz C, Lang L, Neely J, Tang H, Dastani HB, Melero I.","Lancet. 2017 Jun 24;389(10088):2492-2502. doi: 10.1016/S0140-6736(17)31046-2. Epub 2017 Apr 20.","Lancet.  2017","PubMed","citation","PMID:28434648","pubmed","28434648","create date:2017/04/25 | first author:El-Khoueiry AB",
"Immune Gene Expression Is Associated with Genomic Aberrations in Breast Cancer.","/pubmed/28428277","Safonov A, Jiang T, Bianchini G, Győrffy B, Karn T, Hatzis C, Pusztai L.","Cancer Res. 2017 Jun 15;77(12):3317-3324. doi: 10.1158/0008-5472.CAN-16-3478. Epub 2017 Apr 20.","Cancer Res.  2017","PubMed","citation","PMID:28428277","pubmed","28428277","create date:2017/04/22 | first author:Safonov A",
"HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.","/pubmed/28423700","Schrörs B, Lübcke S, Lennerz V, Fatho M, Bicker A, Wölfel C, Derigs P, Hankeln T, Schadendorf D, Paschen A, Wölfel T.","Oncotarget. 2017 Apr 25;8(17):28312-28327. doi: 10.18632/oncotarget.16048.","Oncotarget.  2017","PubMed","citation","PMID:28423700 | PMCID:PMC5438652","pubmed","28423700","create date:2017/04/21 | first author:Schrörs B",
"Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma.","/pubmed/28423487","de Coaña YP, Wolodarski M, Poschke I, Yoshimoto Y, Yang Y, Nyström M, Edbäck U, Brage SE, Lundqvist A, Masucci GV, Hansson J, Kiessling R.","Oncotarget. 2017 Mar 28;8(13):21539-21553. doi: 10.18632/oncotarget.15368.","Oncotarget.  2017","PubMed","citation","PMID:28423487 | PMCID:PMC5400604","pubmed","28423487","create date:2017/04/21 | first author:de Coaña YP",
"Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.","/pubmed/28412732","Weber H, Valbuena JR, Barbhuiya MA, Stein S, Kunkel H, García P, Bizama C, Riquelme I, Espinoza JA, Kurtz SE, Tyner JW, Calderon JF, Corvalán AH, Grez M, Pandey A, Leal-Rojas P, Roa JC.","Oncotarget. 2017 Apr 18;8(16):26169-26184. doi: 10.18632/oncotarget.15410.","Oncotarget.  2017","PubMed","citation","PMID:28412732 | PMCID:PMC5432248","pubmed","28412732","create date:2017/04/17 | first author:Weber H",
"Human papilloma virus load and PD-1/PD-L1, CD8(+) and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy.","/pubmed/28405521","Balermpas P, Martin D, Wieland U, Rave-Fränk M, Strebhardt K, Rödel C, Fokas E, Rödel F.","Oncoimmunology. 2017 Feb 6;6(3):e1288331. doi: 10.1080/2162402X.2017.1288331. eCollection 2017.","Oncoimmunology.  2017","PubMed","citation","PMID:28405521 | PMCID:PMC5384387","pubmed","28405521","create date:2017/04/14 | first author:Balermpas P",
"PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcoma.","/pubmed/28405504","Budczies J, Mechtersheimer G, Denkert C, Klauschen F, Mughal SS, Chudasama P, Bockmayr M, Jöhrens K, Endris V, Lier A, Lasitschka F, Penzel R, Dietel M, Brors B, Gröschel S, Glimm H, Schirmacher P, Renner M, Fröhling S, Stenzinger A.","Oncoimmunology. 2017 Jan 27;6(3):e1279777. doi: 10.1080/2162402X.2017.1279777. eCollection 2017.","Oncoimmunology.  2017","PubMed","citation","PMID:28405504 | PMCID:PMC5384369","pubmed","28405504","create date:2017/04/14 | first author:Budczies J",
"MiR-200b and miR-155 as predictive biomarkers for the efficacy of chemoradiation in locally advanced head and neck squamous cell carcinoma.","/pubmed/28347920","Hess AK, Müer A, Mairinger FD, Weichert W, Stenzinger A, Hummel M, Budach V, Tinhofer I.","Eur J Cancer. 2017 May;77:3-12. doi: 10.1016/j.ejca.2017.02.018. Epub 2017 Mar 26.","Eur J Cancer.  2017","PubMed","citation","PMID:28347920","pubmed","28347920","create date:2017/03/30 | first author:Hess AK",
"Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer.","/pubmed/28344890","Dewi DL, Mohapatra SR, Blanco Cabañes S, Adam I, Somarribas Patterson LF, Berdel B, Kahloon M, Thürmann L, Loth S, Heilmann K, Weichenhan D, Mücke O, Heiland I, Wimberger P, Kuhlmann JD, Kellner KH, Schott S, Plass C, Platten M, Gerhäuser C, Trump S, Opitz CA.","Oncoimmunology. 2017 Jan 3;6(2):e1274477. doi: 10.1080/2162402X.2016.1274477. eCollection 2017.","Oncoimmunology.  2017","PubMed","citation","PMID:28344890 | PMCID:PMC5353999","pubmed","28344890","create date:2017/03/28 | first author:Dewi DL",
"A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer.","/pubmed/28303530","Thomas M, Sadjadian P, Kollmeier J, Lowe J, Mattson P, Trout JR, Gargano M, Patchen ML, Walsh R, Beliveau M, Marier JF, Bose N, Gorden K, Schneller F 3rd.","Invest New Drugs. 2017 Jun;35(3):345-358. doi: 10.1007/s10637-017-0450-3. Epub 2017 Mar 16.","Invest New Drugs.  2017","PubMed","citation","PMID:28303530 | PMCID:PMC5418307","pubmed","28303530","create date:2017/03/18 | first author:Thomas M",
"Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review.","/pubmed/28277102","Abdel-Rahman O, Oweira H, Petrausch U, Helbling D, Schmidt J, Mannhart M, Mehrabi A, Schöb O, Giryes A.","Expert Rev Anticancer Ther. 2017 Apr;17(4):387-394. doi: 10.1080/14737140.2017.1296765. Epub 2017 Feb 24. Review.","Expert Rev Anticancer Ther.  2017","PubMed","citation","PMID:28277102","pubmed","28277102","create date:2017/03/10 | first author:Abdel-Rahman O",
"Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.","/pubmed/28262583","Zschäbitz S, Lasitschka F, Hadaschik B, Hofheinz RD, Jentsch-Ullrich K, Grüner M, Jäger D, Grüllich C.","Eur J Cancer. 2017 May;76:1-7. doi: 10.1016/j.ejca.2017.01.033. Epub 2017 Mar 4.","Eur J Cancer.  2017","PubMed","citation","PMID:28262583","pubmed","28262583","create date:2017/03/07 | first author:Zschäbitz S",
"Synthesis and formulation studies of griseofulvin analogues with improved solubility and metabolic stability.","/pubmed/28258034","Petersen AB, Andersen NS, Konotop G, Hanafiah NH, Raab MS, Krämer A, Clausen MH.","Eur J Med Chem. 2017 Apr 21;130:240-247. doi: 10.1016/j.ejmech.2017.02.055. Epub 2017 Feb 22.","Eur J Med Chem.  2017","PubMed","citation","PMID:28258034","pubmed","28258034","create date:2017/03/05 | first author:Petersen AB",
"The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma.","/pubmed/28257959","Thapa B, Salcedo A, Lin X, Walkiewicz M, Murone C, Ameratunga M, Asadi K, Deb S, Barnett SA, Knight S, Mitchell P, Watkins DN, Boutros PC, John T.","J Thorac Oncol. 2017 May;12(5):850-859. doi: 10.1016/j.jtho.2017.02.013. Epub 2017 Feb 28.","J Thorac Oncol.  2017","PubMed","citation","PMID:28257959","pubmed","28257959","create date:2017/03/05 | first author:Thapa B",
"Reinduction of PD1-inhibitor therapy: first experience in eight patients with metastatic melanoma.","/pubmed/28257394","Blasig H, Bender C, Hassel JC, Eigentler TK, Sachse MM, Hiernickel J, Koop A, Satzger I, Gutzmer R.","Melanoma Res. 2017 Aug;27(4):321-325. doi: 10.1097/CMR.0000000000000341.","Melanoma Res.  2017","PubMed","citation","PMID:28257394","pubmed","28257394","create date:2017/03/04 | first author:Blasig H",
"Gene signature driving invasive mucinous adenocarcinoma of the lung.","/pubmed/28255028","Guo M, Tomoshige K, Meister M, Muley T, Fukazawa T, Tsuchiya T, Karns R, Warth A, Fink-Baldauf IM, Nagayasu T, Naomoto Y, Xu Y, Mall MA, Maeda Y.","EMBO Mol Med. 2017 Apr;9(4):462-481. doi: 10.15252/emmm.201606711.","EMBO Mol Med.  2017","PubMed","citation","PMID:28255028 | PMCID:PMC5376761","pubmed","28255028","create date:2017/03/04 | first author:Guo M",
"Imaging Flow Cytometry for Multiparametric Analysis of Molecular Mechanism Involved in the Cytotoxicity of Human CD8(+) T-cells.","/pubmed/28252214","Wabnitz GH, Kirchgessner H, Samstag Y.","J Cell Biochem. 2017 Sep;118(9):2528-2533. doi: 10.1002/jcb.25963. Epub 2017 Apr 27.","J Cell Biochem.  2017","PubMed","citation","PMID:28252214","pubmed","28252214","create date:2017/03/03 | first author:Wabnitz GH",
"PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer.","/pubmed/28228704","Hartkopf AD, Taran FA, Wallwiener M, Walter CB, Krämer B, Grischke EM, Brucker SY.","Breast Care (Basel). 2016 Dec;11(6):385-390. doi: 10.1159/000453569. Epub 2016 Dec 8. Review.","Breast Care (Basel).  2016","PubMed","citation","PMID:28228704 | PMCID:PMC5290437","pubmed","28228704","create date:2017/02/24 | first author:Hartkopf AD",
"[Possible Significance of Bronchoalveolar Lavage Cytology at Initial Diagnosis and Follow-up of Lung Cancer].","/pubmed/28222478","Grünewaldt A, Hügel C, Hermann E, Wagner TO.","Pneumologie. 2017 Feb;71(2):106-110. doi: 10.1055/s-0042-118054. Epub 2017 Feb 21. German. ","Pneumologie.  2017","PubMed","citation","PMID:28222478","pubmed","28222478","create date:2017/02/22 | first author:Grünewaldt A",
"Alpha tocopherol transfer protein (αTTP) is expressed in endometrial carcinoma and is correlated with FIGO stage and 5-year survival.","/pubmed/28213729","Heublein S, Vrekoussis T, Etzl R, Rotzoll D, Kuhn C, Faigle G, Navrozoglou I, Stefos T, Makrigiannakis A, Jeschke U.","J Cancer Res Clin Oncol. 2017 May;143(5):773-781. doi: 10.1007/s00432-017-2340-7. Epub 2017 Feb 17.","J Cancer Res Clin Oncol.  2017","PubMed","citation","PMID:28213729","pubmed","28213729","create date:2017/02/19 | first author:Heublein S",
"Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma.","/pubmed/28201977","Podar K, Jager D.","Curr Cancer Drug Targets. 2017;17(9):782-805. doi: 10.2174/1568009617666170214103834. Review.","Curr Cancer Drug Targets.  2017","PubMed","citation","PMID:28201977","pubmed","28201977","create date:2017/02/17 | first author:Podar K",
"Checkpoint inhibition for advanced mucosal melanoma.","/pubmed/28174141","Thierauf J, Veit JA, Hess J, Treiber N, Lisson C, Weissinger SE, Bommer M, Hoffmann TK.","Eur J Dermatol. 2017 Apr 1;27(2):160-165. doi: 10.1684/ejd.2016.2949.","Eur J Dermatol.  2017","PubMed","citation","PMID:28174141","pubmed","28174141","create date:2017/02/09 | first author:Thierauf J",
"RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.","/pubmed/28151480","Hänggi K, Vasilikos L, Valls AF, Yerbes R, Knop J, Spilgies LM, Rieck K, Misra T, Bertin J, Gough PJ, Schmidt T, de Almodòvar CR, Wong WW.","Cell Death Dis. 2017 Feb 2;8(2):e2588. doi: 10.1038/cddis.2017.20.","Cell Death Dis.  2017","PubMed","citation","PMID:28151480 | PMCID:PMC5386469","pubmed","28151480","create date:2017/02/06 | first author:Hänggi K",
"Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease.","/pubmed/28110411","Veldhuijzen van Zanten SE, Baugh J, Chaney B, De Jongh D, Sanchez Aliaga E, Barkhof F, Noltes J, De Wolf R, Van Dijk J, Cannarozzo A, Damen-Korbijn CM, Lieverst JA, Colditz N, Hoffmann M, Warmuth-Metz M, Bison B, Jones DT, Sturm D, Gielen GH, Jones C, Hulleman E, Calmon R, et al.","J Neurooncol. 2017 Apr;132(2):255-266. doi: 10.1007/s11060-016-2363-y. Epub 2017 Jan 21.","J Neurooncol.  2017","PubMed","citation","PMID:28110411 | PMCID:PMC5378734","pubmed","28110411","create date:2017/01/23 | first author:Veldhuijzen van Zanten SE",
"Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion.","/pubmed/28103033","Prescher H, Frank M, Gütgemann S, Kuhfeldt E, Schweizer A, Nitschke L, Watzl C, Brossmer R.","J Med Chem. 2017 Feb 9;60(3):941-956. doi: 10.1021/acs.jmedchem.6b01111. Epub 2017 Jan 19.","J Med Chem.  2017","PubMed","citation","PMID:28103033","pubmed","28103033","create date:2017/01/20 | first author:Prescher H",
"Proposed diagnostic criteria and classification of basophilic leukemias and related disorders.","/pubmed/28090091","Valent P, Sotlar K, Blatt K, Hartmann K, Reiter A, Sadovnik I, Sperr WR, Bettelheim P, Akin C, Bauer K, George TI, Hadzijusufovic E, Wolf D, Gotlib J, Mahon FX, Metcalfe DD, Horny HP, Arock M.","Leukemia. 2017 Apr;31(4):788-797. doi: 10.1038/leu.2017.15. Epub 2017 Jan 16. Review.","Leukemia.  2017","PubMed","citation","PMID:28090091","pubmed","28090091","create date:2017/01/17 | first author:Valent P",
"Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.","/pubmed/28090089","Neuenhahn M, Albrecht J, Odendahl M, Schlott F, Dössinger G, Schiemann M, Lakshmipathi S, Martin K, Bunjes D, Harsdorf S, Weissinger EM, Menzel H, Verbeek M, Uharek L, Kröger N, Wagner E, Kobbe G, Schroeder T, Schmitt M, Held G, Herr W, Germeroth L, et al.","Leukemia. 2017 Oct;31(10):2161-2171. doi: 10.1038/leu.2017.16. Epub 2017 Jan 16.","Leukemia.  2017","PubMed","citation","PMID:28090089","pubmed","28090089","create date:2017/01/17 | first author:Neuenhahn M",
"The seven faces of SIRT7.","/pubmed/28067587","Blank MF, Grummt I.","Transcription. 2017 Mar 15;8(2):67-74. doi: 10.1080/21541264.2016.1276658. Epub 2017 Jan 9. Review.","Transcription.  2017","PubMed","citation","PMID:28067587 | PMCID:PMC5423475","pubmed","28067587","create date:2017/01/10 | first author:Blank MF",
"Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.","/pubmed/28056206","D'Angelo SP, Larkin J, Sosman JA, Lebbé C, Brady B, Neyns B, Schmidt H, Hassel JC, Hodi FS, Lorigan P, Savage KJ, Miller WH Jr, Mohr P, Marquez-Rodas I, Charles J, Kaatz M, Sznol M, Weber JS, Shoushtari AN, Ruisi M, Jiang J, Wolchok JD.","J Clin Oncol. 2017 Jan 10;35(2):226-235. Epub 2016 Nov 7.","J Clin Oncol.  2017","PubMed","citation","PMID:28056206 | PMCID:PMC5559888","pubmed","28056206","create date:2017/01/06 | first author:D'Angelo SP",
"Are there HIV-specific Differences for Anal Cancer Patients Treated with Standard Chemoradiotherapy in the Era of Combined Antiretroviral Therapy?","/pubmed/28049602","Martin D, Balermpas P, Fokas E, Rödel C, Yildirim M.","Clin Oncol (R Coll Radiol). 2017 Apr;29(4):248-255. doi: 10.1016/j.clon.2016.12.010. Epub 2016 Dec 31.","Clin Oncol (R Coll Radiol).  2017","PubMed","citation","PMID:28049602","pubmed","28049602","create date:2017/01/05 | first author:Martin D",
"Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.","/pubmed/28049532","Isono M, Hoffmann MJ, Pinkerneil M, Sato A, Michaelis M, Cinatl J Jr, Niegisch G, Schulz WA.","J Exp Clin Cancer Res. 2017 Jan 3;36(1):1. doi: 10.1186/s13046-016-0473-1.","J Exp Clin Cancer Res.  2017","PubMed","citation","PMID:28049532 | PMCID:PMC5209915","pubmed","28049532","create date:2017/01/05 | first author:Isono M",
"The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models.","/pubmed/28036269","Pajtler KW, Sadowski N, Ackermann S, Althoff K, Schönbeck K, Batzke K, Schäfers S, Odersky A, Heukamp L, Astrahantseff K, Künkele A, Deubzer HE, Schramm A, Sprüssel A, Thor T, Lindner S, Eggert A, Fischer M, Schulte JH.","Oncotarget. 2017 Jan 24;8(4):6730-6741. doi: 10.18632/oncotarget.14268.","Oncotarget.  2017","PubMed","citation","PMID:28036269 | PMCID:PMC5351666","pubmed","28036269","create date:2016/12/31 | first author:Pajtler KW",
"Neurological sequelae of cancer immunotherapies and targeted therapies.","/pubmed/27924751","Wick W, Hertenstein A, Platten M.","Lancet Oncol. 2016 Dec;17(12):e529-e541. doi: 10.1016/S1470-2045(16)30571-X. Review.","Lancet Oncol.  2016","PubMed","citation","PMID:27924751","pubmed","27924751","create date:2016/12/08 | first author:Wick W",
"Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.","/pubmed/27916938","Pehserl AM, Ress AL, Stanzer S, Resel M, Karbiener M, Stadelmeyer E, Stiegelbauer V, Gerger A, Mayr C, Scheideler M, Hutterer GC, Bauernhofer T, Kiesslich T, Pichler M.","Int J Mol Sci. 2016 Dec 1;17(12). pii: E2011.","Int J Mol Sci.  2016","PubMed","citation","PMID:27916938 | PMCID:PMC5187811","pubmed","27916938","create date:2016/12/06 | first author:Pehserl AM",
"Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.","/pubmed/27916512","Lucchini G, Labopin M, Beohou E, Dalissier A, Dalle JH, Cornish J, Zecca M, Samarasinghe S, Gibson B, Locatelli F, Bertrand Y, Abdel-Rahman F, Socie G, Sundin M, Lankester A, Sedlacek P, Hamladji RM, Heilmann C, Afanasyev B, Hough R, Peters C, Bader P, et al.","Biol Blood Marrow Transplant. 2017 Mar;23(3):467-474. doi: 10.1016/j.bbmt.2016.11.022. Epub 2016 Dec 1.","Biol Blood Marrow Transplant.  2017","PubMed","citation","PMID:27916512","pubmed","27916512","create date:2016/12/06 | first author:Lucchini G",
"Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification.","/pubmed/27900363","Gröschel S, Bommer M, Hutter B, Budczies J, Bonekamp D, Heining C, Horak P, Fröhlich M, Uhrig S, Hübschmann D, Geörg C, Richter D, Pfarr N, Pfütze K, Wolf S, Schirmacher P, Jäger D, von Kalle C, Brors B, Glimm H, Weichert W, Stenzinger A, et al.","Cold Spring Harb Mol Case Stud. 2016 Nov;2(6):a001180.","Cold Spring Harb Mol Case Stud.  2016","PubMed","citation","PMID:27900363 | PMCID:PMC5111004","pubmed","27900363","create date:2016/12/03 | first author:Gröschel S",
"Treatment-related Death in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.","/pubmed/27894673","Abdel-Rahman O, Helbling D, Schmidt J, Petrausch U, Giryes A, Mehrabi A, Schöb O, Mannhart M, Oweira H.","Clin Oncol (R Coll Radiol). 2017 Apr;29(4):218-230. doi: 10.1016/j.clon.2016.11.007. Epub 2016 Nov 25. Review.","Clin Oncol (R Coll Radiol).  2017","PubMed","citation","PMID:27894673","pubmed","27894673","create date:2016/11/30 | first author:Abdel-Rahman O",
"Acidic stress induced G1 cell cycle arrest and intrinsic apoptotic pathway in Jurkat T-lymphocytes.","/pubmed/27884681","Kim JY, Cheng X, Wölfl S.","Exp Cell Res. 2017 Jan 1;350(1):140-146. doi: 10.1016/j.yexcr.2016.11.015. Epub 2016 Nov 21.","Exp Cell Res.  2017","PubMed","citation","PMID:27884681","pubmed","27884681","create date:2016/11/26 | first author:Kim JY",
"Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.","/pubmed/27863192","von Bueren AO, Kortmann RD, von Hoff K, Friedrich C, Mynarek M, Müller K, Goschzik T, Zur Mühlen A, Gerber N, Warmuth-Metz M, Soerensen N, Deinlein F, Benesch M, Zwiener I, Kwiecien R, Faldum A, Bode U, Fleischhack G, Hovestadt V, Kool M, Jones D, Northcott P, et al.","J Clin Oncol. 2016 Dec;34(34):4151-4160. Epub 2016 Oct 31.","J Clin Oncol.  2016","PubMed","citation","PMID:27863192","pubmed","27863192","create date:2016/11/20 | first author:von Bueren AO",
"Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG ""GERMELATOX survey"") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy.","/pubmed/27861370","Kaehler KC, Blome C, Forschner A, Gutzmer R, Haalck T, Heinzerling L, Kornek T, Livingstone E, Loquai C, Maul LV, Lang BM, Schadendorf D, Stade B, Terheyden P, Utikal J, Wagner T, Hauschild A, Garbe C, Augustin M.","Medicine (Baltimore). 2016 Nov;95(46):e5375.","Medicine (Baltimore).  2016","PubMed","citation","PMID:27861370 | PMCID:PMC5120927","pubmed","27861370","create date:2016/11/20 | first author:Kaehler KC",
"High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).","/pubmed/27843136","Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Möhle R, Löw S, Binder M, Atta J, Keller U, Wolf HH, Krause SW, Heß G, Naumann R, Sasse S, Hirt C, Lamprecht M, Martens U, Morgner A, Panse J, Frickhofen N, Röth A, et al.","Leukemia. 2017 Apr;31(4):846-852. doi: 10.1038/leu.2016.334. Epub 2016 Nov 15.","Leukemia.  2017","PubMed","citation","PMID:27843136 | PMCID:PMC5383936","pubmed","27843136","create date:2016/11/16 | first author:Fritsch K",
"Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells.","/pubmed/27838375","Schäfer C, Göder A, Beyer M, Kiweler N, Mahendrarajah N, Rauch A, Nikolova T, Stojanovic N, Wieczorek M, Reich TR, Tomicic MT, Linnebacher M, Sonnemann J, Dietrich S, Sellmer A, Mahboobi S, Heinzel T, Schneider G, Krämer OH.","Cell Signal. 2017 Jan;29:218-225. doi: 10.1016/j.cellsig.2016.11.002. Epub 2016 Nov 9.","Cell Signal.  2017","PubMed","citation","PMID:27838375","pubmed","27838375","create date:2016/11/14 | first author:Schäfer C",
"Control of diabetic hyperglycaemia and insulin resistance through TSC22D4.","/pubmed/27827363","Ekim Üstünel B, Friedrich K, Maida A, Wang X, Krones-Herzig A, Seibert O, Sommerfeld A, Jones A, Sijmonsma TP, Sticht C, Gretz N, Fleming T, Nawroth PP, Stremmel W, Rose AJ, Berriel-Diaz M, Blüher M, Herzig S.","Nat Commun. 2016 Nov 9;7:13267. doi: 10.1038/ncomms13267.","Nat Commun.  2016","PubMed","citation","PMID:27827363 | PMCID:PMC5105165","pubmed","27827363","create date:2016/11/09 | first author:Ekim Üstünel B",
"[Cutaneous squamous cell carcinoma].","/pubmed/27680009","Leiter U, Gutzmer R, Alter M, Ulrich C, Lonsdorf AS, Sachse MM, Hillen U.","Hautarzt. 2016 Nov;67(11):857-866. Review. German. ","Hautarzt.  2016","PubMed","citation","PMID:27680009","pubmed","27680009","create date:2016/11/01 | first author:Leiter U",
"Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab.","/pubmed/27185375","Weide B, Martens A, Hassel JC, Berking C, Postow MA, Bisschop K, Simeone E, Mangana J, Schilling B, Di Giacomo AM, Brenner N, Kähler K, Heinzerling L, Gutzmer R, Bender A, Gebhardt C, Romano E, Meier F, Martus P, Maio M, Blank C, Schadendorf D, et al.","Clin Cancer Res. 2016 Nov 15;22(22):5487-5496. doi: 10.1158/1078-0432.CCR-16-0127. Epub 2016 May 16.","Clin Cancer Res.  2016","PubMed","citation","PMID:27185375 | PMCID:PMC5572569","pubmed","27185375","create date:2016/11/01 | first author:Weide B",
"Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.","/pubmed/27578530","Jandaghi P, Najafabadi HS, Bauer AS, Papadakis AI, Fassan M, Hall A, Monast A, von Knebel Doeberitz M, Neoptolemos JP, Costello E, Greenhalf W, Scarpa A, Sipos B, Auld D, Lathrop M, Park M, Büchler MW, Strobel O, Hackert T, Giese NA, Zogopoulos G, Sangwan V, et al.","Gastroenterology. 2016 Dec;151(6):1218-1231. doi: 10.1053/j.gastro.2016.08.040. Epub 2016 Aug 28.","Gastroenterology.  2016","PubMed","citation","PMID:27578530","pubmed","27578530","create date:2016/10/30 | first author:Jandaghi P",
"PD-1 blockade: a therapeutic option for treatment of metastatic Merkel cell carcinoma.","/pubmed/27038231","Winkler JK, Bender C, Kratochwil C, Enk A, Hassel JC.","Br J Dermatol. 2017 Jan;176(1):216-219. doi: 10.1111/bjd.14632. Epub 2016 Oct 23.","Br J Dermatol.  2017","PubMed","citation","PMID:27038231","pubmed","27038231","create date:2016/10/25 | first author:Winkler JK",
"Immunotherapy in melanoma: Recent advances and future directions.","/pubmed/27769635","Franklin C, Livingstone E, Roesch A, Schilling B, Schadendorf D.","Eur J Surg Oncol. 2017 Mar;43(3):604-611. doi: 10.1016/j.ejso.2016.07.145. Epub 2016 Sep 2. Review.","Eur J Surg Oncol.  2017","PubMed","citation","PMID:27769635","pubmed","27769635","create date:2016/10/23 | first author:Franklin C",
"A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage.","/pubmed/27668799","Koay HF, Gherardin NA, Enders A, Loh L, Mackay LK, Almeida CF, Russ BE, Nold-Petry CA, Nold MF, Bedoui S, Chen Z, Corbett AJ, Eckle SB, Meehan B, d'Udekem Y, Konstantinov IE, Lappas M, Liu L, Goodnow CC, Fairlie DP, Rossjohn J, Chong MM, et al.","Nat Immunol. 2016 Nov;17(11):1300-1311. doi: 10.1038/ni.3565. Epub 2016 Sep 26.","Nat Immunol.  2016","PubMed","citation","PMID:27668799","pubmed","27668799","create date:2016/10/21 | first author:Koay HF",
"Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.","/pubmed/27733243","Sharma P, Callahan MK, Bono P, Kim J, Spiliopoulou P, Calvo E, Pillai RN, Ott PA, de Braud F, Morse M, Le DT, Jaeger D, Chan E, Harbison C, Lin CS, Tschaika M, Azrilevich A, Rosenberg JE.","Lancet Oncol. 2016 Nov;17(11):1590-1598. doi: 10.1016/S1470-2045(16)30496-X. Epub 2016 Oct 9.","Lancet Oncol.  2016","PubMed","citation","PMID:27733243 | PMCID:PMC5648054","pubmed","27733243","create date:2016/10/14 | first author:Sharma P",
"The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC.","/pubmed/27729297","Manegold C, Dingemans AC, Gray JE, Nakagawa K, Nicolson M, Peters S, Reck M, Wu YL, Brustugun OT, Crinò L, Felip E, Fennell D, Garrido P, Huber RM, Marabelle A, Moniuszko M, Mornex F, Novello S, Papotti M, Pérol M, Smit EF, Syrigos K, et al.","J Thorac Oncol. 2017 Feb;12(2):194-207. doi: 10.1016/j.jtho.2016.10.003. Epub 2016 Oct 8. Review.","J Thorac Oncol.  2017","PubMed","citation","PMID:27729297","pubmed","27729297","create date:2016/10/13 | first author:Manegold C",
"Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.","/pubmed/27717298","Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, Lebbé C, Ferraresi V, Smylie M, Weber JS, Maio M, Bastholt L, Mortier L, Thomas L, Tahir S, Hauschild A, Hassel JC, Hodi FS, et al.","N Engl J Med. 2016 Nov 10;375(19):1845-1855. Epub 2016 Oct 7.","N Engl J Med.  2016","PubMed","citation","PMID:27717298 | PMCID:PMC5648545","pubmed","27717298","create date:2016/10/09 | first author:Eggermont AM",
"Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.","/pubmed/27716369","Muranen TA, Blomqvist C, Dörk T, Jakubowska A, Heikkilä P, Fagerholm R, Greco D, Aittomäki K, Bojesen SE, Shah M, Dunning AM, Rhenius V, Hall P, Czene K, Brand JS, Darabi H, Chang-Claude J, Rudolph A, Nordestgaard BG, Couch FJ, Hart SN, Figueroa J, et al.","Breast Cancer Res. 2016 Oct 3;18(1):98.","Breast Cancer Res.  2016","PubMed","citation","PMID:27716369 | PMCID:PMC5048645","pubmed","27716369","create date:2016/10/08 | first author:Muranen TA",
"The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.","/pubmed/27716272","Hrgovic I, Doll M, Kleemann J, Wang XF, Zoeller N, Pinter A, Kippenberger S, Kaufmann R, Meissner M.","BMC Cancer. 2016 Sep 30;16(1):763.","BMC Cancer.  2016","PubMed","citation","PMID:27716272 | PMCID:PMC5045659","pubmed","27716272","create date:2016/10/08 | first author:Hrgovic I",
"Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.","/pubmed/27711073","Muranen TA, Greco D, Blomqvist C, Aittomäki K, Khan S, Hogervorst F, Verhoef S, Pharoah PDP, Dunning AM, Shah M, Luben R, Bojesen SE, Nordestgaard BG, Schoemaker M, Swerdlow A, García-Closas M, Figueroa J, Dörk T, Bogdanova NV, Hall P, Li J, Khusnutdinova E, et al.","Genet Med. 2017 May;19(5):599-603. doi: 10.1038/gim.2016.147. Epub 2016 Oct 6.","Genet Med.  2017","PubMed","citation","PMID:27711073 | PMCID:PMC5382131","pubmed","27711073","create date:2016/10/07 | first author:Muranen TA",
"A strong host response and lack of MYC expression are characteristic for diffuse large B cell lymphoma transformed from nodular lymphocyte predominant Hodgkin lymphoma.","/pubmed/27708232","Schuhmacher B, Rengstl B, Döring C, Bein J, Newrzela S, Brunnberg U, Kvasnicka HM, Vornanen M, Küppers R, Hansmann ML, Hartmann S.","Oncotarget. 2016 Nov 1;7(44):72197-72210. doi: 10.18632/oncotarget.12363.","Oncotarget.  2016","PubMed","citation","PMID:27708232 | PMCID:PMC5342154","pubmed","27708232","create date:2016/10/07 | first author:Schuhmacher B",
"Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.","/pubmed/27707976","Kramer M, Ribeiro D, Arsenian-Henriksson M, Deller T, Rohrer H.","J Neurosci. 2016 Oct 5;36(40):10425-10439.","J Neurosci.  2016","PubMed","citation","PMID:27707976","pubmed","27707976","create date:2016/10/07 | first author:Kramer M",
"Targeting the Bone Marrow Microenvironment.","/pubmed/27696259","Moschetta M, Kawano Y, Podar K.","Cancer Treat Res. 2016;169:63-102. Review.","Cancer Treat Res.  2016","PubMed","citation","PMID:27696259","pubmed","27696259","create date:2016/10/04 | first author:Moschetta M",
"PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception?","/pubmed/27696122","Erlmeier F, Hartmann A, Autenrieth M, Wiedemann M, Ivanyi P, Steffens S, Weichert W.","Med Oncol. 2016 Nov;33(11):120. Epub 2016 Sep 30.","Med Oncol.  2016","PubMed","citation","PMID:27696122","pubmed","27696122","create date:2016/10/04 | first author:Erlmeier F",
"Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.","/pubmed/27683114","Rieke DT, Ochsenreither S, Klinghammer K, Seiwert TY, Klauschen F, Tinhofer I, Keilholz U.","Oncotarget. 2016 Nov 15;7(46):75379-75393. doi: 10.18632/oncotarget.12211.","Oncotarget.  2016","PubMed","citation","PMID:27683114 | PMCID:PMC5342748","pubmed","27683114","create date:2016/09/30 | first author:Rieke DT",
"Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer.","/pubmed/27620277","George J, Saito M, Tsuta K, Iwakawa R, Shiraishi K, Scheel AH, Uchida S, Watanabe SI, Nishikawa R, Noguchi M, Peifer M, Jang SJ, Petersen I, Büttner R, Harris CC, Yokota J, Thomas RK, Kohno T.","Clin Cancer Res. 2017 Mar 1;23(5):1220-1226. doi: 10.1158/1078-0432.CCR-16-1069. Epub 2016 Sep 12.","Clin Cancer Res.  2017","PubMed","citation","PMID:27620277","pubmed","27620277","create date:2016/09/14 | first author:George J",
"Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient.","/pubmed/27614165","Herz S, Höfer T, Papapanagiotou M, Leyh JC, Meyenburg S, Schadendorf D, Ugurel S, Roesch A, Livingstone E, Schilling B, Franklin C.","Eur J Cancer. 2016 Nov;67:66-72. doi: 10.1016/j.ejca.2016.07.026. Epub 2016 Sep 8.","Eur J Cancer.  2016","PubMed","citation","PMID:27614165","pubmed","27614165","create date:2016/09/11 | first author:Herz S",
"PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.","/pubmed/27595995","Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, Reis-Filho J, Teo ZL, Radice P, Catucci I, Peterlongo P, Tsimiklis H, Odefrey FA, et al.","J Med Genet. 2016 Dec;53(12):800-811. doi: 10.1136/jmedgenet-2016-103839. Epub 2016 Sep 5.","J Med Genet.  2016","PubMed","citation","PMID:27595995 | PMCID:PMC5200636","pubmed","27595995","create date:2016/09/07 | first author:Southey MC",
"Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma?","/pubmed/27592804","Hauschild A, Schadendorf D.","Lancet Oncol. 2016 Oct;17(10):1337-1339. doi: 10.1016/S1470-2045(16)30441-7. Epub 2016 Sep 1. No abstract available. ","Lancet Oncol.  2016","PubMed","citation","PMID:27592804","pubmed","27592804","create date:2016/09/07 | first author:Hauschild A",
"Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab.","/pubmed/27568879","Ku M, Chong G, Hawkes EA.","Blood Rev. 2017 Jan;31(1):23-35. doi: 10.1016/j.blre.2016.08.001. Epub 2016 Aug 12. Review.","Blood Rev.  2017","PubMed","citation","PMID:27568879","pubmed","27568879","create date:2016/08/30 | first author:Ku M",
"NOTCH1 mediates a switch between two distinct secretomes during senescence.","/pubmed/27525720","Hoare M, Ito Y, Kang TW, Weekes MP, Matheson NJ, Patten DA, Shetty S, Parry AJ, Menon S, Salama R, Antrobus R, Tomimatsu K, Howat W, Lehner PJ, Zender L, Narita M.","Nat Cell Biol. 2016 Sep;18(9):979-92. doi: 10.1038/ncb3397. Epub 2016 Aug 15.","Nat Cell Biol.  2016","PubMed","citation","PMID:27525720 | PMCID:PMC5008465","pubmed","27525720","create date:2016/08/16 | first author:Hoare M",
"Treatment of Chronic Lymphocytic Leukemia With del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-Signaling Inhibitors?","/pubmed/27521330","Montserrat E, Dreger P.","Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S74-81. doi: 10.1016/j.clml.2016.02.013. Review.","Clin Lymphoma Myeloma Leuk.  2016","PubMed","citation","PMID:27521330","pubmed","27521330","create date:2016/08/16 | first author:Montserrat E",
"Perspectives for immunotherapy in endocrine cancer.","/pubmed/27485460","Latteyer S, Tiedje V, Schilling B, Führer D.","Endocr Relat Cancer. 2016 Oct;23(10):R469-84. doi: 10.1530/ERC-16-0169. Epub 2016 Aug 2. Review.","Endocr Relat Cancer.  2016","PubMed","citation","PMID:27485460","pubmed","27485460","create date:2016/08/04 | first author:Latteyer S",
"Concepts in glioma immunotherapy.","/pubmed/27460064","Platten M, Bunse L, Wick W, Bunse T.","Cancer Immunol Immunother. 2016 Oct;65(10):1269-75. doi: 10.1007/s00262-016-1874-x. Epub 2016 Jul 26. Review.","Cancer Immunol Immunother.  2016","PubMed","citation","PMID:27460064","pubmed","27460064","create date:2016/07/28 | first author:Platten M",
"L-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies.","/pubmed/27457521","Lee FT, Burvenich IJ, Guo N, Kocovski P, Tochon-Danguy H, Ackermann U, O'Keefe GJ, Gong S, Rigopoulos A, Liu Z, Gan HK, Scott AM.","Mol Imaging. 2016 Jul 25;15. pii: 1536012116647535. doi: 10.1177/1536012116647535. Print 2016.","Mol Imaging.  2016","PubMed","citation","PMID:27457521 | PMCID:PMC5470130","pubmed","27457521","create date:2016/07/28 | first author:Lee FT",
"Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma.","/pubmed/27449089","Prince EW, Balakrishnan I, Shah M, Mulcahy Levy JM, Griesinger AM, Alimova I, Harris PS, Birks DK, Donson AM, Davidson N, Remke M, Taylor MD, Handler MH, Foreman NK, Venkataraman S, Vibhakar R.","Oncotarget. 2016 Aug 16;7(33):53881-53894. doi: 10.18632/oncotarget.10692.","Oncotarget.  2016","PubMed","citation","PMID:27449089 | PMCID:PMC5288228","pubmed","27449089","create date:2016/07/28 | first author:Prince EW",
"High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers.","/pubmed/27446497","Hettich M, Braun F, Bartholomä MD, Schirmbeck R, Niedermann G.","Theranostics. 2016 Jun 18;6(10):1629-40. doi: 10.7150/thno.15253. eCollection 2016.","Theranostics.  2016","PubMed","citation","PMID:27446497 | PMCID:PMC4955062","pubmed","27446497","create date:2016/07/23 | first author:Hettich M",
"Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma.","/pubmed/27373241","Kähler KC, Hassel JC, Heinzerling L, Loquai C, Mössner R, Ugurel S, Zimmer L, Gutzmer R; “Cutaneous Side Effects” Committee of the Work Group Dermatological Oncology (ADO)..","J Dtsch Dermatol Ges. 2016 Jul;14(7):662-81. doi: 10.1111/ddg.13047.","J Dtsch Dermatol Ges.  2016","PubMed","citation","PMID:27373241","pubmed","27373241","create date:2016/07/05 | first author:Kähler KC",
"Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.","/pubmed/27363491","Denkert C, Wienert S, Poterie A, Loibl S, Budczies J, Badve S, Bago-Horvath Z, Bane A, Bedri S, Brock J, Chmielik E, Christgen M, Colpaert C, Demaria S, Van den Eynden G, Floris G, Fox SB, Gao D, Ingold Heppner B, Kim SR, Kos Z, Kreipe HH, et al.","Mod Pathol. 2016 Oct;29(10):1155-64. doi: 10.1038/modpathol.2016.109. Epub 2016 Jul 1.","Mod Pathol.  2016","PubMed","citation","PMID:27363491","pubmed","27363491","create date:2016/07/02 | first author:Denkert C",
"Treatment-associated Fatigue in Cancer Patients Treated with Immune Checkpoint Inhibitors; a Systematic Review and Meta-analysis.","/pubmed/27339403","Abdel-Rahman O, Helbling D, Schmidt J, Petrausch U, Giryes A, Mehrabi A, Schöb O, Mannhart M, Zidan A, Oweira H.","Clin Oncol (R Coll Radiol). 2016 Oct;28(10):e127-38. doi: 10.1016/j.clon.2016.06.008. Epub 2016 Jun 20. Review.","Clin Oncol (R Coll Radiol).  2016","PubMed","citation","PMID:27339403","pubmed","27339403","create date:2016/06/25 | first author:Abdel-Rahman O",
"Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.","/pubmed/27325645","Bakdash G, Buschow SI, Gorris MA, Halilovic A, Hato SV, Sköld AE, Schreibelt G, Sittig SP, Torensma R, Duiveman-de Boer T, Schröder C, Smits EL, Figdor CG, de Vries IJ.","Cancer Res. 2016 Aug 1;76(15):4332-46. doi: 10.1158/0008-5472.CAN-15-1695. Epub 2016 Jun 20.","Cancer Res.  2016","PubMed","citation","PMID:27325645","pubmed","27325645","create date:2016/06/22 | first author:Bakdash G",
"Checkpoint Antibodies but not T Cell-Recruiting Diabodies Effectively Synergize with TIL-Inducing γ-Irradiation.","/pubmed/27302161","Hettich M, Lahoti J, Prasad S, Niedermann G.","Cancer Res. 2016 Aug 15;76(16):4673-83. doi: 10.1158/0008-5472.CAN-15-3451. Epub 2016 Jun 14.","Cancer Res.  2016","PubMed","citation","PMID:27302161","pubmed","27302161","create date:2016/06/16 | first author:Hettich M",
"Functional interdependence of BRD4 and DOT1L in MLL leukemia.","/pubmed/27294782","Gilan O, Lam EY, Becher I, Lugo D, Cannizzaro E, Joberty G, Ward A, Wiese M, Fong CY, Ftouni S, Tyler D, Stanley K, MacPherson L, Weng CF, Chan YC, Ghisi M, Smil D, Carpenter C, Brown P, Garton N, Blewitt ME, Bannister AJ, et al.","Nat Struct Mol Biol. 2016 Jul;23(7):673-81. doi: 10.1038/nsmb.3249. Epub 2016 Jun 13.","Nat Struct Mol Biol.  2016","PubMed","citation","PMID:27294782","pubmed","27294782","create date:2016/06/14 | first author:Gilan O",
"Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis.","/pubmed/27294607","Heppt MV, Eigentler TK, Kähler KC, Herbst RA, Göppner D, Gambichler T, Ulrich J, Dippel E, Loquai C, Schell B, Schilling B, Schäd SG, Schultz ES, Matheis F, Tietze JK, Berking C.","Cancer Immunol Immunother. 2016 Aug;65(8):951-9. doi: 10.1007/s00262-016-1856-z. Epub 2016 Jun 13.","Cancer Immunol Immunother.  2016","PubMed","citation","PMID:27294607","pubmed","27294607","create date:2016/06/14 | first author:Heppt MV",
"Systemic therapy in metastatic renal cell carcinoma.","/pubmed/27277600","Bedke J, Gauler T, Grünwald V, Hegele A, Herrmann E, Hinz S, Janssen J, Schmitz S, Schostak M, Tesch H, Zastrow S, Miller K.","World J Urol. 2017 Feb;35(2):179-188. doi: 10.1007/s00345-016-1868-5. Epub 2016 Jun 9. Review.","World J Urol.  2017","PubMed","citation","PMID:27277600 | PMCID:PMC5272893","pubmed","27277600","create date:2016/06/10 | first author:Bedke J",
"Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.","/pubmed/27269948","Schmidt MK, Hogervorst F, van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, Waisfisz Q, Hollestelle A, Schutte M, van den Ouweland A, Hooning M, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Arndt V, Bermisheva M, Bogdanova NV, Bolla MK, Brauch H, Brenner H, et al.","J Clin Oncol. 2016 Aug 10;34(23):2750-60. doi: 10.1200/JCO.2016.66.5844. Epub 2016 Jun 6.","J Clin Oncol.  2016","PubMed","citation","PMID:27269948 | PMCID:PMC5019754","pubmed","27269948","create date:2016/06/09 | first author:Schmidt MK",
"Immunotherapy in Breast Cancer.","/pubmed/27260697","Marmé F.","Oncol Res Treat. 2016;39(6):335-45. doi: 10.1159/000446340. Epub 2016 May 25. Review.","Oncol Res Treat.  2016","PubMed","citation","PMID:27260697","pubmed","27260697","create date:2016/06/05 | first author:Marmé F",
"Immunotherapy of Colorectal Cancer.","/pubmed/27259331","Jäger D, Halama N, Zörnig I, Klug P, Krauss J, Haag GM.","Oncol Res Treat. 2016;39(6):346-50. doi: 10.1159/000446713. Epub 2016 May 25. Review.","Oncol Res Treat.  2016","PubMed","citation","PMID:27259331","pubmed","27259331","create date:2016/06/05 | first author:Jäger D",
"Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment.","/pubmed/27249713","Berghoff AS, Venur VA, Preusser M, Ahluwalia MS.","Am Soc Clin Oncol Educ Book. 2016;35:e116-22. doi: 10.14694/EDBK_100005. Review.","Am Soc Clin Oncol Educ Book.  2016","PubMed","citation","PMID:27249713","pubmed","27249713","create date:2016/06/02 | first author:Berghoff AS",
"A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.","/pubmed/27213815","Dauch D, Rudalska R, Cossa G, Nault JC, Kang TW, Wuestefeld T, Hohmeyer A, Imbeaud S, Yevsa T, Hoenicke L, Pantsar T, Bozko P, Malek NP, Longerich T, Laufer S, Poso A, Zucman-Rossi J, Eilers M, Zender L.","Nat Med. 2016 Jul;22(7):744-53. doi: 10.1038/nm.4107. Epub 2016 May 23.","Nat Med.  2016","PubMed","citation","PMID:27213815","pubmed","27213815","create date:2016/05/24 | first author:Dauch D",
"Vemurafenib and ipilimumab: A promising combination? Results of a case series.","/pubmed/27141385","Hassel JC, Lee SB, Meiss F, Meier F, Dimitrakopoulou-Strauss A, Jäger D, Enk AH.","Oncoimmunology. 2015 Oct 29;5(4):e1101207. eCollection 2016 Apr.","Oncoimmunology.  2016","PubMed","citation","PMID:27141385 | PMCID:PMC4839308","pubmed","27141385","create date:2016/05/04 | first author:Hassel JC",
"Vitamin C enhances epigenetic modifications induced by 5-azacytidine and cell cycle arrest in the hepatocellular carcinoma cell lines HLE and Huh7.","/pubmed/27134688","Sajadian SO, Tripura C, Samani FS, Ruoss M, Dooley S, Baharvand H, Nussler AK.","Clin Epigenetics. 2016 Apr 30;8:46. doi: 10.1186/s13148-016-0213-6. eCollection 2016.","Clin Epigenetics.  2016","PubMed","citation","PMID:27134688 | PMCID:PMC4851801","pubmed","27134688","create date:2016/05/03 | first author:Sajadian SO",
"Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer.","/pubmed/27106131","Kumar S, Chaudhary AK, Kumar R, O'Malley J, Dubrovska A, Wang X, Yadav N, Goodrich DW, Chandra D.","Mol Oncol. 2016 Aug;10(7):949-65. doi: 10.1016/j.molonc.2016.03.007. Epub 2016 Mar 31.","Mol Oncol.  2016","PubMed","citation","PMID:27106131 | PMCID:PMC4972665","pubmed","27106131","create date:2016/04/24 | first author:Kumar S",
"Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy.","/pubmed/27085692","Hofmann L, Forschner A, Loquai C, Goldinger SM, Zimmer L, Ugurel S, Schmidgen MI, Gutzmer R, Utikal JS, Göppner D, Hassel JC, Meier F, Tietze JK, Thomas I, Weishaupt C, Leverkus M, Wahl R, Dietrich U, Garbe C, Kirchberger MC, Eigentler T, Berking C, et al.","Eur J Cancer. 2016 Jun;60:190-209. doi: 10.1016/j.ejca.2016.02.025. Epub 2016 Apr 13.","Eur J Cancer.  2016","PubMed","citation","PMID:27085692","pubmed","27085692","create date:2016/04/18 | first author:Hofmann L",
"Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy.","/pubmed/27084345","Zimmer L, Goldinger SM, Hofmann L, Loquai C, Ugurel S, Thomas I, Schmidgen MI, Gutzmer R, Utikal JS, Göppner D, Hassel JC, Meier F, Tietze JK, Forschner A, Weishaupt C, Leverkus M, Wahl R, Dietrich U, Garbe C, Kirchberger MC, Eigentler T, Berking C, et al.","Eur J Cancer. 2016 Jun;60:210-25. doi: 10.1016/j.ejca.2016.02.024. Epub 2016 Apr 13.","Eur J Cancer.  2016","PubMed","citation","PMID:27084345","pubmed","27084345","create date:2016/04/17 | first author:Zimmer L",
"Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation.","/pubmed/27043409","Monticelli LA, Buck MD, Flamar AL, Saenz SA, Tait Wojno ED, Yudanin NA, Osborne LC, Hepworth MR, Tran SV, Rodewald HR, Shah H, Cross JR, Diamond JM, Cantu E, Christie JD, Pearce EL, Artis D.","Nat Immunol. 2016 Jun;17(6):656-65. doi: 10.1038/ni.3421. Epub 2016 Apr 4.","Nat Immunol.  2016","PubMed","citation","PMID:27043409 | PMCID:PMC4873382","pubmed","27043409","create date:2016/04/05 | first author:Monticelli LA",
"Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives.","/pubmed/27039171","Moehler M, Delic M, Goepfert K, Aust D, Grabsch HI, Halama N, Heinrich B, Julie C, Lordick F, Lutz MP, Mauer M, Alsina Maqueda M, Schild H, Schimanski CC, Wagner AD, Roth A, Ducreux M.","Eur J Cancer. 2016 May;59:160-170. doi: 10.1016/j.ejca.2016.02.020. Epub 2016 Mar 31. Review.","Eur J Cancer.  2016","PubMed","citation","PMID:27039171","pubmed","27039171","create date:2016/04/04 | first author:Moehler M",
"Activity of immune checkpoint inhibition in platinum refractory germ-cell tumors.","/pubmed/27029705","Zschäbitz S, Lasitschka F, Jäger D, Grüllich C.","Ann Oncol. 2016 Jul;27(7):1356-60. doi: 10.1093/annonc/mdw146. Epub 2016 Mar 30. No abstract available. ","Ann Oncol.  2016","PubMed","citation","PMID:27029705","pubmed","27029705","create date:2016/04/01 | first author:Zschäbitz S",
"Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers.","/pubmed/26981247","Ranki T, Pesonen S, Hemminki A, Partanen K, Kairemo K, Alanko T, Lundin J, Linder N, Turkki R, Ristimäki A, Jäger E, Karbach J, Wahle C, Kankainen M, Backman C, von Euler M, Haavisto E, Hakonen T, Heiskanen R, Jaderberg M, Juhila J, Priha P, et al.","J Immunother Cancer. 2016 Mar 15;4:17. doi: 10.1186/s40425-016-0121-5. eCollection 2016.","J Immunother Cancer.  2016","PubMed","citation","PMID:26981247 | PMCID:PMC4791966","pubmed","26981247","create date:2016/03/17 | first author:Ranki T",
"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.","/pubmed/26940869","McGranahan N, Furness AJ, Rosenthal R, Ramskov S, Lyngaa R, Saini SK, Jamal-Hanjani M, Wilson GA, Birkbak NJ, Hiley CT, Watkins TB, Shafi S, Murugaesu N, Mitter R, Akarca AU, Linares J, Marafioti T, Henry JY, Van Allen EM, Miao D, Schilling B, Schadendorf D, et al.","Science. 2016 Mar 25;351(6280):1463-9. doi: 10.1126/science.aaf1490. Epub 2016 Mar 3.","Science.  2016","PubMed","citation","PMID:26940869 | PMCID:PMC4984254","pubmed","26940869","create date:2016/03/05 | first author:McGranahan N",
"Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy.","/pubmed/26922661","Eigentler TK, Hassel JC, Berking C, Aberle J, Bachmann O, Grünwald V, Kähler KC, Loquai C, Reinmuth N, Steins M, Zimmer L, Sendl A, Gutzmer R.","Cancer Treat Rev. 2016 Apr;45:7-18. doi: 10.1016/j.ctrv.2016.02.003. Epub 2016 Feb 18. Review.","Cancer Treat Rev.  2016","PubMed","citation","PMID:26922661","pubmed","26922661","create date:2016/02/29 | first author:Eigentler TK",
"CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity.","/pubmed/26918453","Straub M, Drecoll E, Pfarr N, Weichert W, Langer R, Hapfelmeier A, Götz C, Wolff KD, Kolk A, Specht K.","Oncotarget. 2016 Mar 15;7(11):12024-34. doi: 10.18632/oncotarget.7593.","Oncotarget.  2016","PubMed","citation","PMID:26918453 | PMCID:PMC4914266","pubmed","26918453","create date:2016/02/27 | first author:Straub M",
"Genotyping of colorectal cancer for cancer precision medicine: Results from the IPH Center for Molecular Pathology.","/pubmed/26917275","Jesinghaus M, Pfarr N, Endris V, Kloor M, Volckmar AL, Brandt R, Herpel E, Muckenhuber A, Lasitschka F, Schirmacher P, Penzel R, Weichert W, Stenzinger A.","Genes Chromosomes Cancer. 2016 Jun;55(6):505-21. doi: 10.1002/gcc.22352. Epub 2016 Mar 22.","Genes Chromosomes Cancer.  2016","PubMed","citation","PMID:26917275","pubmed","26917275","create date:2016/02/27 | first author:Jesinghaus M",
"Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.","/pubmed/26907172","Jayachandran A, Lo PH, Chueh AC, Prithviraj P, Molania R, Davalos-Salas M, Anaka M, Walkiewicz M, Cebon J, Behren A.","BMC Cancer. 2016 Feb 22;16:134. doi: 10.1186/s12885-016-2185-5.","BMC Cancer.  2016","PubMed","citation","PMID:26907172 | PMCID:PMC4763451","pubmed","26907172","create date:2016/02/26 | first author:Jayachandran A",
"Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response.","/pubmed/26892811","Sunami Y, Ringelhan M, Kokai E, Lu M, O'Connor T, Lorentzen A, Weber A, Rodewald AK, Müllhaupt B, Terracciano L, Gul S, Wissel S, Leithäuser F, Krappmann D, Riedl P, Hartmann D, Schirmbeck R, Strnad P, Hüser N, Kleeff J, Friess H, Schmid RM, et al.","Hepatology. 2016 May;63(5):1592-607. doi: 10.1002/hep.28435. Epub 2016 Mar 4.","Hepatology.  2016","PubMed","citation","PMID:26892811","pubmed","26892811","create date:2016/02/20 | first author:Sunami Y",
"New Strategies in Breast Cancer: Immunotherapy.","/pubmed/26867935","Pusztai L, Karn T, Safonov A, Abu-Khalaf MM, Bianchini G.","Clin Cancer Res. 2016 May 1;22(9):2105-10. doi: 10.1158/1078-0432.CCR-15-1315. Epub 2016 Feb 11.","Clin Cancer Res.  2016","PubMed","citation","PMID:26867935","pubmed","26867935","create date:2016/02/13 | first author:Pusztai L",
"Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair.","/pubmed/26854237","Gutschner T, Haemmerle M, Genovese G, Draetta GF, Chin L.","Cell Rep. 2016 Feb 16;14(6):1555-1566. doi: 10.1016/j.celrep.2016.01.019. Epub 2016 Feb 4.","Cell Rep.  2016","PubMed","citation","PMID:26854237","pubmed","26854237","create date:2016/02/09 | first author:Gutschner T",
"TIGIT-CD155 Interactions in Melanoma: A Novel Co-Inhibitory Pathway with Potential for Clinical Intervention.","/pubmed/26763417","Mahnke K, Enk AH.","J Invest Dermatol. 2016 Jan;136(1):9-11. doi: 10.1016/j.jid.2015.10.048.","J Invest Dermatol.  2016","PubMed","citation","PMID:26763417","pubmed","26763417","create date:2016/01/15 | first author:Mahnke K",
"Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade.","/pubmed/26751469","Marchini A, Scott EM, Rommelaere J.","Viruses. 2016 Jan 6;8(1). pii: E9. doi: 10.3390/v8010009. Review.","Viruses.  2016","PubMed","citation","PMID:26751469 | PMCID:PMC4728569","pubmed","26751469","create date:2016/01/12 | first author:Marchini A",
"FOXO1 couples metabolic activity and growth state in the vascular endothelium.","/pubmed/26735015","Wilhelm K, Happel K, Eelen G, Schoors S, Oellerich MF, Lim R, Zimmermann B, Aspalter IM, Franco CA, Boettger T, Braun T, Fruttiger M, Rajewsky K, Keller C, Brüning JC, Gerhardt H, Carmeliet P, Potente M.","Nature. 2016 Jan 14;529(7585):216-20. doi: 10.1038/nature16498. Epub 2016 Jan 6.","Nature.  2016","PubMed","citation","PMID:26735015 | PMCID:PMC5380221","pubmed","26735015","create date:2016/01/07 | first author:Wilhelm K",
"DNA-damage response gene GADD45A induces differentiation in hematopoietic stem cells without inhibiting cell cycle or survival.","/pubmed/26731607","Wingert S, Thalheimer FB, Haetscher N, Rehage M, Schroeder T, Rieger MA.","Stem Cells. 2016 Mar;34(3):699-710. doi: 10.1002/stem.2282. Epub 2016 Jan 26.","Stem Cells.  2016","PubMed","citation","PMID:26731607 | PMCID:PMC4832267","pubmed","26731607","create date:2016/01/06 | first author:Wingert S",
"Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.","/pubmed/26716651","Lub S, Maes A, Maes K, De Veirman K, De Bruyne E, Menu E, Fostier K, Kassambara A, Moreaux J, Hose D, Leleu X, King RW, Vanderkerken K, Van Valckenborgh E.","Oncotarget. 2016 Jan 26;7(4):4062-76. doi: 10.18632/oncotarget.6768.","Oncotarget.  2016","PubMed","citation","PMID:26716651 | PMCID:PMC4826190","pubmed","26716651","create date:2015/12/31 | first author:Lub S",
"Stem Cell-Specific Mechanisms Ensure Genomic Fidelity within HSCs and upon Aging of HSCs.","/pubmed/26686632","Moehrle BM, Nattamai K, Brown A, Florian MC, Ryan M, Vogel M, Bliederhaeuser C, Soller K, Prows DR, Abdollahi A, Schleimer D, Walter D, Milsom MD, Stambrook P, Porteus M, Geiger H.","Cell Rep. 2015 Dec 22;13(11):2412-2424. doi: 10.1016/j.celrep.2015.11.030. Epub 2015 Dec 10.","Cell Rep.  2015","PubMed","citation","PMID:26686632 | PMCID:PMC4691560","pubmed","26686632","create date:2015/12/22 | first author:Moehrle BM",
"Dimethylfumarate effectively inhibits lymphangiogenesis via p21 induction and G1 cell cycle arrest.","/pubmed/26663097","Valesky EM, Hrgovic I, Doll M, Wang XF, Pinter A, Kleemann J, Kaufmann R, Kippenberger S, Meissner M.","Exp Dermatol. 2016 Mar;25(3):200-5. doi: 10.1111/exd.12907. Epub 2016 Feb 10.","Exp Dermatol.  2016","PubMed","citation","PMID:26663097","pubmed","26663097","create date:2015/12/15 | first author:Valesky EM",
"Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma.","/pubmed/26658840","Hartmann S, Schuhmacher B, Rausch T, Fuller L, Döring C, Weniger M, Lollies A, Weiser C, Thurner L, Rengstl B, Brunnberg U, Vornanen M, Pfreundschuh M, Benes V, Küppers R, Newrzela S, Hansmann ML.","Leukemia. 2016 Apr;30(4):844-53. doi: 10.1038/leu.2015.328. Epub 2015 Dec 10.","Leukemia.  2016","PubMed","citation","PMID:26658840","pubmed","26658840","create date:2015/12/15 | first author:Hartmann S",
"Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.","/pubmed/26633184","Johnson DB, Sullivan RJ, Ott PA, Carlino MS, Khushalani NI, Ye F, Guminski A, Puzanov I, Lawrence DP, Buchbinder EI, Mudigonda T, Spencer K, Bender C, Lee J, Kaufman HL, Menzies AM, Hassel JC, Mehnert JM, Sosman JA, Long GV, Clark JI.","JAMA Oncol. 2016 Feb;2(2):234-40. doi: 10.1001/jamaoncol.2015.4368.","JAMA Oncol.  2016","PubMed","citation","PMID:26633184","pubmed","26633184","create date:2015/12/04 | first author:Johnson DB",
"Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest.","/pubmed/26607953","Carén H, Stricker SH, Bulstrode H, Gagrica S, Johnstone E, Bartlett TE, Feber A, Wilson G, Teschendorff AE, Bertone P, Beck S, Pollard SM.","Stem Cell Reports. 2015 Nov 10;5(5):829-842. doi: 10.1016/j.stemcr.2015.09.014.","Stem Cell Reports.  2015","PubMed","citation","PMID:26607953 | PMCID:PMC4649264","pubmed","26607953","create date:2015/11/27 | first author:Carén H",
"Anticancer activity of cryptotanshinone on acute lymphoblastic leukemia cells.","/pubmed/26564229","Wu CF, Klauck SM, Efferth T.","Arch Toxicol. 2016 Sep;90(9):2275-2286. doi: 10.1007/s00204-015-1616-4. Epub 2015 Nov 13.","Arch Toxicol.  2016","PubMed","citation","PMID:26564229","pubmed","26564229","create date:2015/11/14 | first author:Wu CF",
"Targeted Therapies in Triple-Negative Breast Cancer.","/pubmed/26557820","Marmé F, Schneeweiss A.","Breast Care (Basel). 2015 Jul;10(3):159-66. doi: 10.1159/000433622. Epub 2015 Jun 24. Review.","Breast Care (Basel).  2015","PubMed","citation","PMID:26557820 | PMCID:PMC4569194","pubmed","26557820","create date:2015/11/12 | first author:Marmé F",
"A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition.","/pubmed/26546739","Stockklausner C, Raffel S, Klermund J, Bandapalli OR, Beier F, Brümmendorf TH, Bürger F, Sauer SW, Hoffmann GF, Lorenz H, Tagliaferri L, Nowak D, Hofmann WK, Buergermeister R, Kerber C, Rausch T, Korbel JO, Luke B, Trumpp A, Kulozik AE.","Aging (Albany NY). 2015 Nov;7(11):911-27.","Aging (Albany NY).  2015","PubMed","citation","PMID:26546739 | PMCID:PMC4694062","pubmed","26546739","create date:2015/11/08 | first author:Stockklausner C",
"Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study.","/pubmed/26537763","Clifford GM, Franceschi S, Keiser O, Schöni-Affolter F, Lise M, Dehler S, Levi F, Mousavi M, Bouchardy C, Wolfensberger A, Darling KE, Staehelin C, Bertisch B, Kuenzli E, Bernasconi E, Pawlita M, Egger M; Swiss HIV Cohort Study..","Int J Cancer. 2016 Apr 1;138(7):1732-40. doi: 10.1002/ijc.29913. Epub 2015 Nov 20.","Int J Cancer.  2016","PubMed","citation","PMID:26537763","pubmed","26537763","create date:2015/11/06 | first author:Clifford GM",
"Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.","/pubmed/26534878","Thomas de Montpréville V, Quilhot P, Chalabreysse L, De Muret A, Hofman V, Lantuéjoul S, Parrens M, Payan MJ, Rouquette I, Secq V, Girard N, Besse B, Marx A, Molina TJ.","Pathol Res Pract. 2015 Dec;211(12):996-1002. doi: 10.1016/j.prp.2015.10.005. Epub 2015 Oct 19.","Pathol Res Pract.  2015","PubMed","citation","PMID:26534878","pubmed","26534878","create date:2015/11/05 | first author:Thomas de Montpréville V",
"Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases.","/pubmed/26517811","Harter PN, Bernatz S, Scholz A, Zeiner PS, Zinke J, Kiyose M, Blasel S, Beschorner R, Senft C, Bender B, Ronellenfitsch MW, Wikman H, Glatzel M, Meinhardt M, Juratli TA, Steinbach JP, Plate KH, Wischhusen J, Weide B, Mittelbronn M.","Oncotarget. 2015 Dec 1;6(38):40836-49. doi: 10.18632/oncotarget.5696.","Oncotarget.  2015","PubMed","citation","PMID:26517811 | PMCID:PMC4747372","pubmed","26517811","create date:2015/10/31 | first author:Harter PN",
"Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy.","/pubmed/26516225","Reardon DA, Gilbert MR, Wick W, Liau L.","Neuro Oncol. 2015 Nov;17 Suppl 7:vii32-vii40. doi: 10.1093/neuonc/nov178. Review.","Neuro Oncol.  2015","PubMed","citation","PMID:26516225 | PMCID:PMC4625894","pubmed","26516225","create date:2015/10/31 | first author:Reardon DA",
"Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.","/pubmed/26514172","Rylova SN, Del Pozzo L, Klingeberg C, Tönnesmann R, Illert AL, Meyer PT, Maecke HR, Holland JP.","J Nucl Med. 2016 Jan;57(1):96-102. doi: 10.2967/jnumed.115.162735. Epub 2015 Oct 29.","J Nucl Med.  2016","PubMed","citation","PMID:26514172","pubmed","26514172","create date:2015/10/31 | first author:Rylova SN",
"Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?","/pubmed/26501438","Preusser M, Berghoff AS, Wick W, Weller M.","Clin Neuropathol. 2015 Nov-Dec;34(6):313-21. Review.","Clin Neuropathol.  2015","PubMed","citation","PMID:26501438 | PMCID:PMC4766797","pubmed","26501438","create date:2015/10/27 | first author:Preusser M",
"The Influence of Host Factors on the Prognosis of Breast Cancer: Stroma and Immune Cell Components as Cancer Biomarkers.","/pubmed/26452382","Karn T, Pusztai L, Rody A, Holtrich U, Becker S.","Curr Cancer Drug Targets. 2015;15(8):652-64. Review.","Curr Cancer Drug Targets.  2015","PubMed","citation","PMID:26452382","pubmed","26452382","create date:2015/10/11 | first author:Karn T",
"PARP Inhibitors Sensitize Ewing Sarcoma Cells to Temozolomide-Induced Apoptosis via the Mitochondrial Pathway.","/pubmed/26438158","Engert F, Schneider C, Weiβ LM, Probst M, Fulda S.","Mol Cancer Ther. 2015 Dec;14(12):2818-30. doi: 10.1158/1535-7163.MCT-15-0587. Epub 2015 Oct 5.","Mol Cancer Ther.  2015","PubMed","citation","PMID:26438158","pubmed","26438158","create date:2015/10/07 | first author:Engert F",
"Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.","/pubmed/26424751","Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N; Australian Cancer Study (Ovarian Cancer).; Australian Ovarian Cancer Study Group., Bandera EV, Bean Y, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, et al.","Carcinogenesis. 2015 Nov;36(11):1341-53. doi: 10.1093/carcin/bgv138. Epub 2015 Sep 29.","Carcinogenesis.  2015","PubMed","citation","PMID:26424751 | PMCID:PMC4635670","pubmed","26424751","create date:2015/10/02 | first author:Lawrenson K",
"Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.","/pubmed/26412456","Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, Barlesi F, Kohlhäufl M, Arrieta O, Burgio MA, Fayette J, Lena H, Poddubskaya E, Gerber DE, Gettinger SN, Rudin CM, Rizvi N, Crinò L, et al.","N Engl J Med. 2015 Oct 22;373(17):1627-39. doi: 10.1056/NEJMoa1507643. Epub 2015 Sep 27.","N Engl J Med.  2015","PubMed","citation","PMID:26412456 | PMCID:PMC5705936","pubmed","26412456","create date:2015/09/29 | first author:Borghaei H",
"Development of Next-Generation Immunomodulatory Antibodies for Cancer Therapy through Optimization of the IgG Framework.","/pubmed/26373272","Offringa R, Glennie MJ.","Cancer Cell. 2015 Sep 14;28(3):273-5. doi: 10.1016/j.ccell.2015.08.008.","Cancer Cell.  2015","PubMed","citation","PMID:26373272","pubmed","26373272","create date:2015/09/17 | first author:Offringa R",
"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.","/pubmed/26359337","Van Allen EM, Miao D, Schilling B, Shukla SA, Blank C, Zimmer L, Sucker A, Hillen U, Foppen MHG, Goldinger SM, Utikal J, Hassel JC, Weide B, Kaehler KC, Loquai C, Mohr P, Gutzmer R, Dummer R, Gabriel S, Wu CJ, Schadendorf D, Garraway LA.","Science. 2015 Oct 9;350(6257):207-211. doi: 10.1126/science.aad0095. Epub 2015 Sep 10. Erratum in: Science. 2015 Nov 13;350(6262):aad8366.  Science. 2016 Apr 15;352(6283). pii: aaf8264. doi: 10.1126/science.aaf8264. ","Science.  2015","PubMed","citation","PMID:26359337 | PMCID:PMC5054517","pubmed","26359337","create date:2015/09/12 | first author:Van Allen EM",
"Absence of RIPK3 predicts necroptosis resistance in malignant melanoma.","/pubmed/26355347","Geserick P, Wang J, Schilling R, Horn S, Harris PA, Bertin J, Gough PJ, Feoktistova M, Leverkus M.","Cell Death Dis. 2015 Sep 10;6:e1884. doi: 10.1038/cddis.2015.240.","Cell Death Dis.  2015","PubMed","citation","PMID:26355347 | PMCID:PMC4650439","pubmed","26355347","create date:2015/09/12 | first author:Geserick P",
"Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism.","/pubmed/26239198","Krupka C, Kufer P, Kischel R, Zugmaier G, Lichtenegger FS, Köhnke T, Vick B, Jeremias I, Metzeler KH, Altmann T, Schneider S, Fiegl M, Spiekermann K, Bauerle PA, Hiddemann W, Riethmüller G, Subklewe M.","Leukemia. 2016 Feb;30(2):484-91. doi: 10.1038/leu.2015.214. Epub 2015 Aug 4.","Leukemia.  2016","PubMed","citation","PMID:26239198","pubmed","26239198","create date:2015/08/05 | first author:Krupka C",
"Cytokinesis failure in RhoA-deficient mouse erythroblasts involves actomyosin and midbody dysregulation and triggers p53 activation.","/pubmed/26228485","Konstantinidis DG, Giger KM, Risinger M, Pushkaran S, Zhou P, Dexheimer P, Yerneni S, Andreassen P, Klingmüller U, Palis J, Zheng Y, Kalfa TA.","Blood. 2015 Sep 17;126(12):1473-82. doi: 10.1182/blood-2014-12-616169. Epub 2015 Jul 30.","Blood.  2015","PubMed","citation","PMID:26228485 | PMCID:PMC4573870","pubmed","26228485","create date:2015/08/01 | first author:Konstantinidis DG",
"First-line nivolumab (anti-PD-1) monotherapy in advanced NSCLC: the story of immune checkpoint inhibitors and ""the sorcerers apprentice"".","/pubmed/26207206","Schmid-Bindert G, Jiang T.","Transl Lung Cancer Res. 2015 Jun;4(3):215-6. doi: 10.3978/j.issn.2218-6751.2015.01.12. No abstract available. ","Transl Lung Cancer Res.  2015","PubMed","citation","PMID:26207206 | PMCID:PMC4483480","pubmed","26207206","create date:2015/07/25 | first author:Schmid-Bindert G",
"Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer.","/pubmed/26188965","Bacher P, Jochheim-Richter A, Mockel-Tenbrink N, Kniemeyer O, Wingenfeld E, Alex R, Ortigao A, Karpova D, Lehrnbecher T, Ullmann AJ, Hamprecht A, Cornely O, Brakhage AA, Assenmacher M, Bonig H, Scheffold A.","Cytotherapy. 2015 Oct;17(10):1396-405. doi: 10.1016/j.jcyt.2015.05.011. Epub 2015 Jul 15.","Cytotherapy.  2015","PubMed","citation","PMID:26188965","pubmed","26188965","create date:2015/07/21 | first author:Bacher P",
"Primary melanoma of the prostate: case report and review of the literature.","/pubmed/26169921","Tosev G, Kuru TH, Huber J, Freier G, Bergmann F, Hassel JC, Pahernik SA, Hohenfellner M, Hadaschik BA.","BMC Urol. 2015 Jul 14;15:68. doi: 10.1186/s12894-015-0052-3. Review.","BMC Urol.  2015","PubMed","citation","PMID:26169921 | PMCID:PMC4501120","pubmed","26169921","create date:2015/07/15 | first author:Tosev G",
"T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response.","/pubmed/26160687","Pfirschke C, Gebhardt C, Zörnig I, Pritsch M, Eichmüller SB, Jäger D, Enk A, Beckhove P.","Cancer Immunol Immunother. 2015 Nov;64(11):1369-81. doi: 10.1007/s00262-015-1739-8. Epub 2015 Jul 10.","Cancer Immunol Immunother.  2015","PubMed","citation","PMID:26160687","pubmed","26160687","create date:2015/07/15 | first author:Pfirschke C",
"Cezanne regulates E2F1-dependent HIF2α expression.","/pubmed/26148512","Moniz S, Bandarra D, Biddlestone J, Campbell KJ, Komander D, Bremm A, Rocha S.","J Cell Sci. 2015 Aug 15;128(16):3082-93. doi: 10.1242/jcs.168864. Epub 2015 Jul 6.","J Cell Sci.  2015","PubMed","citation","PMID:26148512 | PMCID:PMC4541044","pubmed","26148512","create date:2015/07/08 | first author:Moniz S",
"Novel drugs in clinical development for hepatocellular carcinoma.","/pubmed/26108356","Waidmann O, Trojan J.","Expert Opin Investig Drugs. 2015;24(8):1075-82. doi: 10.1517/13543784.2015.1058776. Epub 2015 Jun 24. Review.","Expert Opin Investig Drugs.  2015","PubMed","citation","PMID:26108356","pubmed","26108356","create date:2015/06/26 | first author:Waidmann O",
"Transcriptional co-factor Transducin beta-like (TBL) 1 acts as a checkpoint in pancreatic cancer malignancy.","/pubmed/26070712","Stoy C, Sundaram A, Rios Garcia M, Wang X, Seibert O, Zota A, Wendler S, Männle D, Hinz U, Sticht C, Muciek M, Gretz N, Rose AJ, Greiner V, Hofmann TG, Bauer A, Hoheisel J, Berriel Diaz M, Gaida MM, Werner J, Schafmeier T, Strobel O, et al.","EMBO Mol Med. 2015 Aug;7(8):1048-62. doi: 10.15252/emmm.201404837.","EMBO Mol Med.  2015","PubMed","citation","PMID:26070712 | PMCID:PMC4551343","pubmed","26070712","create date:2015/06/14 | first author:Stoy C",
"Mangrove dolabrane-type of diterpenes tagalsins suppresses tumor growth via ROS-mediated apoptosis and ATM/ATR-Chk1/Chk2-regulated cell cycle arrest.","/pubmed/26061604","Neumann J, Yang Y, Köhler R, Giaisi M, Witzens-Harig M, Liu D, Krammer PH, Lin W, Li-Weber M.","Int J Cancer. 2015 Dec 1;137(11):2739-48. doi: 10.1002/ijc.29629. Epub 2015 Jun 30.","Int J Cancer.  2015","PubMed","citation","PMID:26061604 | PMCID:PMC4755134","pubmed","26061604","create date:2015/06/11 | first author:Neumann J",
"Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action.","/pubmed/26044878","Scherzberg MC, Kiehl A, Zivkovic A, Stark H, Stein J, Fürst R, Steinhilber D, Ulrich-Rückert S.","Toxicol Appl Pharmacol. 2015 Aug 15;287(1):67-76. doi: 10.1016/j.taap.2015.05.020. Epub 2015 Jun 2.","Toxicol Appl Pharmacol.  2015","PubMed","citation","PMID:26044878","pubmed","26044878","create date:2015/06/06 | first author:Scherzberg MC",
"Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors.","/pubmed/26029996","Schwermer M, Lee S, Köster J, van Maerken T, Stephan H, Eggert A, Morik K, Schulte JH, Schramm A.","Oncotarget. 2015 Jun 20;6(17):15425-35.","Oncotarget.  2015","PubMed","citation","PMID:26029996 | PMCID:PMC4558161","pubmed","26029996","create date:2015/06/02 | first author:Schwermer M",
"Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.","/pubmed/26028407","Brahmer J, Reckamp KL, Baas P, Crinò L, Eberhardt WE, Poddubskaya E, Antonia S, Pluzanski A, Vokes EE, Holgado E, Waterhouse D, Ready N, Gainor J, Arén Frontera O, Havel L, Steins M, Garassino MC, Aerts JG, Domine M, Paz-Ares L, Reck M, Baudelet C, et al.","N Engl J Med. 2015 Jul 9;373(2):123-35. doi: 10.1056/NEJMoa1504627. Epub 2015 May 31.","N Engl J Med.  2015","PubMed","citation","PMID:26028407 | PMCID:PMC4681400","pubmed","26028407","create date:2015/06/02 | first author:Brahmer J",
"[What opportunities does Immuno-oncology indicate for overarching long-term survival?].","/pubmed/25966812","Bergmann L, Brugger W, Herr W, Mackensen A, Multhoff G.","Oncol Res Treat. 2015;38 Suppl 3:6-11. doi: 10.1159/000381363. Epub 2015 Apr 28. German.  No abstract available. ","Oncol Res Treat.  2015","PubMed","citation","PMID:25966812","pubmed","25966812","create date:2015/05/15 | first author:Bergmann L",
"Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma.","/pubmed/25965393","Sundarasetty BS, Chan L, Darling D, Giunti G, Farzaneh F, Schenck F, Naundorf S, Kuehlcke K, Ruggiero E, Schmidt M, von Kalle C, Rothe M, Hoon DS, Gerasch L, Figueiredo C, Koehl U, Blasczyk R, Gutzmer R, Stripecke R.","Gene Ther. 2015 Sep;22(9):707-20. doi: 10.1038/gt.2015.43. Epub 2015 May 28.","Gene Ther.  2015","PubMed","citation","PMID:25965393 | PMCID:PMC4561294","pubmed","25965393","create date:2015/05/13 | first author:Sundarasetty BS",
"CD8(+)/FOXP3(+)-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study.","/pubmed/25949908","Fritzsching B, Fellenberg J, Moskovszky L, Sápi Z, Krenacs T, Machado I, Poeschl J, Lehner B, Szendrõi M, Bosch AL, Bernd L, Csóka M, Mechtersheimer G, Ewerbeck V, Kinscherf R, Kunz P.","Oncoimmunology. 2015 Apr 2;4(3):e990800. eCollection 2015 Mar.","Oncoimmunology.  2015","PubMed","citation","PMID:25949908 | PMCID:PMC4404826","pubmed","25949908","create date:2015/05/08 | first author:Fritzsching B",
"Cytotoxicity of arctigenin and matairesinol against the T-cell lymphoma cell line CCRF-CEM.","/pubmed/25922263","Su S, Cheng X, Wink M.","J Pharm Pharmacol. 2015 Sep;67(9):1316-23. doi: 10.1111/jphp.12426. Epub 2015 Apr 29.","J Pharm Pharmacol.  2015","PubMed","citation","PMID:25922263","pubmed","25922263","create date:2015/04/30 | first author:Su S",
"Evolving treatment paradigms in lung cancer: role of immuno-oncology.","/pubmed/25913638","Mitchell P.","Asia Pac J Clin Oncol. 2015 Apr;11 Suppl 1:1. doi: 10.1111/ajco.12360. No abstract available. ","Asia Pac J Clin Oncol.  2015","PubMed","citation","PMID:25913638","pubmed","25913638","create date:2015/04/29 | first author:Mitchell P",
"Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.","/pubmed/25821063","Bramante S, Kaufmann JK, Veckman V, Liikanen I, Nettelbeck DM, Hemminki O, Vassilev L, Cerullo V, Oksanen M, Heiskanen R, Joensuu T, Kanerva A, Pesonen S, Matikainen S, Vähä-Koskela M, Koski A, Hemminki A.","Int J Cancer. 2015 Oct 1;137(7):1775-83. doi: 10.1002/ijc.29536. Epub 2015 Apr 11.","Int J Cancer.  2015","PubMed","citation","PMID:25821063","pubmed","25821063","create date:2015/03/31 | first author:Bramante S",
"PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia.","/pubmed/25800048","McClanahan F, Hanna B, Miller S, Clear AJ, Lichter P, Gribben JG, Seiffert M.","Blood. 2015 Jul 9;126(2):203-11. doi: 10.1182/blood-2015-01-622936. Epub 2015 Mar 23.","Blood.  2015","PubMed","citation","PMID:25800048 | PMCID:PMC4497961","pubmed","25800048","create date:2015/03/25 | first author:McClanahan F",
"Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest.","/pubmed/25796091","Kriegs M, Gurtner K, Can Y, Brammer I, Rieckmann T, Oertel R, Wysocki M, Dorniok F, Gal A, Grob TJ, Laban S, Kasten-Pisula U, Petersen C, Baumann M, Krause M, Dikomey E.","Radiother Oncol. 2015 Apr;115(1):120-7. doi: 10.1016/j.radonc.2015.02.018. Epub 2015 Mar 18.","Radiother Oncol.  2015","PubMed","citation","PMID:25796091","pubmed","25796091","create date:2015/03/23 | first author:Kriegs M",
"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.","/pubmed/25795410","Weber JS, D'Angelo SP, Minor D, Hodi FS, Gutzmer R, Neyns B, Hoeller C, Khushalani NI, Miller WH Jr, Lao CD, Linette GP, Thomas L, Lorigan P, Grossmann KF, Hassel JC, Maio M, Sznol M, Ascierto PA, Mohr P, Chmielowski B, Bryce A, Svane IM, et al.","Lancet Oncol. 2015 Apr;16(4):375-84. doi: 10.1016/S1470-2045(15)70076-8. Epub 2015 Mar 18.","Lancet Oncol.  2015","PubMed","citation","PMID:25795410","pubmed","25795410","create date:2015/03/22 | first author:Weber JS",
"Development and Validation of an Immuno-PET Tracer as a Companion Diagnostic Agent for Antibody-Drug Conjugate Therapy to Target the CA6 Epitope.","/pubmed/25734548","Ilovich O, Natarajan A, Hori S, Sathirachinda A, Kimura R, Srinivasan A, Gebauer M, Kruip J, Focken I, Lange C, Carrez C, Sassoon I, Blanc V, Sarkar SK, Gambhir SS.","Radiology. 2015 Jul;276(1):191-8. doi: 10.1148/radiol.15140058. Epub 2015 Feb 27.","Radiology.  2015","PubMed","citation","PMID:25734548 | PMCID:PMC4570559","pubmed","25734548","create date:2015/03/04 | first author:Ilovich O",
"IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction.","/pubmed/25729923","Nold-Petry CA, Lo CY, Rudloff I, Elgass KD, Li S, Gantier MP, Lotz-Havla AS, Gersting SW, Cho SX, Lao JC, Ellisdon AM, Rotter B, Azam T, Mangan NE, Rossello FJ, Whisstock JC, Bufler P, Garlanda C, Mantovani A, Dinarello CA, Nold MF.","Nat Immunol. 2015 Apr;16(4):354-65. doi: 10.1038/ni.3103. Epub 2015 Mar 2.","Nat Immunol.  2015","PubMed","citation","PMID:25729923","pubmed","25729923","create date:2015/03/03 | first author:Nold-Petry CA",
"A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes.","/pubmed/25691366","Khandelwal N, Breinig M, Speck T, Michels T, Kreutzer C, Sorrentino A, Sharma AK, Umansky L, Conrad H, Poschke I, Offringa R, König R, Bernhard H, Machlenkin A, Boutros M, Beckhove P.","EMBO Mol Med. 2015 Apr;7(4):450-63. doi: 10.15252/emmm.201404414.","EMBO Mol Med.  2015","PubMed","citation","PMID:25691366 | PMCID:PMC4403046","pubmed","25691366","create date:2015/02/19 | first author:Khandelwal N",
"[Melanoma: introduction and special demands on radiology].","/pubmed/25609505","Schiller M, Hassel JC.","Radiologe. 2015 Feb;55(2):93-8. doi: 10.1007/s00117-014-2758-8. German. ","Radiologe.  2015","PubMed","citation","PMID:25609505","pubmed","25609505","create date:2015/01/23 | first author:Schiller M",
"Effective targeting of the P53-MDM2 axis in preclinical models of infant MLL-rearranged acute lymphoblastic leukemia.","/pubmed/25573381","Richmond J, Carol H, Evans K, High L, Mendomo A, Robbins A, Meyer C, Venn NC, Marschalek R, Henderson M, Sutton R, Kurmasheva RT, Kees UR, Houghton PJ, Smith MA, Lock RB.","Clin Cancer Res. 2015 Mar 15;21(6):1395-405. doi: 10.1158/1078-0432.CCR-14-2300. Epub 2015 Jan 8.","Clin Cancer Res.  2015","PubMed","citation","PMID:25573381 | PMCID:PMC4359964","pubmed","25573381","create date:2015/01/13 | first author:Richmond J",
"Melanoma.","/pubmed/27188223","Schadendorf D, Fisher DE, Garbe C, Gershenwald JE, Grob JJ, Halpern A, Herlyn M, Marchetti MA, McArthur G, Ribas A, Roesch A, Hauschild A.","Nat Rev Dis Primers. 2015 Apr 23;1:15003. doi: 10.1038/nrdp.2015.3. Review.","Nat Rev Dis Primers.  2015","PubMed","citation","PMID:27188223","pubmed","27188223","create date:2015/01/01 | first author:Schadendorf D",
"Classification of current anticancer immunotherapies.","/pubmed/25537519","Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, et al.","Oncotarget. 2014 Dec 30;5(24):12472-508. Review.","Oncotarget.  2014","PubMed","citation","PMID:25537519 | PMCID:PMC4350348","pubmed","25537519","create date:2014/12/30 | first author:Galluzzi L",
"New Approaches in Immunotherapy for the Treatment of Lung Cancer.","/pubmed/25522903","Quaratino S, Forssmann U, Marschner JP.","Curr Top Microbiol Immunol. 2017;405:1-31. doi: 10.1007/82_2014_428.","Curr Top Microbiol Immunol.  2017","PubMed","citation","PMID:25522903","pubmed","25522903","create date:2014/12/20 | first author:Quaratino S",
"L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor.","/pubmed/25510351","Doberstein K, Milde-Langosch K, Bretz NP, Schirmer U, Harari A, Witzel I, Ben-Arie A, Hubalek M, Müller-Holzner E, Reinold S, Zeimet AG, Altevogt P, Fogel M.","BMC Cancer. 2014 Dec 15;14:958. doi: 10.1186/1471-2407-14-958.","BMC Cancer.  2014","PubMed","citation","PMID:25510351 | PMCID:PMC4301892","pubmed","25510351","create date:2014/12/17 | first author:Doberstein K",
"Mesenchymal stem cells are resistant to carbon ion radiotherapy.","/pubmed/25504442","Nicolay NH, Liang Y, Lopez Perez R, Bostel T, Trinh T, Sisombath S, Weber KJ, Ho AD, Debus J, Saffrich R, Huber PE.","Oncotarget. 2015 Feb 10;6(4):2076-87.","Oncotarget.  2015","PubMed","citation","PMID:25504442 | PMCID:PMC4385837","pubmed","25504442","create date:2014/12/17 | first author:Nicolay NH",
"Protumorigenic role of Timeless in hepatocellular carcinoma.","/pubmed/25405317","Elgohary N, Pellegrino R, Neumann O, Elzawahry HM, Saber MM, Zeeneldin AA, Geffers R, Ehemann V, Schemmer P, Schirmacher P, Longerich T.","Int J Oncol. 2015 Feb;46(2):597-606. doi: 10.3892/ijo.2014.2751. Epub 2014 Nov 14.","Int J Oncol.  2015","PubMed","citation","PMID:25405317","pubmed","25405317","create date:2014/11/19 | first author:Elgohary N",
"Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.","/pubmed/25355681","Berghoff AS, Kiesel B, Widhalm G, Rajky O, Ricken G, Wöhrer A, Dieckmann K, Filipits M, Brandstetter A, Weller M, Kurscheid S, Hegi ME, Zielinski CC, Marosi C, Hainfellner JA, Preusser M, Wick W.","Neuro Oncol. 2015 Aug;17(8):1064-75. doi: 10.1093/neuonc/nou307. Epub 2014 Oct 29.","Neuro Oncol.  2015","PubMed","citation","PMID:25355681 | PMCID:PMC4490866","pubmed","25355681","create date:2014/10/31 | first author:Berghoff AS",
"WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response.","/pubmed/25331887","Abu-Odeh M, Salah Z, Herbel C, Hofmann TG, Aqeilan RI.","Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):E4716-25. doi: 10.1073/pnas.1409252111. Epub 2014 Oct 20.","Proc Natl Acad Sci U S A.  2014","PubMed","citation","PMID:25331887 | PMCID:PMC4226089","pubmed","25331887","create date:2014/10/22 | first author:Abu-Odeh M",
"Vanillin-derived antiproliferative compounds influence Plk1 activity.","/pubmed/25304894","Carrasco-Gomez R, Keppner-Witter S, Hieke M, Lange L, Schneider G, Schubert-Zsilavecz M, Proschak E, Spänkuch B.","Bioorg Med Chem Lett. 2014 Nov 1;24(21):5063-9. doi: 10.1016/j.bmcl.2014.09.015. Epub 2014 Sep 16.","Bioorg Med Chem Lett.  2014","PubMed","citation","PMID:25304894","pubmed","25304894","create date:2014/10/12 | first author:Carrasco-Gomez R",
"Aurora kinases as targets in drug-resistant neuroblastoma cells.","/pubmed/25268132","Michaelis M, Selt F, Rothweiler F, Löschmann N, Nüsse B, Dirks WG, Zehner R, Cinatl J Jr.","PLoS One. 2014 Sep 30;9(9):e108758. doi: 10.1371/journal.pone.0108758. eCollection 2014.","PLoS One.  2014","PubMed","citation","PMID:25268132 | PMCID:PMC4182628","pubmed","25268132","create date:2014/10/01 | first author:Michaelis M",
"Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features.","/pubmed/25261934","Lessel D, Vaz B, Halder S, Lockhart PJ, Marinovic-Terzic I, Lopez-Mosqueda J, Philipp M, Sim JC, Smith KR, Oehler J, Cabrera E, Freire R, Pope K, Nahid A, Norris F, Leventer RJ, Delatycki MB, Barbi G, von Ameln S, Högel J, Degoricija M, Fertig R, et al.","Nat Genet. 2014 Nov;46(11):1239-44. doi: 10.1038/ng.3103. Epub 2014 Sep 28.","Nat Genet.  2014","PubMed","citation","PMID:25261934 | PMCID:PMC4343211","pubmed","25261934","create date:2014/09/30 | first author:Lessel D",
"A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells.","/pubmed/25253202","Cheng X, Holenya P, Can S, Alborzinia H, Rubbiani R, Ott I, Wölfl S.","Mol Cancer. 2014 Sep 25;13:221. doi: 10.1186/1476-4598-13-221.","Mol Cancer.  2014","PubMed","citation","PMID:25253202 | PMCID:PMC4190468","pubmed","25253202","create date:2014/09/26 | first author:Cheng X",
"Pan-Bcl-2 inhibitor obatoclax delays cell cycle progression and blocks migration of colorectal cancer cells.","/pubmed/25192188","Koehler BC, Scherr AL, Lorenz S, Elssner C, Kautz N, Welte S, Jaeger D, Urbanik T, Schulze-Bergkamen H.","PLoS One. 2014 Sep 5;9(9):e106571. doi: 10.1371/journal.pone.0106571. eCollection 2014.","PLoS One.  2014","PubMed","citation","PMID:25192188 | PMCID:PMC4156353","pubmed","25192188","create date:2014/09/06 | first author:Koehler BC",
"Induction of apoptosis in cervical cancer cells by the duplex drug 5-FdU-ECyd, coupling 2'-deoxy-5-fluorouridine and 3'-C-ethinylcytidine.","/pubmed/25178996","Schott S, Brüning A.","Gynecol Oncol. 2014 Nov;135(2):342-8. doi: 10.1016/j.ygyno.2014.08.034. Epub 2014 Aug 30.","Gynecol Oncol.  2014","PubMed","citation","PMID:25178996","pubmed","25178996","create date:2014/09/03 | first author:Schott S",
"CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy.","/pubmed/25156126","Engeland CE, Grossardt C, Veinalde R, Bossow S, Lutz D, Kaufmann JK, Shevchenko I, Umansky V, Nettelbeck DM, Weichert W, Jäger D, von Kalle C, Ungerechts G.","Mol Ther. 2014 Nov;22(11):1949-59. doi: 10.1038/mt.2014.160. Epub 2014 Aug 26.","Mol Ther.  2014","PubMed","citation","PMID:25156126 | PMCID:PMC4429737","pubmed","25156126","create date:2014/08/27 | first author:Engeland CE",
"Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.","/pubmed/25143484","Hoellein A, Fallahi M, Schoeffmann S, Steidle S, Schaub FX, Rudelius M, Laitinen I, Nilsson L, Goga A, Peschel C, Nilsson JA, Cleveland JL, Keller U.","Blood. 2014 Sep 25;124(13):2081-90. doi: 10.1182/blood-2014-06-584524. Epub 2014 Aug 20.","Blood.  2014","PubMed","citation","PMID:25143484 | PMCID:PMC4186537","pubmed","25143484","create date:2014/08/22 | first author:Hoellein A",
"Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2.","/pubmed/25136960","Makarević J, Rutz J, Juengel E, Kaulfuss S, Reiter M, Tsaur I, Bartsch G, Haferkamp A, Blaheta RA.","PLoS One. 2014 Aug 19;9(8):e105590. doi: 10.1371/journal.pone.0105590. eCollection 2014.","PLoS One.  2014","PubMed","citation","PMID:25136960 | PMCID:PMC4138189","pubmed","25136960","create date:2014/08/20 | first author:Makarević J",
"Evolving role of tumor antigens for future melanoma therapies.","/pubmed/25052755","Andrews MC, Woods K, Cebon J, Behren A.","Future Oncol. 2014 Jun;10(8):1457-68. doi: 10.2217/fon.14.84. Review.","Future Oncol.  2014","PubMed","citation","PMID:25052755","pubmed","25052755","create date:2014/07/24 | first author:Andrews MC",
"Therapeutic use of anti-CTLA-4 antibodies.","/pubmed/25038057","Blank CU, Enk A.","Int Immunol. 2015 Jan;27(1):3-10. doi: 10.1093/intimm/dxu076. Epub 2014 Jul 18. Review.","Int Immunol.  2015","PubMed","citation","PMID:25038057","pubmed","25038057","create date:2014/07/20 | first author:Blank CU",
"Reduced expression of the retinoblastoma protein shows that the related signaling pathway is essential for mediating the antineoplastic activity of erufosine.","/pubmed/24987858","Zaharieva MM, Kirilov M, Chai M, Berger SM, Konstantinov S, Berger MR.","PLoS One. 2014 Jul 2;9(7):e100950. doi: 10.1371/journal.pone.0100950. eCollection 2014.","PLoS One.  2014","PubMed","citation","PMID:24987858 | PMCID:PMC4079453","pubmed","24987858","create date:2014/07/06 | first author:Zaharieva MM",
"Gene expression profiling of colorectal tumors and normal mucosa by microarrays meta-analysis using prediction analysis of microarray, artificial neural network, classification, and regression trees.","/pubmed/24959000","Chu CM, Yao CT, Chang YT, Chou HL, Chou YC, Chen KH, Terng HJ, Huang CS, Lee CC, Su SL, Liu YC, Lin FG, Wetter T, Chang CW.","Dis Markers. 2014;2014:634123. doi: 10.1155/2014/634123. Epub 2014 May 19.","Dis Markers.  2014","PubMed","citation","PMID:24959000 | PMCID:PMC4055246","pubmed","24959000","create date:2014/06/25 | first author:Chu CM",
"Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.","/pubmed/24939732","Vella LJ, Andrews MC, Behren A, Cebon J, Woods K.","Expert Rev Clin Immunol. 2014 Aug;10(8):1107-23. doi: 10.1586/1744666X.2014.929943. Epub 2014 Jun 17. Review.","Expert Rev Clin Immunol.  2014","PubMed","citation","PMID:24939732","pubmed","24939732","create date:2014/06/19 | first author:Vella LJ",
"HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A.","/pubmed/24935000","Juengel E, Nowaz S, Makarevi J, Natsheh I, Werner I, Nelson K, Reiter M, Tsaur I, Mani J, Harder S, Bartsch G, Haferkamp A, Blaheta RA.","Mol Cancer. 2014 Jun 16;13:152. doi: 10.1186/1476-4598-13-152.","Mol Cancer.  2014","PubMed","citation","PMID:24935000 | PMCID:PMC4073177","pubmed","24935000","create date:2014/06/18 | first author:Juengel E",
"High-risk prostate cancer: a disease of genomic instability.","/pubmed/24931269","Tapia-Laliena MA, Korzeniewski N, Hohenfellner M, Duensing S.","Urol Oncol. 2014 Nov;32(8):1101-7. doi: 10.1016/j.urolonc.2014.02.005. Epub 2014 Jun 13. Review.","Urol Oncol.  2014","PubMed","citation","PMID:24931269","pubmed","24931269","create date:2014/06/17 | first author:Tapia-Laliena MA",
"Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines).","/pubmed/24895251","Li-Weber M.","Int J Cancer. 2015 Oct 15;137(8):1791-9. doi: 10.1002/ijc.29013. Epub 2014 Jun 11. Review.","Int J Cancer.  2015","PubMed","citation","PMID:24895251","pubmed","24895251","create date:2014/06/05 | first author:Li-Weber M",
"Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.","/pubmed/24880342","Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, Chatterjee N, Thorleifsson G, Sulem P, Liu G, Kaaks R, Henrion M, Kinnersley B, et al.","Nat Genet. 2014 Jul;46(7):736-41. doi: 10.1038/ng.3002. Epub 2014 Jun 1. Erratum in: Nat Genet. 2017 Mar 30;49(4):651. ","Nat Genet.  2014","PubMed","citation","PMID:24880342 | PMCID:PMC4074058","pubmed","24880342","create date:2014/06/02 | first author:Wang Y",
"Imaging the assembly, structure, and function of the nuclear pore inside cells.","/pubmed/24857732","Otsuka S, Szymborska A, Ellenberg J.","Methods Cell Biol. 2014;122:219-38. doi: 10.1016/B978-0-12-417160-2.00010-2.","Methods Cell Biol.  2014","PubMed","citation","PMID:24857732","pubmed","24857732","create date:2014/05/27 | first author:Otsuka S",
"Disialoganglioside GD3-synthase over expression inhibits survival and angiogenesis of pancreatic cancer cells through cell cycle arrest at S-phase and disruption of integrin-β1-mediated anchorage.","/pubmed/24842107","Mandal C, Sarkar S, Chatterjee U, Schwartz-Albiez R, Mandal C.","Int J Biochem Cell Biol. 2014 Aug;53:162-73. doi: 10.1016/j.biocel.2014.05.015. Epub 2014 May 16.","Int J Biochem Cell Biol.  2014","PubMed","citation","PMID:24842107","pubmed","24842107","create date:2014/05/21 | first author:Mandal C",
"Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.","/pubmed/24832787","Rack B, Schindlbeck C, Jückstock J, Andergassen U, Hepp P, Zwingers T, Friedl TW, Lorenz R, Tesch H, Fasching PA, Fehm T, Schneeweiss A, Lichtenegger W, Beckmann MW, Friese K, Pantel K, Janni W; SUCCESS Study Group..","J Natl Cancer Inst. 2014 May 15;106(5). pii: dju066. doi: 10.1093/jnci/dju066. Erratum in: J Natl Cancer Inst. 2014 Sep;106(9):doi/10.1093/jnci/dju273. ","J Natl Cancer Inst.  2014","PubMed","citation","PMID:24832787 | PMCID:PMC4112925","pubmed","24832787","create date:2014/05/17 | first author:Rack B",
"The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele.","/pubmed/24832469","Shetzer Y, Kagan S, Koifman G, Sarig R, Kogan-Sakin I, Charni M, Kaufman T, Zapatka M, Molchadsky A, Rivlin N, Dinowitz N, Levin S, Landan G, Goldstein I, Goldfinger N, Pe'er D, Radlwimmer B, Lichter P, Rotter V, Aloni-Grinstein R.","Cell Death Differ. 2014 Sep;21(9):1419-31. doi: 10.1038/cdd.2014.57. Epub 2014 May 16.","Cell Death Differ.  2014","PubMed","citation","PMID:24832469 | PMCID:PMC4131174","pubmed","24832469","create date:2014/05/17 | first author:Shetzer Y",
"Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production.","/pubmed/24777678","Pico de Coaña Y, Poschke I, Gentilcore G, Mao Y, Nyström M, Hansson J, Masucci GV, Kiessling R.","Cancer Immunol Res. 2013 Sep;1(3):158-62. doi: 10.1158/2326-6066.CIR-13-0016. Epub 2013 Aug 2. Erratum in: Cancer Immunol Res. 2013 Dec;1(6):438. ","Cancer Immunol Res.  2013","PubMed","citation","PMID:24777678","pubmed","24777678","create date:2014/04/30 | first author:Pico de Coaña Y",
"Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis.","/pubmed/24719358","Stremmel W, Staffer S, Wannhoff A, Pathil A, Chamulitrat W.","FASEB J. 2014 Jul;28(7):3159-70. doi: 10.1096/fj.14-249763. Epub 2014 Apr 9.","FASEB J.  2014","PubMed","citation","PMID:24719358","pubmed","24719358","create date:2014/04/11 | first author:Stremmel W",
"Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1.","/pubmed/24531536","Bageritz J, Puccio L, Piro RM, Hovestadt V, Phillips E, Pankert T, Lohr J, Herold-Mende C, Lichter P, Goidts V.","Cell Death Differ. 2014 Jun;21(6):929-40. doi: 10.1038/cdd.2014.12. Epub 2014 Feb 14.","Cell Death Differ.  2014","PubMed","citation","PMID:24531536 | PMCID:PMC4013511","pubmed","24531536","create date:2014/02/18 | first author:Bageritz J",
"HERG K+ channel-dependent apoptosis and cell cycle arrest in human glioblastoma cells.","/pubmed/24516604","Staudacher I, Jehle J, Staudacher K, Pledl HW, Lemke D, Schweizer PA, Becker R, Katus HA, Thomas D.","PLoS One. 2014 Feb 6;9(2):e88164. doi: 10.1371/journal.pone.0088164. eCollection 2014.","PLoS One.  2014","PubMed","citation","PMID:24516604 | PMCID:PMC3916397","pubmed","24516604","create date:2014/02/12 | first author:Staudacher I",
"3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions.","/pubmed/24480576","Wenzel C, Riefke B, Gründemann S, Krebs A, Christian S, Prinz F, Osterland M, Golfier S, Räse S, Ansari N, Esner M, Bickle M, Pampaloni F, Mattheyer C, Stelzer EH, Parczyk K, Prechtl S, Steigemann P.","Exp Cell Res. 2014 Apr 15;323(1):131-43. doi: 10.1016/j.yexcr.2014.01.017. Epub 2014 Jan 27.","Exp Cell Res.  2014","PubMed","citation","PMID:24480576","pubmed","24480576","create date:2014/02/01 | first author:Wenzel C",
"Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.","/pubmed/24373506","Chuang WY, Ströbel P, Bohlender-Willke AL, Rieckmann P, Nix W, Schalke B, Gold R, Opitz A, Klinker E, Inoue M, Müller-Hermelink HK, Saruhan-Direskeneli G, Bugert P, Willcox N, Marx A.","J Autoimmun. 2014 Aug;52:122-9. doi: 10.1016/j.jaut.2013.12.006. Epub 2013 Dec 24.","J Autoimmun.  2014","PubMed","citation","PMID:24373506","pubmed","24373506","create date:2014/01/01 | first author:Chuang WY",
"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.","/pubmed/24220271","Dawson MA, Gudgin EJ, Horton SJ, Giotopoulos G, Meduri E, Robson S, Cannizzaro E, Osaki H, Wiese M, Putwain S, Fong CY, Grove C, Craig J, Dittmann A, Lugo D, Jeffrey P, Drewes G, Lee K, Bullinger L, Prinjha RK, Kouzarides T, Vassiliou GS, et al.","Leukemia. 2014 Feb;28(2):311-20. doi: 10.1038/leu.2013.338. Epub 2013 Nov 13.","Leukemia.  2014","PubMed","citation","PMID:24220271 | PMCID:PMC3918873","pubmed","24220271","create date:2013/11/14 | first author:Dawson MA",
"The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints.","/pubmed/24150948","Neumann J, Boerries M, Köhler R, Giaisi M, Krammer PH, Busch H, Li-Weber M.","Int J Cancer. 2014 Apr 15;134(8):1991-2002. doi: 10.1002/ijc.28521. Epub 2013 Oct 21.","Int J Cancer.  2014","PubMed","citation","PMID:24150948","pubmed","24150948","create date:2013/10/24 | first author:Neumann J",
"Notch1-dependent regulation of p27 determines cell fate in colorectal cancer.","/pubmed/24141420","Hristova NR, Tagscherer KE, Fassl A, Kopitz J, Roth W.","Int J Oncol. 2013 Dec;43(6):1967-75. doi: 10.3892/ijo.2013.2140. Epub 2013 Oct 17.","Int J Oncol.  2013","PubMed","citation","PMID:24141420","pubmed","24141420","create date:2013/10/22 | first author:Hristova NR",
"The molecular chaperone Hsp90 is required for cell cycle exit in Drosophila melanogaster.","/pubmed/24086162","Bandura JL, Jiang H, Nickerson DW, Edgar BA.","PLoS Genet. 2013;9(9):e1003835. doi: 10.1371/journal.pgen.1003835. Epub 2013 Sep 26.","PLoS Genet.  2013","PubMed","citation","PMID:24086162 | PMCID:PMC3784567","pubmed","24086162","create date:2013/10/03 | first author:Bandura JL",
"Tumor-specific T-cell help is associated with improved survival in melanoma.","/pubmed/23864163","Woods K, Cebon J.","Clin Cancer Res. 2013 Aug 1;19(15):4021-3. doi: 10.1158/1078-0432.CCR-13-1349. Epub 2013 Jul 17.","Clin Cancer Res.  2013","PubMed","citation","PMID:23864163","pubmed","23864163","create date:2013/07/19 | first author:Woods K",
"Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan.","/pubmed/23806170","Rashid MU, Muhammad N, Faisal S, Amin A, Hamann U.","BMC Cancer. 2013 Jun 27;13:312. doi: 10.1186/1471-2407-13-312.","BMC Cancer.  2013","PubMed","citation","PMID:23806170 | PMCID:PMC3699428","pubmed","23806170","create date:2013/06/29 | first author:Rashid MU",
"Targeting ATR in DNA damage response and cancer therapeutics.","/pubmed/23583268","Fokas E, Prevo R, Hammond EM, Brunner TB, McKenna WG, Muschel RJ.","Cancer Treat Rev. 2014 Feb;40(1):109-17. doi: 10.1016/j.ctrv.2013.03.002. Epub 2013 Apr 11. Review.","Cancer Treat Rev.  2014","PubMed","citation","PMID:23583268","pubmed","23583268","create date:2013/04/16 | first author:Fokas E",
"Transcriptional cofactor TBLR1 controls lipid mobilization in white adipose tissue.","/pubmed/23499424","Rohm M, Sommerfeld A, Strzoda D, Jones A, Sijmonsma TP, Rudofsky G, Wolfrum C, Sticht C, Gretz N, Zeyda M, Leitner L, Nawroth PP, Stulnig TM, Berriel Diaz M, Vegiopoulos A, Herzig S.","Cell Metab. 2013 Apr 2;17(4):575-85. doi: 10.1016/j.cmet.2013.02.010. Epub 2013 Mar 14.","Cell Metab.  2013","PubMed","citation","PMID:23499424","pubmed","23499424","create date:2013/03/19 | first author:Rohm M",
"CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage.","/pubmed/23462184","Gogolin S, Ehemann V, Becker G, Brueckner LM, Dreidax D, Bannert S, Nolte I, Savelyeva L, Bell E, Westermann F.","Cell Cycle. 2013 Apr 1;12(7):1091-104. doi: 10.4161/cc.24091. Epub 2013 Mar 5.","Cell Cycle.  2013","PubMed","citation","PMID:23462184 | PMCID:PMC3646865","pubmed","23462184","create date:2013/03/07 | first author:Gogolin S",
"Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.","/pubmed/23343716","Dreidax D, Gogolin S, Schroeder C, Muth D, Brueckner LM, Hess EM, Zapatka M, Theißen J, Fischer M, Ehemann V, Schwab M, Savelyeva L, Westermann F.","Hum Mol Genet. 2013 May 1;22(9):1735-45. doi: 10.1093/hmg/ddt020. Epub 2013 Jan 23.","Hum Mol Genet.  2013","PubMed","citation","PMID:23343716","pubmed","23343716","create date:2013/01/25 | first author:Dreidax D",
"HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis.","/pubmed/23169233","Hofmann TG, Glas C, Bitomsky N.","Bioessays. 2013 Jan;35(1):55-64. doi: 10.1002/bies.201200060. Epub 2012 Nov 21. Review.","Bioessays.  2013","PubMed","citation","PMID:23169233","pubmed","23169233","create date:2012/11/22 | first author:Hofmann TG",
"Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.","/pubmed/23055533","Altmann A, Markert A, Askoxylakis V, Schöning T, Jesenofsky R, Eisenhut M, Haberkorn U.","J Nucl Med. 2012 Nov;53(11):1764-71. doi: 10.2967/jnumed.111.101295. Epub 2012 Oct 10.","J Nucl Med.  2012","PubMed","citation","PMID:23055533","pubmed","23055533","create date:2012/10/12 | first author:Altmann A",
"Overexpression of EVI1 interferes with cytokinesis and leads to accumulation of cells with supernumerary centrosomes in G0/1 phase.","/pubmed/22894935","Karakaya K, Herbst F, Ball C, Glimm H, Krämer A, Löffler H.","Cell Cycle. 2012 Sep 15;11(18):3492-503. doi: 10.4161/cc.21801. Epub 2012 Aug 16.","Cell Cycle.  2012","PubMed","citation","PMID:22894935 | PMCID:PMC3467026","pubmed","22894935","create date:2012/08/17 | first author:Karakaya K",
"A killer promoting survival: p53 as a selective means to avoid side effects of chemotherapy.","/pubmed/22622088","Kranz D, Dobbelstein M.","Cell Cycle. 2012 Jun 1;11(11):2053-4. doi: 10.4161/cc.20698. Epub 2012 Jun 1. No abstract available. ","Cell Cycle.  2012","PubMed","citation","PMID:22622088","pubmed","22622088","create date:2012/05/25 | first author:Kranz D",
"The endoperoxide ascaridol shows strong differential cytotoxicity in nucleotide excision repair-deficient cells.","/pubmed/22280988","Abbasi R, Efferth T, Kuhmann C, Opatz T, Hao X, Popanda O, Schmezer P.","Toxicol Appl Pharmacol. 2012 Mar 15;259(3):302-10. doi: 10.1016/j.taap.2012.01.006. Epub 2012 Jan 17.","Toxicol Appl Pharmacol.  2012","PubMed","citation","PMID:22280988","pubmed","22280988","create date:2012/01/28 | first author:Abbasi R",
"RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.","/pubmed/22266866","Thaler S, Schmidt M, Schad A, Sleeman JP.","Oncogene. 2012 Nov 22;31(47):4912-22. doi: 10.1038/onc.2011.658. Epub 2012 Jan 23.","Oncogene.  2012","PubMed","citation","PMID:22266866","pubmed","22266866","create date:2012/01/24 | first author:Thaler S",
"The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines.","/pubmed/22170433","Glienke W, Maute L, Wicht J, Bergmann L.","Tumour Biol. 2012 Jun;33(3):757-65. doi: 10.1007/s13277-011-0290-2. Epub 2011 Dec 15.","Tumour Biol.  2012","PubMed","citation","PMID:22170433","pubmed","22170433","create date:2011/12/16 | first author:Glienke W",
"The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis.","/pubmed/22147553","Augustin I, Goidts V, Bongers A, Kerr G, Vollert G, Radlwimmer B, Hartmann C, Herold-Mende C, Reifenberger G, von Deimling A, Boutros M.","EMBO Mol Med. 2012 Jan;4(1):38-51. doi: 10.1002/emmm.201100186. Epub 2011 Dec 7.","EMBO Mol Med.  2012","PubMed","citation","PMID:22147553 | PMCID:PMC3306557","pubmed","22147553","create date:2011/12/08 | first author:Augustin I",
"[Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1)].","/pubmed/21894557","Sertel S, Eichhorn T, Plinkert PK, Efferth T.","HNO. 2011 Dec;59(12):1203-8. doi: 10.1007/s00106-011-2274-3. German. ","HNO.  2011","PubMed","citation","PMID:21894557","pubmed","21894557","create date:2011/09/07 | first author:Sertel S",
"Fly meets yeast: checking the correct orientation of cell division.","/pubmed/21705221","Pereira G, Yamashita YM.","Trends Cell Biol. 2011 Sep;21(9):526-33. doi: 10.1016/j.tcb.2011.05.004. Epub 2011 Jun 24. Review.","Trends Cell Biol.  2011","PubMed","citation","PMID:21705221 | PMCID:PMC3164393","pubmed","21705221","create date:2011/06/28 | first author:Pereira G",
"[Initial experience with transoral robotic surgery using the da Vinci® surgical system].","/pubmed/21424364","Simon C, El-Baba B, Albrecht T, Holsinger FC, Plinkert PK.","HNO. 2011 Mar;59(3):261-5. doi: 10.1007/s00106-010-2254-z. German. ","HNO.  2011","PubMed","citation","PMID:21424364","pubmed","21424364","create date:2011/03/23 | first author:Simon C",
"Mitochondrial translocation of oxidized cofilin induces caspase-independent necrotic-like programmed cell death of T cells.","/pubmed/21364663","Wabnitz GH, Goursot C, Jahraus B, Kirchgessner H, Hellwig A, Klemke M, Konstandin MH, Samstag Y.","Cell Death Dis. 2010 Jul 22;1:e58. doi: 10.1038/cddis.2010.36.","Cell Death Dis.  2010","PubMed","citation","PMID:21364663 | PMCID:PMC3032559","pubmed","21364663","create date:2011/03/03 | first author:Wabnitz GH",
"The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.","/pubmed/21167409","Felcht M, Booken N, Stroebel P, Goerdt S, Klemke CD.","J Am Acad Dermatol. 2011 Jan;64(1):135-43, 143.e1-4. doi: 10.1016/j.jaad.2009.12.062.","J Am Acad Dermatol.  2011","PubMed","citation","PMID:21167409","pubmed","21167409","create date:2010/12/21 | first author:Felcht M",
"A CRM1-dependent nuclear export pathway is involved in the regulation of MutLα subcellular localization.","/pubmed/21064154","Brieger A, Adam R, Passmann S, Plotz G, Zeuzem S, Trojan J.","Genes Chromosomes Cancer. 2011 Feb;50(2):59-70. doi: 10.1002/gcc.20832.","Genes Chromosomes Cancer.  2011","PubMed","citation","PMID:21064154","pubmed","21064154","create date:2010/11/11 | first author:Brieger A",
"Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806.","/pubmed/20484439","Lee FT, O'Keefe GJ, Gan HK, Mountain AJ, Jones GR, Saunder TH, Sagona J, Rigopoulos A, Smyth FE, Johns TG, Govindan SV, Goldenberg DM, Old LJ, Scott AM.","J Nucl Med. 2010 Jun;51(6):967-72. doi: 10.2967/jnumed.109.068395. Epub 2010 May 19.","J Nucl Med.  2010","PubMed","citation","PMID:20484439","pubmed","20484439","create date:2010/05/21 | first author:Lee FT",
"Vertebrate cells genetically deficient for Cdc14A or Cdc14B retain DNA damage checkpoint proficiency but are impaired in DNA repair.","/pubmed/20479464","Mocciaro A, Berdougo E, Zeng K, Black E, Vagnarelli P, Earnshaw W, Gillespie D, Jallepalli P, Schiebel E.","J Cell Biol. 2010 May 17;189(4):631-9. doi: 10.1083/jcb.200910057.","J Cell Biol.  2010","PubMed","citation","PMID:20479464 | PMCID:PMC2872905","pubmed","20479464","create date:2010/05/19 | first author:Mocciaro A",
"Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells.","/pubmed/20455200","Pinto-Garcia L, Efferth T, Torres A, Hoheisel JD, Youns M.","Planta Med. 2010 Aug;76(11):1155-61. doi: 10.1055/s-0030-1249931. Epub 2010 May 7.","Planta Med.  2010","PubMed","citation","PMID:20455200","pubmed","20455200","create date:2010/05/11 | first author:Pinto-Garcia L",
"Inhibition of epidermal growth factor receptor-overexpressing cancer cells by camptothecin, 20-(N,N-diethyl) glycinate.","/pubmed/20206609","Konkimalla VB, Efferth T.","Biochem Pharmacol. 2010 Jul 1;80(1):39-49. doi: 10.1016/j.bcp.2010.02.022. Epub 2010 Mar 4.","Biochem Pharmacol.  2010","PubMed","citation","PMID:20206609","pubmed","20206609","create date:2010/03/09 | first author:Konkimalla VB",
"68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours.","/pubmed/20157706","Eder M, Knackmuss S, Le Gall F, Reusch U, Rybin V, Little M, Haberkorn U, Mier W, Eisenhut M.","Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1397-407. doi: 10.1007/s00259-010-1392-6. Epub 2010 Feb 16.","Eur J Nucl Med Mol Imaging.  2010","PubMed","citation","PMID:20157706","pubmed","20157706","create date:2010/02/17 | first author:Eder M",
"Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?","/pubmed/19584260","Karpel-Massler G, Schmidt U, Unterberg A, Halatsch ME.","Mol Cancer Res. 2009 Jul;7(7):1000-12. doi: 10.1158/1541-7786.MCR-08-0479. Epub 2009 Jul 7. Review.","Mol Cancer Res.  2009","PubMed","citation","PMID:19584260","pubmed","19584260","create date:2009/07/09 | first author:Karpel-Massler G",
"Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.","/pubmed/18636150","Wente MN, Gaida MM, Mayer C, Michalski CW, Haag N, Giese T, Felix K, Bergmann F, Giese NA, Friess H.","Int J Oncol. 2008 Aug;33(2):297-308.","Int J Oncol.  2008","PubMed","citation","PMID:18636150","pubmed","18636150","create date:2008/07/19 | first author:Wente MN",
"Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.","/pubmed/18536714","Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J, Hofmann TG.","Nat Cell Biol. 2008 Jul;10(7):812-24. doi: 10.1038/ncb1743. Epub 2008 Jun 8.","Nat Cell Biol.  2008","PubMed","citation","PMID:18536714","pubmed","18536714","create date:2008/06/10 | first author:Winter M",
"Immunotherapy of pancreatic carcinoma.","/pubmed/18474022","Märten A.","Rev Recent Clin Trials. 2008 May;3(2):121-5. Review.","Rev Recent Clin Trials.  2008","PubMed","citation","PMID:18474022","pubmed","18474022","create date:2008/05/14 | first author:Märten A",
"Repair and translesion DNA polymerases as anticancer drug targets.","/pubmed/18473728","Maga G, Hübscher U.","Anticancer Agents Med Chem. 2008 May;8(4):431-47. Review.","Anticancer Agents Med Chem.  2008","PubMed","citation","PMID:18473728","pubmed","18473728","create date:2008/05/14 | first author:Maga G",
"[Adjuvant simultaneous mistletoe chemotherapy in breast cancer--influence on immunological parameters, quality of life and tolerability].","/pubmed/18334811","Loewe-Mesch A, Kuehn JJ, Borho K, Abel U, Bauer C, Gerhard I, Schneeweiss A, Sohn C, Strowitzki T, v Hagens C.","Forsch Komplementmed. 2008 Feb;15(1):22-30. doi: 10.1159/000112860. German. ","Forsch Komplementmed.  2008","PubMed","citation","PMID:18334811","pubmed","18334811","create date:2008/03/13 | first author:Loewe-Mesch A",
"The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies.","/pubmed/17952127","Gast D, Riedle S, Issa Y, Pfeifer M, Beckhove P, Sanderson MP, Arlt M, Moldenhauer G, Fogel M, Krüger A, Altevogt P.","Oncogene. 2008 Feb 21;27(9):1281-9. Epub 2007 Oct 22.","Oncogene.  2008","PubMed","citation","PMID:17952127","pubmed","17952127","create date:2007/10/24 | first author:Gast D",
"Role of PP2Calpha in cell growth, in radio- and chemosensitivity, and in tumorigenicity.","/pubmed/17941990","Lammers T, Peschke P, Ehemann V, Debus J, Slobodin B, Lavi S, Huber P.","Mol Cancer. 2007 Oct 17;6:65.","Mol Cancer.  2007","PubMed","citation","PMID:17941990 | PMCID:PMC2100065","pubmed","17941990","create date:2007/10/19 | first author:Lammers T",
"Suppression of polyploidy by the BRCA2 protein.","/pubmed/17686574","Sagulenko E, Savelyeva L, Ehemann V, Sagulenko V, Hofmann W, Arnold K, Claas A, Scherneck S, Schwab M.","Cancer Lett. 2007 Nov 8;257(1):65-72. Epub 2007 Aug 7.","Cancer Lett.  2007","PubMed","citation","PMID:17686574","pubmed","17686574","create date:2007/08/10 | first author:Sagulenko E",
"Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM.","/pubmed/17332358","Dauth I, Krüger J, Hofmann TG.","Cancer Res. 2007 Mar 1;67(5):2274-9.","Cancer Res.  2007","PubMed","citation","PMID:17332358","pubmed","17332358","create date:2007/03/03 | first author:Dauth I",
"Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer.","/pubmed/17317820","Maurer GD, Leupold JH, Schewe DM, Biller T, Kates RE, Hornung HM, Lau-Werner U, Post S, Allgayer H.","Clin Cancer Res. 2007 Feb 15;13(4):1123-32.","Clin Cancer Res.  2007","PubMed","citation","PMID:17317820","pubmed","17317820","create date:2007/02/24 | first author:Maurer GD",
"Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake.","/pubmed/16794736","Loeffler M, Krüger JA, Niethammer AG, Reisfeld RA.","J Clin Invest. 2006 Jul;116(7):1955-62. Epub 2006 Jun 22. Erratum in: J Clin Invest. 2009 Feb;119(2):421. ","J Clin Invest.  2006","PubMed","citation","PMID:16794736 | PMCID:PMC1481657","pubmed","16794736","create date:2006/06/24 | first author:Loeffler M",
"Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours.","/pubmed/16488082","Halatsch ME, Schmidt U, Behnke-Mursch J, Unterberg A, Wirtz CR.","Cancer Treat Rev. 2006 Apr;32(2):74-89. Epub 2006 Feb 20. Review.","Cancer Treat Rev.  2006","PubMed","citation","PMID:16488082","pubmed","16488082","create date:2006/02/21 | first author:Halatsch ME",
"Alveolar macrophage function is altered in patients with lung cancer.","/pubmed/16412062","Pouniotis DS, Plebanski M, Apostolopoulos V, McDonald CF.","Clin Exp Immunol. 2006 Feb;143(2):363-72.","Clin Exp Immunol.  2006","PubMed","citation","PMID:16412062 | PMCID:PMC1809587","pubmed","16412062","create date:2006/01/18 | first author:Pouniotis DS",
"Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients.","/pubmed/16331344","Tan XL, Popanda O, Ambrosone CB, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J.","Breast Cancer Res Treat. 2006 Jun;97(3):255-62. Epub 2005 Dec 6.","Breast Cancer Res Treat.  2006","PubMed","citation","PMID:16331344","pubmed","16331344","create date:2005/12/07 | first author:Tan XL",
"German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer.","/pubmed/16239104","Rashid MU, Jakubowska A, Justenhoven C, Harth V, Pesch B, Baisch C, Pierl CB, Brüning T, Ko Y, Benner A, Wichmann HE, Brauch H, Hamann U; GENICA Network..","Eur J Cancer. 2005 Dec;41(18):2896-903. Epub 2005 Oct 18.","Eur J Cancer.  2005","PubMed","citation","PMID:16239104","pubmed","16239104","create date:2005/10/22 | first author:Rashid MU",
"Synthesis of junctional proteins in metastasizing colon cancer cells.","/pubmed/15819418","Kartenbeck J, Haselmann U, Gassler N.","Eur J Cell Biol. 2005 Mar;84(2-3):417-30.","Eur J Cell Biol.  2005","PubMed","citation","PMID:15819418","pubmed","15819418","create date:2005/04/12 | first author:Kartenbeck J",
"Comparative analysis of cell populations involved in the proliferative and inflammatory processes in diffuse and localised pigmented villonodular synovitis.","/pubmed/15168328","Berger I, Ehemann V, Helmchen B, Penzel R, Weckauf H.","Histol Histopathol. 2004 Jul;19(3):687-92. doi: 10.14670/HH-19.687.","Histol Histopathol.  2004","PubMed","citation","PMID:15168328","pubmed","15168328","create date:2004/05/29 | first author:Berger I",
"Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.","/pubmed/15073049","Guweidhi A, Kleeff J, Giese N, El Fitori J, Ketterer K, Giese T, Büchler MW, Korc M, Friess H.","Carcinogenesis. 2004 Sep;25(9):1575-85. Epub 2004 Apr 8.","Carcinogenesis.  2004","PubMed","citation","PMID:15073049","pubmed","15073049","create date:2004/04/10 | first author:Guweidhi A",
"Vectors based on autonomous parvoviruses: novel tools to treat cancer?","/pubmed/14978762","Cornelis JJ, Salomé N, Dinsart C, Rommelaere J.","J Gene Med. 2004 Feb;6 Suppl 1:S193-202. Review.","J Gene Med.  2004","PubMed","citation","PMID:14978762","pubmed","14978762","create date:2004/02/24 | first author:Cornelis JJ",
"Immuno-PET for tumor targeting.","/pubmed/12902419","Lee FT, Scott AM.","J Nucl Med. 2003 Aug;44(8):1282-3. No abstract available. ","J Nucl Med.  2003","PubMed","citation","PMID:12902419","pubmed","12902419","create date:2003/08/07 | first author:Lee FT",
"Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint.","/pubmed/12759351","Hassepass I, Voit R, Hoffmann I.","J Biol Chem. 2003 Aug 8;278(32):29824-9. Epub 2003 May 20.","J Biol Chem.  2003","PubMed","citation","PMID:12759351","pubmed","12759351","create date:2003/05/22 | first author:Hassepass I",
"Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking.","/pubmed/12507931","Godschalk R, Nair J, van Schooten FJ, Risch A, Drings P, Kayser K, Dienemann H, Bartsch H.","Carcinogenesis. 2002 Dec;23(12):2081-6.","Carcinogenesis.  2002","PubMed","citation","PMID:12507931","pubmed","12507931","create date:2003/01/01 | first author:Godschalk R",
"Telerobotic minimally invasive procedures in urology--laparoscopic radical prostatectomy.","/pubmed/12384861","Binder J, Kramer W.","Surg Technol Int. 2002 Sep;10:45-8.","Surg Technol Int.  2002","PubMed","citation","PMID:12384861","pubmed","12384861","create date:2002/10/18 | first author:Binder J",
"Primary colorectal carcinomas and their intrapulmonary metastases: clinical, glyco-, immuno- and lectin histochemical, nuclear and syntactic structure analysis with emphasis on correlation with period of occurrence of metastases and survival.","/pubmed/12193204","Kayser K, Zink S, André S, Schüring MP, Hecker E, Klar E, Bovin NV, Kaltner H, Gabius HJ.","APMIS. 2002 Jun;110(6):435-46.","APMIS.  2002","PubMed","citation","PMID:12193204","pubmed","12193204","create date:2002/08/24 | first author:Kayser K",
"[Prognostic value of antibodies against p53 in patients with oral squamous cell carcinoma--five years survival rate].","/pubmed/12001023","Hofele C, Schwager-Schmitt M, Volkmann M.","Laryngorhinootologie. 2002 May;81(5):342-5. German. ","Laryngorhinootologie.  2002","PubMed","citation","PMID:12001023","pubmed","12001023","create date:2002/05/10 | first author:Hofele C",
"Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols.","/pubmed/11895473","Lindner M, Schirrmacher V.","Eur J Clin Invest. 2002 Mar;32(3):207-17.","Eur J Clin Invest.  2002","PubMed","citation","PMID:11895473","pubmed","11895473","create date:2002/03/16 | first author:Lindner M",
"Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.","/pubmed/11337573","Lee FT, Hall C, Rigopoulos A, Zweit J, Pathmaraj K, O'Keefe GJ, Smyth FE, Welt S, Old LJ, Scott AM.","J Nucl Med. 2001 May;42(5):764-9.","J Nucl Med.  2001","PubMed","citation","PMID:11337573","pubmed","11337573","create date:2001/05/05 | first author:Lee FT",
"Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias.","/pubmed/11248330","Hofmann WK, Miller CW, Tsukasaki K, Tavor S, Ikezoe T, Hoelzer D, Takeuchi S, Koeffler HP.","Leuk Res. 2001 Apr;25(4):333-8.","Leuk Res.  2001","PubMed","citation","PMID:11248330","pubmed","11248330","create date:2001/03/15 | first author:Hofmann WK",
"Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts.","/pubmed/10822378","Alunni-Fabbroni M, Littlewood T, Deleu L, Caldeira S, Giarrè M, Dell' Orco M, Tommasino M.","Oncogene. 2000 May 4;19(19):2277-85.","Oncogene.  2000","PubMed","citation","PMID:10822378","pubmed","10822378","create date:2000/05/24 | first author:Alunni-Fabbroni M",
"Association of concentration of asbestos and asbestos-like fibers with the patient's survival and the binding capacity of lung parenchyma to galectin-1 and natural alpha-galactoside- and alpha-mannoside-binding immunoglobulin G subfractions from human serum.","/pubmed/10707363","Kayser K, Seemann C, André S, Kugler C, Becker C, Dong X, Kaltner H, Gabius HJ.","Pathol Res Pract. 2000;196(2):81-7.","Pathol Res Pract.  2000","PubMed","citation","PMID:10707363","pubmed","10707363","create date:2000/03/09 | first author:Kayser K",
"Expression of p16 and lack of pRB in primary small cell lung cancer.","/pubmed/10547597","Yuan J, Knorr J, Altmannsberger M, Goeckenjan G, Ahr A, Scharl A, Strebhardt K.","J Pathol. 1999 Nov;189(3):358-62.","J Pathol.  1999","PubMed","citation","PMID:10547597","pubmed","10547597","create date:1999/11/05 | first author:Yuan J",
"Spontaneous T cell responses to melanoma differentiation antigens from melanoma patients and healthy subjects.","/pubmed/9875671","Chen Q, Jackson H, Gibbs P, Davis ID, Trapani J, Cebon J.","Cancer Immunol Immunother. 1998 Dec;47(4):191-7.","Cancer Immunol Immunother.  1998","PubMed","citation","PMID:9875671","pubmed","9875671","create date:1999/01/06 | first author:Chen Q",
"Identification of four genes in endothelial cells whose expression is affected by tumor cells and host immune status--a study in ex vivo-isolated endothelial cells.","/pubmed/9787179","Liliensiek B, Rocha M, Umansky V, Benner A, Lin J, Ziegler R, Nawroth PP, Schirrmacher V.","Blood. 1998 Nov 1;92(9):3394-404.","Blood.  1998","PubMed","citation","PMID:9787179","pubmed","9787179","create date:1998/10/27 | first author:Liliensiek B",
"Immuno-isolation of highly purified peroxisomes using magnetic beads and continuous immunomagnetic sorting.","/pubmed/9662184","Lüers GH, Hartig R, Mohr H, Hausmann M, Fahimi HD, Cremer C, Völkl A.","Electrophoresis. 1998 Jun;19(7):1205-10.","Electrophoresis.  1998","PubMed","citation","PMID:9662184","pubmed","9662184","create date:1998/07/14 | first author:Lüers GH",
"Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinoma.","/pubmed/9645354","Volm M, Koomägi R, Rittgen W.","Int J Cancer. 1998 Jun 19;79(3):294-9.","Int J Cancer.  1998","PubMed","citation","PMID:9645354","pubmed","9645354","create date:1998/06/30 | first author:Volm M",
"The human papillomavirus type 16 E7 protein is associated with the nucleolus in mammalian and yeast cells.","/pubmed/9121762","Zatsepina O, Braspenning J, Robberson D, Hajibagheri MA, Blight KJ, Ely S, Hibma M, Spitkovsky D, Trendelenburg M, Crawford L, Tommasino M.","Oncogene. 1997 Mar 13;14(10):1137-45.","Oncogene.  1997","PubMed","citation","PMID:9121762","pubmed","9121762","create date:1997/03/13 | first author:Zatsepina O",
"[Brain metastases in renal cell carcinoma. Results of treatment and prognosis].","/pubmed/9199038","Pomer S, Klopp M, Steiner HH, Brkovic D, Staehler G, Cabillin-Engenhart R.","Urologe A. 1997 Mar;36(2):117-25. German. ","Urologe A.  1997","PubMed","citation","PMID:9199038","pubmed","9199038","create date:1997/03/01 | first author:Pomer S",
"A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.","/pubmed/9034168","Bork P, Hofmann K, Bucher P, Neuwald AF, Altschul SF, Koonin EV.","FASEB J. 1997 Jan;11(1):68-76.","FASEB J.  1997","PubMed","citation","PMID:9034168","pubmed","9034168","create date:1997/01/01 | first author:Bork P",
"Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically.","/pubmed/8888802","Kayser K, Kayser C, Rahn W, Bovin NV, Gabius HJ.","J Surg Oncol. 1996 Oct;63(2):99-106.","J Surg Oncol.  1996","PubMed","citation","PMID:8888802","pubmed","8888802","create date:1996/10/01 | first author:Kayser K",
"[Repetitive immuno-embolization of inoperative liver metastases of renal cell carcinoma. Method characterization and preliminary results].","/pubmed/8928360","Pomer S, Brado M, Roeren T, Brkovic D, Wiesel M, Staehler G, Keilholz U.","Urologe A. 1996 Jul;35(4):310-4. German. ","Urologe A.  1996","PubMed","citation","PMID:8928360","pubmed","8928360","create date:1996/07/01 | first author:Pomer S",
"Liver endothelial cells participate in T-cell-dependent host resistance to lymphoma metastasis by production of nitric oxide in vivo.","/pubmed/7591240","Rocha M, Krüger A, Van Rooijen N, Schirrmacher V, Umansky V.","Int J Cancer. 1995 Nov 3;63(3):405-11.","Int J Cancer.  1995","PubMed","citation","PMID:7591240","pubmed","7591240","create date:1995/11/03 | first author:Rocha M",
"Biotherapy of cancer. Perspectives of immunotherapy and gene therapy.","/pubmed/7642685","Schirrmacher V.","J Cancer Res Clin Oncol. 1995;121(8):443-51. Review.","J Cancer Res Clin Oncol.  1995","PubMed","citation","PMID:7642685","pubmed","7642685","create date:1995/01/01 | first author:Schirrmacher V",
"[Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure].","/pubmed/7989226","Kiefer J, Baum RP, Knecht R, Hertel A, Niesen A, von Ilberg C, Hör G.","HNO. 1994 Sep;42(9):546-52. German. ","HNO.  1994","PubMed","citation","PMID:7989226","pubmed","7989226","create date:1994/09/01 | first author:Kiefer J",
"Influence of cisplatinum and 5-fluorouracil on the oral mucosa.","/pubmed/7920167","Zöller J, Flentje M, Born IA, Osswald H.","Eur J Cancer B Oral Oncol. 1994 May;30B(3):200-3.","Eur J Cancer B Oral Oncol.  1994","PubMed","citation","PMID:7920167","pubmed","7920167","create date:1994/05/01 | first author:Zöller J",
"CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest.","/pubmed/8125258","Barone MV, Crozat A, Tabaee A, Philipson L, Ron D.","Genes Dev. 1994 Feb 15;8(4):453-64.","Genes Dev.  1994","PubMed","citation","PMID:8125258","pubmed","8125258","create date:1994/02/15 | first author:Barone MV",
"Free cholesterol induces activation but not translocation of protein kinase C in cultured ascites tumour cells.","/pubmed/8086283","Haeffner EW, Wittmann U.","Cell Signal. 1994 Feb;6(2):201-7.","Cell Signal.  1994","PubMed","citation","PMID:8086283","pubmed","8086283","create date:1994/02/01 | first author:Haeffner EW",
"Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients.","/pubmed/7524466","Nindl I, Benitez-Bribiesca L, Berumen J, Farmanara N, Fisher S, Gross G, Lopez-Carillo L, Müller M, Tommasino M, Vazquez-Curiel A, et al.","Arch Virol. 1994;137(3-4):341-53.","Arch Virol.  1994","PubMed","citation","PMID:7524466","pubmed","7524466","create date:1994/01/01 | first author:Nindl I",
"Immuno-biochemical assay for determination of nuclear steroid receptors during tamoxifen therapy.","/pubmed/8491762","Vering A, Vockel A, Stegmüller M, Bender HG.","J Cancer Res Clin Oncol. 1993;119(7):415-20.","J Cancer Res Clin Oncol.  1993","PubMed","citation","PMID:8491762","pubmed","8491762","create date:1993/01/01 | first author:Vering A",
"Establishment of an enzyme-linked immuno-sorbent assay for urinary trypsin inhibitor by using a monoclonal antibody.","/pubmed/1719031","Trefz G, Streit B, Justus CW, Ebert W, Kramer MD.","J Immunoassay. 1991;12(3):347-69.","J Immunoassay.  1991","PubMed","citation","PMID:1719031","pubmed","1719031","create date:1991/01/01 | first author:Trefz G",
"[Immunologic identification of undetectable neuroblastoma cells by current cytohistological studies of bone marrow samples].","/pubmed/2685699","Gussetis ES, Ebener U, Wehner S, Kornhuber B.","Onkologie. 1989 Aug;12 Suppl 1:9-11. German. ","Onkologie.  1989","PubMed","citation","PMID:2685699","pubmed","2685699","create date:1989/08/01 | first author:Gussetis ES",
"[Lipoma of the uterus. Clinical aspects and pathology of a rare disease entity].","/pubmed/2676696","Falk S, Jantzen H, Stutte HJ.","Geburtshilfe Frauenheilkd. 1989 Aug;49(8):762-4. German. ","Geburtshilfe Frauenheilkd.  1989","PubMed","citation","PMID:2676696","pubmed","2676696","create date:1989/08/01 | first author:Falk S",
"Hamartomas of the spleen: a study of 20 biopsy cases.","/pubmed/2759557","Falk S, Stutte HJ.","Histopathology. 1989 Jun;14(6):603-12.","Histopathology.  1989","PubMed","citation","PMID:2759557","pubmed","2759557","create date:1989/06/01 | first author:Falk S",
"Intrathoracic manifestations of disseminated prostatic adenocarcinoma.","/pubmed/2602602","Mestitz H, Pierce RJ, Holmes PW.","Respir Med. 1989 Mar;83(2):161-6.","Respir Med.  1989","PubMed","citation","PMID:2602602","pubmed","2602602","create date:1989/03/01 | first author:Mestitz H",
"Histogenesis of Kaposi's sarcoma associated with AIDS: a histologic, immunohistochemical and enzyme histochemical study.","/pubmed/3684778","Hashimoto H, Müller H, Falk S, Stutte HJ.","Pathol Res Pract. 1987 Oct;182(5):658-68.","Pathol Res Pract.  1987","PubMed","citation","PMID:3684778","pubmed","3684778","create date:1987/10/01 | first author:Hashimoto H",
"Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.","/pubmed/2445089","Dunzendorfer U, Jurincic C.","Urol Int. 1987;42(4):248-53.","Urol Int.  1987","PubMed","citation","PMID:2445089","pubmed","2445089","create date:1987/01/01 | first author:Dunzendorfer U",
"[Use of fibrin glue in pronounced Dupuytren contracture].","/pubmed/3874125","Eide E, Jurgeit H.","Handchir Mikrochir Plast Chir. 1985 May;17(3):145-6. German. ","Handchir Mikrochir Plast Chir.  1985","PubMed","citation","PMID:3874125","pubmed","3874125","create date:1985/05/01 | first author:Eide E",
